The Membrane Fusion Activities of Native and Reconstituted Mumps and Sendai Viruses by Di Simone, Christopher
THE MEMBRANE FUSION ACTIVITIES OF NATIVE AND 
RECONSTITUTED MUMPS AND SENDAI VIRUSES 
Thesis by 
Christopher Di Simone 
In Partial Fulfillment of the Requirements for the 
Degree of Doctor of Philosophy 
California Institute of Technology 
Pasadena, California 
1992 
(Defended October 17, 1991) 
ii. 
Acknowledgements 
A number of people have been helpful in providing knowledge for me 
to complete this thesis and in collaborating on some of the projects. I am 
grateful to them all. The mumps project was initiated with advice from Fred 
Server and Neal Wax ham, who also sent me virus with which to start the 
project. Viral preparation and plaque assays were accomplished in the 
research labs of John Zaia at the City of Hope Hospital Pediatric Department. 
John was very supportive and encouraging. Delilah Stephans was also 
extremely helpful and instructive in helping me learn the techniques for 
working with virus. Caroline Lowry upheld Delilah's high standards after 
Delilah departed for medical school. Collaborative experiments were also 
conducted at City of Hope with Sean Sullivan and Roy Chang, who were 
working with John Rossi on the delivery of ribozyme to cells. As an 
undergraduate SURF for two summers, Alex Wein provided an extra hand in 
carrying out experiments. David Baselt was very helpful at the end of my 
project in showing me how a real programmer with a real computer could 
reduce my timeload for kinetic fitting to seconds rather than hours. 
At a time when the mumps project was not going well, Tom 
Amatruda contacted our group on a collaboration on transfection of HL60 
cells which provided me with something exciting to work on. Although we 
did not accomplish our goal, we found out a few interesting things. Tom's 
expertise in cloning and transfection provided us with an opportunity to test 
the reconstituted virus as drug delivery vehicles. 
John has served as a helpful, supportive, and encouraging advisor. 
Looking back on my decision to join the JDB group, I now know that it was 
iii. 
the best decision I've made at Caltech. I enjoyed my time at Cal tech a great 
deal and learned a lot about a variety of subjects. 
Regardless of how interesting or exciting my research project was, if my 
work environment had been hell, grad school would have been no fun. The 
people in our lab for the last five years have been really great in both scientific 
and social interactions. Both the old guard, Tracy Handel, Steve Novick, Ray 
Goodrich, John Kramer, Bob Driscoll and Shenda Baker, and the new guard, 
Mitsuko Fujiwara, Mike Youngquist, Roxanne Male, Kyoung Joon Oh, Steve 
Clark, and David Baselt, have all been very humorous and supportive (long 
live the Triumvirate) . Wilton Vannier has served as a lab sage with 
information about everything immunological and has convinced me more 
than anyone else I've met that one can be personally happy in science. 
The people out of my lab have also been very supportive. The people 
at Cal tech have been much more interesting than I anticipated before I came 
here (yes, I was prejudiced) . Tom Brown, Chris Sipes, David Long, Dom 
McGrath, John Kellamis and Jon Vernick have all been good friends. My 
parents and sisters have been ever so supportive. Without Paul Hobe and 
David Draper, my high school and college chemistry mentors, I would never 
have come to Caltech. The best part of my experience here at Caltech is that I 
met Deborah here. She has shown me everything that is beautiful about 
living. 
Thanks to you, whoever you are, for reading my thesis. 
iv. 
Abstract 
The structure and activities of whole and reconstituted Sendai and mumps 
viruses were examined using a number of physical and biological techniques: 
electron microscopy, photon correlation spectroscopy, perturbed angular 
correlation spectroscopy, gel electrophoresis, hemagglutination assays, plaque 
assays, fluorescence microscopy and fluorescent assays of membrane fusion. 
The fluorescent probe octadecyl rhodamine (RIB) was found to have a 
proximal transfer behavior which reduced usage of the probe as a membrane 
fusion indicator to short time periods. Simple bireactant and mass action 
kinetic models were sufficent to fit the data provided by the fluorescent assays 
on viral fusion with cell membranes. The reconstitution of mumps virus 
was optimized by using the detergent Triton X-IOO. Reconstituted virus 
envelopes which were the same size as whole virus and which were active in 
binding and fusing to cells were produced. The reconstituted Sendai and 
mumps virus accumulated in the reticuloendothelial system when injected 
into mice and hamsters, respectively. The kinetics of the membrane fusion 
activity of mumps with ghost erythrocytes and CV-I cells was measured and 
analysed. A general rate of reaction of 3 (±1) x 109 M-l sec1 was found. The 
membrane fusion activity of reconstituted Sendai with HL60, U937, Cos, H9 
and PBL cell lines was also measured and analyzed. The fusion activity was 
utilized to deliver plasmids for transfection to the interiors of the HL60 and 
Cos cells. Luciferase expression was found in the Cos cells but not in the HL60 
cells. Loading of plasm ids into the vesicle interiors was enhanced by a factor 
of ten by complexing the DNA with the positive proteins polylysine, 
lysozyme and protamine. 
v . 
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Chapter 1; Introduction 
Conceptual Background 
Liposomes were first conceived as a mechanism for drug delivery 
shortly after the discovery that one could form these self assembling bilayer 
vesicles from purified lipids. l A tremendous amount of research has been 
done on characterization of the physical properties of liposomes in terms of 
preparation techniques and lipid composition.2 A variety of different size 
vesicles can be prepared with variable degrees of loading of internal contents 
into the vesicles. 
As a potential drug carrier, a liposome should protect a drug from 
interacting with undesired tissue or other bodily elements (and vice versa), 
specifically accumulate in a tissue, and deliver its drug product to that tissue.3 
To deliver a drug product efficiently to a specific tissue, a cancer for 
example, the liposome must be stable in the blood (assuming an intravenous 
approach) and must avoid uptake by the cells of the reticuloendothelial 
system (RES), i.e., the Kupffer cells and hepatocyte cells in the liver and 
spleen. Most liposomes will accumulate in the RES shortly after introduction 
in a body.4 Two mechanisms of drug delivery to a specific tissue can be 
envisioned, the first, active targeting to a tissue and the second, a passive 
accumulation in tissue. 
Active targeting could occur by placing on the surface of the vesicle a 
moiety such as an antibody, a lectin, or a lipid type that specifically binds to a 
specific tissue. Unfortunately the addition of such a molecule often reduces 
vesicle stability and increases the rate of uptake by the RES.s Exploration of 
active targeting has proceeded much more slowly than passive targeting 
2 
mechanisms. Active targeting could allow enhancement of drug dosage in a 
very specific tissue site if a ligand or receptor could be found for that specific 
tissue. 
Passive targeting utilizes reduced drug toxicity and passive tissue 
accumulation to allow drug delivery to occur. A stable vesicle which is taken 
up slowly by the RES is desired. The two cases of successful commercial drug 
delivery both employ passive drug delivery. Lipids complexed with 
amphoteracin B have proved to be successful in treating fungal infections due 
to a reduction in the toxicity allowing an increased dosage of delivered drug 
to be applied.6 In the second case, extremely stable small liposomes have been 
shown to accumulate in cancerous tissue due to poorly developed vesicular 
walls with large fenestrae, i.e., the liposomes leak into the tissue? Liposomes 
can be loaded with radioisotopes for diagnostic imaging of the cancer or drugs 
for tumor chemotherapy. 
Regardless of the mechanism of targeting to a cell exterior, deli very of 
liposome contents to a cell can only occur if a cell takes up the liposomes 
through endocytosis (and other related mechanisms) or if the liposome is able 
to fuse with some cellular membrane. 
Liposome endocytosis is mediated by the cell. The liposomes will be 
taken into endosomal and lysosomal compartments where the vesicle is 
exposed to low pH conditions and vesicle breakdown occurs.S Any delivered 
drug must be stable under these conditions if it is going to have a therapeutic 
effect. Enhancement of the rate of endocytosis by attaching certain moieties to 
the vesicle surface may be plausible. 
Membrane fusion of a liposome with a cell would allow direct delivery 
of liposome contents into the cellular interior.9 Membrane fusion and 
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vesicle formation are normal components of cellular activity in forming and 
fusing cellular subcompartments, i.e., endocytotic vesicles, exocytosis of 
material (release of acetylcholine by nerve cells for example), and transport of 
glycoproteins from ribosome to cellular surface via the golgi. However, 
unmodified lipid vesicles are very stable and do not fuse spontaneously.l0 
Modification of lipid vesicles surfaces by proteins or polymers may make 
them more fusogenic. 
In many ways a virus is a highly optimized drug delivery system. The 
virus can enter the body by various pathways, bind to a tissue, and deliver its 
nucleic acid to the cellular interior. Those viruses which have been 
characterized for entry behavior generally contain a ligand for a cellular 
surface moiety and an active mechanism for cell entry. The availability of a 
cellular receptor for the virus and ability of the virus to enter the cell can 
determine tissue tropism, i.e., the range of tissues which a virus can infect.ll 
A number of viruses (vaccinia virus, retroviruses, baculoviruses) have been 
altered to serve as delivery devices of genetic material for cellular 
expression.1 2 
Of the 21 major families of animal viruses, 13 families have an exterior 
"shell" made of lipids and glycoproteins.13 These lipid coated viruses 
undergo protein mediated membrane fusion with a host cell, with the 
cellular membrane or endosomal membrane, in order to deliver their nucleic 
acids to the cellular interior.14 These viruses are essentially liposomes with 
glycoproteins incorporated into their bilayers that are responsible for viral 
surface activity. A liposome-like drug delivery system might be designed 
using viruses or viral proteins. 
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A number of workers have previously worked on the reconstitution of 
viral glycoproteins into lipid vesicles made of endogenous viral lipid or 
exogenous lipid. The viruses influenza, vesicular stomatitis virus, Semliki 
Forest virus, and Sendai have all been reconstituted by dissolving the viral 
glycoproteins and lipid in detergent, removing the viral interior proteins and 
nucleic acids, and dialyzing away the detergent to reform hollow vesicles 
containing the viral proteins. IS These vesicles have been called virosomes or 
reconstituted viral envelopes. These reconstituted systems are functional in 
binding and fusion with target cells and can serve as delivery vehicles to 
cellular interiors. 
In undertaking this project, we wished to explore further the possibility 
of using reconstituted viruses as drug delivery systems. To add further 
incentive to our studies we choose a viral system with a neuroinvasive 
property and which was infective to humans, the paramyxovirus mumps.16 
Drug delivery to the brain is especially difficult due to the existence of a blood 
brain barrier. The fenestrate junctions between the endothelial cells lining 
the capillaries in the brain are closed so that all material that enters the brain 
must be specifically transported into the brain or be so hydrophobic that it can 
diffuse across the lipid bilayers of the lining cells.17 The mumps virus is able 
to invade and propagate throughout the eNS. 
Though the potential for achievement of our goal was slim, that being 
specific drug delivery to the central nervous system, the possibilities for 
serendipitous discovery are always high in such cases and the project was 
undertaken. Other related projects were also undertaken as new questions 
arose and other experiments became possible. 
experiments used another paramyxovirus, Sendai. 
A number of these 
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Thesis Preview 
Each of the chapters summarizes some of the experiments to answer 
hypotheses and questions which arose throughout this project. As each of the 
individual chapters include introductory material, this section is brief. 
Chapter 2-
How reliable are the available assays for membrane fusion? How can 
we describe the kinetics of fusion between virus and target cells? 
A number of different techniques were used to characterize the 
activities and structures of the viruses and reconstituted viruses throughout 
my work. Electron microscopy, photon correlation spectroscopy, gel 
electrophoresis, and protein assays were used to quantitate dimensional 
aspects of the virus, i.e , viral size, form, and number. Viral activity was 
monitored by plaque assays, hemagglutination assays, fluorescence 
microscopy and several quantitative fluorescence assays of membrane fusion. 
The fluorescence assays used to monitor membrane fusion represent the bulk 
of the actual experimental time during my thesis and much of the original 
data collected. Chapter 2 provides a discussion of the fluorescence fusion 
assays and some of my observations on these assays. A discussion on viral 
fusion kinetics is also presented in this chapter. 
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Chapter 3-
Can one reconstitute functionally active mumps? What is the optimal 
detergent for reconstitution? What happens to reconstituted virus when it is 
introduced into animal systems? 
The techniques mentioned above were used to determine an optimal 
procedure for reconstituting mumps and Sendai virus so that they were 
functionally similar to the parent viruses in activity. Morphology was also 
closely studied, as a product that was capable of carrying drugs or other 
materials was desired. The hypothesis that mumps envelopes would 
accumulate in the CNS was tested. 
Chapter 4-
What are the fusion activities and kinetics of the mumps virus? What 
do these activities tell us about the neurotropism of the virus? 
This chapter could have preceded the previous one as it describes the 
fusion activities of whole virus but in the historical context the work 
occurred later. After studying the reconstituted virus we realized that there 
was little information on the activities of the whole virus and this 
information could be useful for comparison to the reconstituted systems and 
understanding of the infective behavior of the virus. 
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Chapter S-
Can reconstituted Sendai vzrus be used as a delivery vehicle to H9 and 
PBL cells, model cell lines for HIV infection? 
This work was in collaboration with John Zaia and Delilah Stephens at 
the City of Hope Hospital with a long term goal of in vitro drug delivery to 
HIV infected cells. 
Chapter 6-
Can reconstituted Sendai virus be used as a delivery vehicle to HL60 
and Cos cells? How can one optimize the loading of nucleic acids into the 
reconstituted Sendai viral envelopes? 
These experiments were done in collaboration with Thomas Amatruda 
in Melvin Simon's research group in biology. Tom Amatruda was looking 
for an alternate method for transfecting HL60 cells as other more standard 
methods had failed. The literature protocols for using reconstituted Sendai 
viral envelopes as delivery vehicles of DNA were optimized. 
8 
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Chapter 2: Use of the fluorescent probes R18 and NBD-PE/Rd-PE to measure 
virus fusion with cell membranes 
Introduction 
Membrane fusion can be described as the process where continuity is 
established between the lipid bilayers of two separate membranes (Figure 1a) 
(Reviewed by Blumenthal, 1989). After this continuity has been established 
the contents of the membranes are free to mix. The mechanisms and 
intermediates in membrane fusion have not yet been well characterized. 
Membrane fusion is an important process in the internal organization of 
living cells as it allows compartimentalization to be a reversible process. In 
animal cells, membrane vesicles are used to transport materials into the cell 
and to store materials for release into the extracellular environment. 
The work in this thesis has focused on the fusion of virus membranes 
with cellular membranes. This fusion process is catalyzed by viral 
glycoproteins responSible for adhesion of the virus to the cellular surface and 
fusion with the cellular membrane (reviewed by Hoekstra and Kok, 1989, 
White, J., 1990). The fusion process is necessary for introduction of the viral 
genetic material into the cellular interior (Figure 1b). 
The fusion of lipid membranes can be measured using a variety of 
fluorescent probes. These probes can be grouped into two general classes, 
membrane mixing probes and contents mixing probes. Both types of probes 
have been used extensively to observe model fusion events (calcium induced 
fusion, peptide induced fusion, etc.) between liposomes. The primary 
contents mixing probe pairs used for examining liposome fusion are 
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Tb / DP A 1 and ANTS/DPX. These probes are loaded into separate vesicle 
populations and upon vesicle fusion interact to cause an increase (Tb/DPA) 
or decrease (ANTS/DPX) in fluorescent intensity. These probes must be 
loaded during formation of the liposomes; this is also true with the majority 
of fluorescent membrane mixing lipid probes. Lipid probes also give an 
increase or decrease in fluorescent intensity upon fusion due to the dilution 
or mixing of the probes into other bilayers. The membrane probes used in 
this thesis were R18 and the resonance energy transfer pair NBD-PE / Rd-PE. 
RI8 
For experiments with intact cells or virus, probes that must be "loaded" 
into the system during formation are not useful. A membrane probe that 
does allow labeling of intact systems is octadecyl rhodamine B (RI8). The 
probe can be dissolved in a small solution of ethanol and mixed with a 
suspension of cells or virus and will spontaneously insert into the cellular or 
viral bilayer. R18 is essentially a rhodamine modified with a long alkyl tail. 
This hydrophobic tail causes the probe to partition preferentially into the 
bilayer (Ediger et aI., 1984) and reduces the rate of exchange out of the bilayer 
(Figure 2). The probe was originally synthesized as a resonance energy 
transfer probe in conjunction with the probe F18 (Keller et aI., 1977). The 
probe was reintroduced as a method to monitor membrane fusion using the 
probe alone in a self quenching fashion (Hoekstra et al ., 1984) 
The probe is selfquenching at concentrations up to 9 mole percent of 
the membrane. The quenching is linear over this range (Figure 3c,d,f). The 
probe's emission band (max ~ 590 nm) overlaps with its excitation band (max 
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~ 560 nm)(Figure 3e}. If resonance energy transfer were the dominant 
mechanism of quenching then one would expect a nonlinear quenching 
curve ( l/r6 for normal resonance energy transfer). Resonance energy transfer 
is the dominant mechanism of quenching at very low concentrations « 1 %) 
while quenching at higher concentrations (1-10%) is due to the formation of 
R18 aggregates that are highly quenched, i.e., a static quenching mechanism 
(Johansson and Niemi, 1987, Ediger et al., 1984). Under the conditions of the 
experiments conducted in this thesis, no signs of R18 photobleaching were 
observed. 
For a R18 experiment with virus, the virus is labeled with R18 and 
then purified by centrifugation or column chromatography to remove free 
R18. The labeled virus is suspended in buffer in a cuvette at regulated 
temperature in the fluorimeter sample chamber. The fluorescence intensity 
is recorded continually and target membrane is added to the cuvette. A 
kinetic recording is taken as shown in Figure 4. As the viral particles fuse 
with the target membrane the fluorescent intensity increases. This is due to 
the dilution of the R18 probe from the viral membrane into the cellular 
membrane (Figure 5) . The lateral movement rate of the probe in bilayers is 
very rapid and should not serve as a rate limiting factor in observation of the 
fusion event (Chen and Blumenthal, 1989, Rubin and Chen, 1990, Morrison 
et aI., 1990). 
To determine the fluorescence intensity of the probe in the 
unquenched or infinitely diluted state the labeled viral sample is treated with 
the detergent Triton X-I00 at a concentration of 1 % at the completion of the 
fusion experiment. This disrupts the membrane vesicles and disperses the 
R18 probe into detergent micelles. In the literature it is often assumed that 
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this intensity represents the 100% value of dequenching although we have 
not been able to find any direct data presentation confirming this assumption. 
A correction factor might be required as the detergent micelle should present 
a different dielectric environment than the lipid membrane and the R18 may 
exist in different aggregation states in the detergent micelles as compared to 
the lipid membrane. We have tested this assumption by preparing PC 
liposomes containing different mole percents of R18 and determining their 
fluorescent intensities. As the percentage of R18 decreased a linear intercept 
of the abscissa was found, representing fluorescence at infinite dilution 
(Figure 3a,b) . This value agreed very closely (±5%) with the value given 
when the vesicles were treated with 1% Triton X-100. Other workers have 
assigned a correction value of 1.54 to the triton intensity when working with 
cellular membranes. This value was determined by adding known amounts 
of RIB to the cells and measuring the quenching observed with and without 
Triton X-100 (Blumenthal et aI., 1987). This correction value might be due to 
the association of RIB with proteins in the membrane. 
The experiments in this thesis all involve the study of whole or 
reconstituted virus fusing with ghost erythrocytes or mammalian cells. The 
surface area of these target membranes is many times larger than the surface 
area of the virus. For Sendai virus fusing with an erythrocyte ghost this ratio 
is 1000:1 (.125 ~2 surface area for Sendai versus 125 ~2 for an erythrocyte), for 
fusion with a green monkey kidney CV-1 cell the ratio is 16,000:1 (with a 
surface area of 2000 ~2 for the CV-1 cell). Thus when a virus fuses with a cell, 
the R18 probe can be considered to dilute nearly infinitely into the target 
membrane and to be subject to no selfquenching. Thus if one had 10 viruses 
that were 90% quenched giving a fluorescent signa! of 100 units (1000 units in 
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the unquenched state), when one of the viruses fused {10% fusion) the 
fluorescent intensity would increase to 190. 
The assumption of infinite dilution is not strictly correct in cases where 
a large number of fusion events occurs with a target cell. We have derived a 
correction formula to determine the true number of fusion events based on 
the ratio of surface area of the virus to the target cell and the amount of R18 
in the viral bilayer. The formula is: 
Observed # Fusion Events (OBS) 
True # Fusion Even ts (N) = -~"--:-:ni"-;;:;-:-:-::-::-:C;:--:--;-;O;-:;-;:;-:-~;"'---~'::"'=''----;~ 1-( N x % Quench of R18 in the Virus (Q») ' 
Do+N 
where Do is the ratio of surface areas of the virus and target cell . R18 
quenches ~ 10 % per mole % it constitutes of the native lipid, i.e., 50% 
quenching is observed when the R18 is added at 5 mole percent of the 
membrane lipid (Figure 3c,d,f). This equation can be rearranged to give 
N= 
-Do + OBS ± --J (00- OBS)2 -4{1-Q)(-OBS x Do) 
2-2Q 
For the amount of R18 used in our usual experiments (3 %) in which up to 20 
virus fuse with one erythrocyte the correction is trivial (20 events correct to 
20.1 events). 
Perturbation of the viral interaction process by the R18 has been 
examined by a number of workers. Some conflicting evidence has been 
presented. Examination of R18 labeled Sendai showed equivalent binding 
and hemolysis with or without label (Hoekstra et al., 1985). However, other 
evidence has shown that the binding of labeled VSV virus to liposomes is 
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enhanced upon R18 labeling (Puri et al ., 1991). Labeled virus appears to work 
equivalently to unlabeled virus in cell syncytial assays (Anne Walter, 
personal comm.). 
In Sendai and mumps virus the binding and membrane fusion 
activities are contained in separate glycoproteins. Control experiments can be 
conducted to confirm that the dequenching of the RI8 probe is due to 
membrane fusion and not due to other transfer processes. Sendai virus is 
able to fuse with ghost erythrocytes (Hoekstra et aI., 1985). Trypsin treatment 
of Sendai virus causes cleavage of the F protein and should prevent viral 
fusion. After trypsin treatment a slow dequenching (slower than that 
observed with untreated virus) occurred in all of our experiments (Figure 4). 
This observation led us to consider carefully possible artifacts with the RI8 
assay and conduct a number of control experiments that are outlined below. 
Mechanisms of Dequenching 
I would propose that there are four mechanisms by which the virus 
associated R18 could dequench upon addition of target cells to a virus 
containing solution. 
The first mechanism is transfer through solution, i.e., the probe leaves 
the viral membrane, crosses solution, and inserts into the target membrane. 
The probe would likely be quenched in an aqueous environment so any free 
probe would not give any fluorescent intensity. The probe could also leave 
the viral membrane and form micelles but again these would be quenched. 
Fluorescent microscopy shows that the R18 probe is actually incorporated into 
the target cell after incubation with labeled virus indicating that the probe 
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does end up in the target membrane. Control experiments which inhibit 
viral binding to the cells totally eliminate dequenching upon the addition of 
target cells indicating that transfer through solution is not a mechanism for 
transfer (Figure 4) . The binding can be inhibited by treatment with protease K 
or extracellular viral receptor (fetuin, which contains a large number of 
terminal sialic acid residues that serve as the viral receptor on cells). 
The second possible mechanism of transfer is proximal transfer, 
transfer of the R18 probe to the target cell when the virus is in close proximity 
or bound to the cellular surface. This type of activity can measured by using a 
control experiment where virus binds to the cell but does not fuse. Trypsin, 
PMSF (Phenyl Methyl Sulphonyl Fluoride), and dithiothreitol are all capable 
of selectively inactivating the Sendai F protein while leaving the binding 
protein HN intact. As already mentioned, trypsin treatment does not 
completely inhibit the R18 dequenching, i.e., a low residual rate is apparent 
(Figure 4) . A number of papers in the literature also use R18 to examine viral 
fusion and show some residual dequenching after trypsin treatment, 
although the authors of these papers do not comment on this effect. The 
residual dequenching observed from the literature is 13±6% (n=9) of the 
uninhibited fusion values (Figure 6). An examination of my accumulated 
data shows an average of 15% residual dequenching of the uninhibited 
dequenching value (Figure 7) . 
R18 labeled Sendai virus treated with trypsin was prepared and allowed 
to interact with cells at various ratios of virus to target cell. The observed 
dequenching was compared to that obtained with untreated virus. The 
amount of de quenching observed correlated well with the ratio of target cells 
to virus as would be expected if binding were a precursor to transfer, as a 
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greater amount of target cells provides a larger number of receptors for viral 
binding (Figure 8). 
The observed slow dequenching after trypsin treatment could be due to 
non-F dependent fusion, incomplete inactivation of F by the trypsin 
treatment, or spontaneous proximal transfer. 
Trypsinized virus is incapable of causing cell-cell fusion and 
trypsinized virus has not been observed to fuse by electron microscopy. 
Reconstituted vesicles containing just the HN protein are unable to fuse with 
cellular membranes at neutral pH. The HN protein is capable of causing 
membrane fusion at low pH but at the neutral pH used in these experiments 
non-F dependent fusion is unlikely. 
Gel analysis of trypsin treated virus shows that trypsin will cleave the F 
protein until it is no longer visible on a silver stained gel. Even if this 
worker's trypsin treatments were inadequate it is unlikely that all those 
reported in the literature are also inadequate although there may be some F 
proteins which are protected from cleavage. Further it has been suggested to 
me that the R18 may protect the F protein from trypsin treatment. A series of 
control experiments were run where the trypsin treatment was applied at 
various times in the preparation procedure. In addition both 
ultracentrifugation and gel chromatography were compared for purification. 
In all cases the residual dequenching existed (Figure 9). 
Further evidence for spontaneous transfer was found by allowing the 
virus to interact with target cells for long time periods. After 18 hours of 
interaction the fluorescent dequenching in trypsin treated samples was the 
same as untreated samples (Figure 10). The rate of dequenching was much 
faster initially in untreated samples but the extent of dequenching was 
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equivalent. In both cases the number of binding sites should be the same and 
hence over long time periods equilibrium of the probe in the two bilayers is 
reached in both treated and untreated samples. 
Spontaneous proximal transfer has been shown to occur in the 
interaction of R18 labeled influenza virions with small unilamellar vesicles 
(Wunderli-Allenspach and Ott, 1990) 
A third mechanism of dequenching is protein mediated transfer. In 
this mechanism the fluorescent probe transfer is catalyzed by the presence of 
hydrophobic material such as proteins which would bridge the gap between 
bilayers (Figure 11). The Sendai F protein contains a highly hydrophobic N 
terminus which most likely enhances lipid transfer between bilayers as an 
early intermediate to membrane fusion. Hydrophobic polymers such as PEG 
have been shown to enhance transfer of lipids in and out of membranes (Wu 
and Lentz, 1991). The range of effects of hydrophobic molecules (such as the 
mellitin peptide) should range from enhanced transfer to hemifusion (fusion 
of the outer bilayers) to full fusion to membrane disruption. 
Due to the hydrophobic nature of the R18 molecule it could directly 
associate with the hydrophobic portions of the F protein. Fluorescent spectra 
were taken of R18 labeled virus as a control. The fluorescence maxima of the 
probe is different for association with protein or lipid (Loyter et aI., 1988, 
Chejanovsky et aI., 1988). The spectra of R18 labeled virus indicated an 
emission wavelength consistent with the probe being present in the lipid 
bilayer , ).,=590 nm (Figures 3e,12) . Kinetic spectra were taken during trypsin 
cleavage of labeled virus. If the probe were associated with the F protein then 
one would expect the fluorescence of the probe to go down as the F protein is 
cleaved away from the viral surface and exposed to buffer. The fluorescent 
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intensity actually increased slightly after trypsin cleavage (Data not shown). 
This result is difficult to interpret, although the cleavage of the F protein 
should result in altered fluidity in the viral membrane which could alter the 
aggregation state of the RIB molecule. 
The fourth mechanism of dequenching is actual membrane fusion and 
transfer of the probe into the target membrane by lateral diffusion through 
the bilayer. The lateral diffusion process is very rapid and should not be a rate 
controlling factor in these virus-cell fusion experiments. 
It is extremely difficult to carry out a control experiment that will 
distinguish protein enhanced transfer from actual membrane fusion . 
Correlation of membrane fluorescent probes with other evidence is one 
method. Membrane fusion does exist as shown by electron microscopy of 
Sendai virus fusing with target membranes (Knutton, 1977). 
A fluorescent contents mixing assay could also provide correlatory 
quantitative measurement of fusion to which the membrane mixing assays 
could be compared. Membrane and contents mixing can occur at different 
rates due to the requirement of opening of a pore between the fused 
membranes before contents mixing can occur (Figure la). A fluorescent 
contents mixing assay should allow visualization of membrane fusion under 
a fluorescent microscope as fluorescent molecules are delivered to the 
interior of a target cell, given that the target cell is large enough for 
visualization. The best example of this type of experiment in the literature is 
a measurement of the fusion of membrane labeled (RIB) and content labeled 
(NBD-taurine) ghost erythrocytes fusing with cells expressing the influenza 
HA fusion protein on their surface (Morris et aI., 1988, Sarkar et aI., 1989). In 
this case the kinetic profiles of dequenching were similar for both probes but 
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the measured extent of fusion differed greatly (20% of the RI8 and 80% for the 
NBD-Taurine) . 
Reconstituted Sendai viral envelopes (RSVE) can be loaded with 
material during their formation. Chapter 6 of this thesis discusses 
experiments where these viral vesicles were used to deliver DNA to cellular 
interiors. Qualitatively, it is clear that DNA delivery does take place but the 
quantitation of fusion by DNA delivery is not feasible. During these 
experiments the RSVE were loaded with carboxy fluorocene, ethidium 
bromide, DNA complexed with ethidium bromide, or trypan blue, allowed to 
interact with cells, and examined under a fluorescence microscope. Carboxy 
fluorocene was visually observed in the interior of the cells but this could not 
be documented with photography as the bleaching of the dye was more rapid 
than the time required for photographic exposure. No successful observation 
of the Ethidium Bromide, Ethidium Bromide/DNA or trypan blue in the 
interior of the cells was made. The cells exposed to RSVE loaded with 
ethidium bromide were dead by the next day, most likely due to the 
introduction of EtBr into their interiors. 
Several attempts were also made to develop a quantitative contents 
mixing assay using RSVE or Sendai in order to compare fusion rates with the 
RI8 membrane mixing probe. 
Whole Sendai virus were mixed with EtBr loaded erythrocyte ghosts. 
If fusion occurs then the EtBr in the ghost interior should be able to 
intercalate into the viral RNA and an increase in fluorescence should be 
observed. At the concentrations at which the experiment was conducted no 
change in signal was found. Control experiments showed that the maximal 
potential increase in fluorescence was less than the noise in the fluorescent 
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signal. (The signal was 500±5 fluorescence units, with 5 being the maximal 
change in fluorescence upon addition of amounts of RNA equivalent to the 
viral interiors to amounts of EtBr equivalent to the ghost interiors.) An 
ethidium dimer probe was also loaded into ghosts as its fluorescent 
enhancement is reported to be 50 times greater than EtBr upon binding to 
nucleic acid (Markovits et aI., 1979) . Upon mixing of virus and ghosts, no 
change in fluorescence signal was found when using this probe. 
The use of carboxyfluorocene loaded RSVE to quantitatively measure 
fusion was also explored, but the RSVE appeared to be leaky in containing CF. 
CF is also prone to photobleaching during long term light exposure. 
RSVE were loaded with Rd-Dextran polymer at a concentration of 1 
mM and mixed with ghost erythrocytes. No change in fluorescent intensity 
was observed during controled lysis of the virus with Triton X-lOa, showing 
that the polymer was not selfquenched at this concentrations. 
NBD-PEI Rd-PE 
The fluorescent membrane probes NBD-PE and Rd-PE were used in a 
number of experiments in this thesis (Figure 13). These fluorescent lipids can 
be incorporated into liposomes during formation or into reconstituted virus 
during detergent dialysis reconstitution. The emission band of the NBD 
probe overlaps the excitation band of the Rhodamine-PE, thus allowing a 
resonance energy transfer to occur (Figure 14). In our experiments the probes 
are both incorporated into the same membrane at a concentration of 1-2 mole 
percent of the membrane. We (c. DiSimone and A. Wein) have generated 
quenching curves for several different ratios of NBD/Rd (Figure 15). Upon 
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fusion with an unlabeled target membrane, the probes dilute into the target 
membrane and the energy transfer rate is decreased due to a reduced density 
of probes (Struck et ai., 1981). The change in the intensity of the NBD 
emission band is the most reliable indicator of the fusion event; upon fusion 
the intensity increases. The maximal dequenching is determined in the same 
fashion as with the R18 assay: the vesicles are solubilized in 1 % Triton X-I00. 
The NBD probe has been reported to be slightly quenched in the micelle 
(Struck et ai., 1981), but the correction factor for this behavior was not 
reported in this reference or in subsequent reports. The identical correction 
formula as given for the R18 assay can be applied in cases where large number 
of fusion events occur. 
Alternately the NBD/Rd probes can be incorporated into separate 
vesicle populations which fuse together and thus cause a decrease in the 
intensity of the NBD emission. This method is more prone to artifactual 
signals as vesicles which are aggregated but not fused can cause quenching of 
the NBD emission signal (Figure 16) (Duzgunes et ai., 1987). 
Comparison of NBD/Rd and RI8 
The fluorescent dequenching kinetic traces given during interaction of 
RSVE with ghost erythrocytes were measured using either R18 or NBD-
PE/Rd-PE (Figure 17). The NBD/Rd probes could be incorporated into the 
RSVE during formation of the vesicles. The NBD/Rd probes should be less 
likely to undergo transfer out of the membrane due to the presence of two 
acyl chains as opposed to one for the R18. Indeed, following trypsin treatment 
no dequenching of the NBD emission was observed, providing further 
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evidence that the F protein is necessary for fusion, that trypsin treatment can 
be 100% effective, and that proximal transfer occurs when using the RIB assay. 
Curiously, the RIB assay reported less dequenching than the NBD-Rd assay at 
equal ratios of virus to cells (Figure IB). The RIB molecule may not 
disaggregate completely upon fusion; this conclusion is supported by the 
results of Sarkar et ai. (Sarkar et ai., 19B9) in which the RIB reported less 
fusion than a NBD-taurine contents mixing assay. Alternatively, the RIB 
molecule might inhibit membrane fusion. 
Contents Mixing Assays 
The contents mixing probe pair Tb/DPA were used to conduct 
experiments on the effects of chao tropic agents on Calcium induced fusion of 
phophatidylserine vesicles (data not shown). Unfortunately, I was unable to 
see any fluorescence intensity alterations when the Terbium was chela ted 
with DPA. Another worker in our laboratory (R. Goodrich, personal 
communication) was unable to achieve any success with this probe system to 
measure membrane fusion . 
A recent report presents data showing that the probe DPX of the 
ANTS/DPX pair used to monitor liposome fusion causes major alterations in 
the membrane behavior in terms of fluidity and hydrophobicity (Walter et al ., 
1991). Many of the literature results gathered with this probe may need to 
reinterpreted in light of this observation. 
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Kinetic Analysis 
With an understanding of the methodology and shortfalls of the 
fluorescent assays, a kinetic evaluation of the obtained data can be 
undertaken. The virus target interaction can most simply be described by the 
scheme 
V +nG~Fused, 
where V is Virus, nG is a cellular receptor and Fused is the Fused product. In 
the following fittings ghost erythrocytes (G) with n receptors on their surface 
act as the fusion target for the virus. 
The rate of formation of fused product can be described by the equation, 
d(Fused) 
dt = k [Yo - FusedHnGo - Fusedl. 
The amount of fused product at time t can be determined by integrating the 
formula, 
J d(Fused) f k dt = (Vo - Fused)(nGo - Fused) 
with the limit Fused=O when t=O to give, 
1 (nGo • (Vo - Fused) ) 
kt= (Vo _ nGo) In Vo' (nGo - Fused) 
which can be rearranged to the form, 
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Fused = V . 
[ 
Vo • ek(Vo - nGo)t - Vo J 
~. ek(Vo - nGo)t - 1 
nGo 
This function was put into a macro subroutine in the plotting and 
fitting program IGOR and used to fit a number of kinetic curves. Fittings for 
three experiments (Figures 8,17,19) already presented in this chapter are 
shown (Figures 20,21,22). 
The fusion of NBD/Rd labeled RSVE with ghosts is shown in Figure 17 
and fits in Figure 20. In this experiment the number of ghost erythrocytes was 
increased while the amount of RSVE was held constant. As the number of 
ghosts was increased, the maximum amount of RSVE fused plateaued at a 
value of 31.6%. Thus only about 31.6% of the RSVE were fusion competent. 
The number of ghost sites involved in fusion in each experiment can be 
determined by dividing the concentration of fusion events by the 
concentration of ghosts. Under non saturating conditions, low ratio of RSVE 
to ghost, increasing the amount of ghost leads to a linear decrease in the 
number of fusion sites per ghost. However, as saturation of the surface occurs 
the number of apparent sites will near the theoretical maximum. In this 
experiment a maximum of 87 sites of fusion per ghost was determined. 
These values were used to determine RSVE and ghost concentrations and 
kinetic fitting were determined . A maximal k of 2.3 x108 M-1 sec 1 was 
determined. As the concentration of ghosts was increased the apparent k 
linearly decreased. 
A more exact description of the viral cell interaction would be 
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V +nG~ VGB~Fused, 
where VGB represents unfused bound virus. No exact solvation for the 
amount of Fused material can be derived, but numerical integration can be 
used to model this behavior. A simple looped algorithm of the Euler form 
can be used, 
From 0 to time t, increment i 







k1 is the forward rate in the binding interaction, k2 is the reverse rate in the 
binding interaction, and k3 is the fate of fusion for bound virus. 
Programs were initially written in the basic language with both Euler 
and Runge Kutta methods (Boyce and DiPrima, 1977) for solution of a 
number of kinetic models (see Chapter 4 on mumps). Ultimately the mass 
action model proved to be optimal for data fitting of our data on Sendai 
fusion. In order to increase computation speed, a data modeling program 
written by David Baselt in the language C was modified to fit mass action 
kinetic data. The program included a "evolutionary" fitting routine which 
allow optimization of data fits. This subroutine takes the provided rate 
guesses and randomly varies them 0 to 10% and then computes the closeness 
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of fit by the standard deviation from the data. A series of 10 variants are 
compared to the original data and optimal fits are selected for the next round 
of evolution. 
Optimal data fitting with mass action kintics requires fitting multiple 
curves with the same sets of rate constants. For a single curve a number of 
different combinations of rate constants can be found that fit the curve very 
precisely. Most notably increasing or decreasing the kl rate can be 
compensated for by doing the opposite to the k3 value. In figure 23 three fits 
to two data curves from the NBD/Rd RSVE experiment are shown. While 
three set of constants can fit the lower data curve, only one set of constants 
will fit both curves. 
For the NBD/Rd labeled RSVE a consistent set of rate constants was 
found to fit all of the data curves. For RSVE fusion activity of 31.7% and 87 
RSVE receptors per ghost, the constants obtained were 1 xl09 M-1sec-1 for kl, 
.0223 sec-1 for k2, and .0078 sec-1 for k3. The data curves have some sigmoidal 
character which is fit more accurately by the mass action model (Figure 24) 
rather than the simpler exponential fitting (Figure 21). 
Mass action fits were also obtained for the data on Sendai fusing with 
erythrocyte ghosts as shown in Figures 8 and 19. For viral fusion activity of 
15% and 8 receptors per ghosts, optimal values of 5.41 xl09 M-1sec-1 for kl, 8.7 
xl0-4 sec-l for k2 and .02 sec-l for k3 were obtained from the data in Figure 8. 
Values of 3.87 xl09 M-1sec1, 7.5 xl0-4 sec1 and .04±.01 sec-1 were obtained 
from the data in Figure 19 , given viral fusion activity of 14±2% and 7 
receptors per ghost. This second set of constants also gave a very good fit to 
the first data set. Given the various errors in data measurement and protein 
determination, general rate constants of 4.5±1 xl09 M-l sec-l, 8±1 xlO-4 sec1, 
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and .035 ±.015 sec-1 for kl,k2, and k3, respectively, with 7.5 ±1 receptor sites 
per ghost, adequately fit all the data on fusion of Sendai with erythrocyte 
ghosts. 
The rate constants show a very rapid binding process with a much 
slower release from the vesicle surface, consistent with other studies of 
Sendai fusion (Hoekstra and Kiappe,1986). The apparent number of receptors 
for Sendai fusion interaction (n=8) is much lower than that reported in the 
literature (n=180) (Hoekstra and Klappe, 1986). The method used in the 
literature to determine the number of receptors was long term incubation of 
R18 labeled virus with cells. As discussed above this could lead to 
spontaneous dequenching occurring and artificially high estimation of the 
number of fusion events. 
The apparent number of fusion sites for the reconstituted virus was 
higher than the number for whole virus. This may be a real effect or due to a 
poor estimate of the number of particles. The number of whole viral particles 
was determined from the molecular weight of the virus and the amount of 
protein per virus: MW= 5-7 xl08 MW, protein content= 70%, gives 1.3 xl09 
particles per microgram protein. For reconstituted virus only glycoprotein is 
recovered. The glycoprotein was estimated to make up 20% of the viral 
protein and thus the number of particles was estimated as five times higher 
for a set amount of protein, 6.5 xl09 particles per I-lg protein. The 
reconstituted viral particles tend to be actually smaller than whole virus so 
this would be a low estimate of the number of viral particles. The interaction 
of reconstituted virus with ghost erythrocyte may be less specific or fusion less 
impeded, perhaps due to the loss of the matrix protein during reconstitution. 
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This protein lines the inside of the viral envelope and may deter viral 
membrane instability and fusion . 
Conclusions 
The probe octadecyl rhodamine was originally chosen to measure viral 
membrane fusion due to its ability to label whole virus, and due to the 
presentation of this system in the literature as a simple method to measure 
membrane fusion. Careful examination of the behaviors of this probe has 
shown that the probe is susceptible to providing artifactual signal due to 
proximal transfer between adjacent membranes. With the RIB probe one 
should be careful of attributing slow dequenching «1 % per minute) as 
membrane fusion. 
The general literature interpretation of the mode of quenching of RIB 
as resonance energy transfer is incorrect, as shown by the quenching curve of 
the probe, an aggregation behavior is likely to be responsible for the 
quenching. 
Even when accounting for the slow proximal transfer behavior with 
control experiments, the fast dequenching seen in viral cell fusion can not be 
attributed with one hundred percent certainty to be membrane fusion. A 
protein mediated transfer of probe could account for this behavior. 
Qualitative observation by electron microscopy or fluorescent microscopy 
shows that fusion does occur. Attempts to correlate contents mixing with 
membrane mixing have not been successful. Furthermore, it is clear that the 
rates of content mixing may not be the same as membrane mixing due to 
difference in the mechanics of the two behaviours. The preferred literature 
contents mixing assays are subject to other artifactual behaviors. At this time 
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there is no "yardstick" assay for membrane fusion to which other assays can 
be compared . Comparison of the different techniques to one another can 
produce a variety of "fusion" values (Duzgunes et a!., 1987). Comparison of 
the R18 and NBD/Rd probes actually showed the R18 to underreport the 
fusion reported by NBD/Rd, the opposite of what one would expect if 
proximal transfer were occuring with the R18. The data from these assays can 
be used in a semi quantitative fashion to compare various cells and virus and 
to study inhibition processes. To facilitate reading throughout the rest of this 
thesis I will in general refer to rapid dequenching as fusion, though the reader 
should keep the above discussion in mind. 
The NBD/Rd membrane fusion assay system has the advantage of 
using double chained lipid membrane anchors that are less susceptible to 
transfer processes. This assay system was used to study fusion when allowed 
(with reconstituted virus) after the problems with R18 were recognized. 
Kinetic models of the early dequenching rates were constructed and 
numerical iteration by computer was used to determine optimal rate 
constants. A rapid and tight binding interaction (4x109 M-1 sec-1 forward and 
7.5x10-4 sec-1 reverse) was apparent as was a limited number of viral fusion 
si tes per ghos t. 
1 Abbreviations: Tb, Terbium; DPA, dipicolinic acid; ANTS, 1-
aminonaphthalene-3,6,8-trisulfonic acid; DPX, N,N ' -p-
xylylenebis(pyridinium bromide); NBD-PE, 7-nitro-2,1,3-benzoxadiazol-4-yl 
phosphatidylethanolamine; Rd-PE, lissamine Rhodamine B sulfonyl 
phophatidylethanolamine; R18, octadecyl rhodamine B; F18, octadecyl 
fluorescein isothiocyanate; PC, phosphitidylcholine; DOPC, dioleayl 
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Methods 
One ~g of Sendai virus is equivalent to 1.3 x 10 9 viral particles while one ~g 
of erythrocyte ghost protein is equivalent to 1.B x 10 6 ghost erythrocytes. One 
mg of Sendai virus protein is associated with 240 nmoles of lipid. 
RIB labeling of virus- General Procedure-
A solution of RIB in ethanol was prepared at a concentration of 1 
mg/ml. 1 to 2 mg of virus protein was labeled with RIB. The RIB was added 
to the virus while rapidly vortexing the viral solution at a concentration of 3 
mole percent lipid or 5-10 ~l (RIB mw = 731). The solution was then 
incubated in the dark for 30 minutes. Removal of unincorporated probe was 
usually accomplished by centrifugation of the viral particles at 30,000 rpm (~ 
IOO,OOOg) in the SW50.1 rotor in the ultracentrifuge for one hour. 
Figure B- I .B mg of Sendai viral protein was labeled with 13 ~g RIB and 
purified by centrifugation. 
Figure 9- 1.3 ml Sendai sample @ 1.B mg/ml was divided into five 
experiments. Sample concentration was maintained throughout these 
experiments by resuspending centrifuge pellets in volumes of PBS equivalent 
to precentrigugation volumes. Experiments 2 and 3 contained 200 ~l Sendai 
and were treated with 40 ~l of trypsin (10 ~g/~l) and then labeled with 2 ~g 
RIB. They were then purified by ultracentrifugation (2) or G50 column 
chromatography (3). Experiments 1,4, and 5 (900 ~) were labeled with 13 ~g 
RIB. For experiment 4, 200 ~l was removed and treated with 40 ~l of trypsin 
and then purified by ultracentrifuge. For experiment 5, 200 ~l were pelleted 
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by ultracentrifugation, resuspended in 200 ~l PBS and then treated with 40 J.1l 
trypsin. Experiment 1 was not trypsin treated. All trypsin treatments lasted 
for one hour at 37°. 
Figure 10- 1.8 mg Sendai and .3 mg mumps virus were labeled with 12 
~g and 4 ~g, respectively, of R18. The sample were purified by centrifugation. 
50 ~g of labeled virus was then treated with 50 ~g trypsin for 2.5 hours at 3?O 
C. 
Erythrocyte ghosts-
Erythrocyte ghosts were prepared by standard lysis procedures, 3 washes 
with PBS and then 7-8 washes with the 5P8 buffer (Steck and Kant, 1974). 
Ghost could be stored in liquid nitrogen with or without 10% glycerol, this 
appeared to have little impact on their ability to serve as fusion targets. 
Fluorescent fusion measurements- General procedure-
Set amounts of labeled viral solution were added to 2ml of PBS and 
placed in the fluorimeter sample chamber. The chamber was maintained at a 
temperature of 37° for most experiments. Emission and excitation slit widths 
were set at 8 nm. The fluorescent signal is a unitless measurement as it 
represents the ratio of intensity of light striking a PMT after the emission 
monochrometer versus the intensity of light striking a standard PMT that 
receives unfiltered light that has not passed through the sample. The 
standard PMT (PMT B) was generally set to a reading of 5 on the scale, 
equivalent to approximately 1.1 kV. The sample PMT (PMT A) was generally 
set between 1.5 and 2.0 kV, such that a ratio reading of greater than 100 but 
less than 1000 was obtained. The signal must be kept low enough so that 
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upon maximal dequenching (Triton X-IOO addition) the signal does not 
exceed 10000. The kinetic data were collected using the provided SLM 
software package. 
The kinetics runs were initiated and run for a short time period (60-
100 seconds) without cell addition to confirm a stable baseline. Ghosts or cells 
were then added to the cuvette, ghosts by means of Hamilton syringe, cells by 
pipetman (in order to avoid shear stress). Records of 600 to 1000 seconds were 
generally undertaken, with one point being accumulated per second, but 
some longer term runs were also recorded. At the conclusion of the 
experiment a solution of 10% Triton X-IOO in buffer was added the cuvette 
and allowed to incubate for 2 to 5 minutes in order to solubilize virus and 
cells. A manual reading of the fluorescence was then taken and recorded. 
Sendai Reconstitution- General Procedure-
1 to 2 mgs of Sendai protein was collected by ultracentrifugation 
(30,000rpm, 100,000g for one hour), and was resuspended in 50~1 of 10% 
Triton X-IOO per mg of viral protein in buffer. The sample was shaken at RT 
for 4 hours and then the nucleocapsid material was pelleted by 
ultracentrifugation. The supernatant was removed and transferred to an 
eppendorf tube to which 50 mg SN-2 biobeads / ~l Triton X-IOO was then 
added. Any additional material to be loaded into the interior or lipid bilayer 
of the vesicles is added at this point to the solution. After four hours shaking 
at room temperature, 50 ~l of high salt solution A (l40mM NaCi, 20mM 
Hepes) and an additional 50mg of SN-2 biobeads per mg starting protein was 
added. The sample was shaken overnight. The cloudy reconstituted viral 
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containing solution was then pelleted by ultracentrifugation and the RSVE 
pellet resuspended in PBS. 
Figure 4- Two mg of virus were used and 100 J.!l of Triton X-IOO. 6 Ilg of 
R18 was added before the biobead dialysis . The RSVE product was 
resuspended in 500 III of PBS at a concentration of .651lg RSVE / Ill. 
Figure 17- 1.4 mg of Sendai virus was divided into two experiments, 
each of which was solubilized in 30 J.!l Triton X-IOO. One half was labeled 
with 4 Ilg of R18, while the other half was labeled with 1 Ilg of NBD-PE and 2 




Figure 1. (a) Two models for intermediates in membrane fusion. (b) 
Schematic drawing of the morphology of (A) exocytosis and (B) viral fusion. 
The drawing is an interpretation of images seen in electron microscopy. Four 
stages going from left to right are shown as follows: (1) the membranes of a 
secretory granule of virion are separate from the plasma membrane; (2) 
triggering, movement, and recognition brings the two into close apposition 
(pre fusion state), perhaps forming a pentalaminar complex; (3) fusion results 
in merging of membranes and contiguity of aqueous compartments; and (4) 
in the final stage the membrane components and aqueous components are 
completely mixed. The membranes of the granule and virion are stippled 
and plasma membrane is cross hatched to indicate separate membrane 
components (lipids, proteins) . After fusion they are intermixed. The granule 
core material (checkered) is seen extruding into the medium during fusion. 
Cytoskeletal components are not shown. The nucleocapsid of the virion 
(drawn as two wavy lines) is seen in the cytoplasm after fusion. The spikes 
on the virion represent viral spike proteins, and the fuzzy motes on the 
plasma membrane represents cell surface carbohydrates (glycoproteins, 
glycolipids). 
Taken from Blumenthal, 1989. 
Figure 2. Structure of octadecyl rhodamine B (RI8) . Molecular weight of 731. 
Figure originally drawn by Steven Novick. 
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Figure 3. (a) Fluorescence for different mole percentages of RIB in DOPC 
MLV's. RIB in EtOH was mixed with lipid in chloroform at different 
concentrations and dried down. The samples were resuspended in PBS and 
the fluorescence intensities of the samples were measured before and after the 
addition of 1 % Triton X-IOO. The "Average Triton Value" represents a 
dilution corrected fluorescent average of all the samples. 
(b) Fluorescence for different mole percentages of RIB in EggPC SUV's. 
Lipid was dried from chloroform with the addition of 2 mole percent RIB. 
Fluorescence was measured on the initial sample. Lower RIB concentrations 
were obtained by addition of EggPC MLV vesicles which were co-sonicated 
with the labeled vesicles. At the conclusion of the serial dilution 
experiments, Triton X-IOO was added to the sample and the fluorescence was 
recorded. This value is recorded at the "0" point of the x axis. A separate 
control was run after this experiment giving a fluorescent value of 670 before 
and 109B after addition of Triton X-IOO. 
(c) Quench curve for data shown in part (a). 
(d) Quench curve for data shown in part (b) . 
(e) Excitation ( - . - ) and emission (- ) spectra of RIB. Curves a are 
excitation and emission spectra of 2 mol % RIB in DOPC vesicles. Curves b 
and c show the emission spectra of RIB in ethanol and chloroform, 
respectively. RIB-containing viruses of ghosts gave identical spectra as those 
obtained in a. From Hoekstra et al ., 19B4. 
(f) Efficiency of self-quenching in RIB in DOPC vesicles (A) and relief of 
selfquenching upon addition of Triton X-IOO to RIB-containing Sendai virus 
(B) . (A) SUV were prepared containing various amounts of RIB. The 
percentage of self-quenching was determined by measuring fluorescence 
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before and after addition of Triton X-I00 (1 % v Iv) . (B) RIB was incorporated 
into Sendai virus membranes (ca. 20 nmol/mg of viral protein) . Emission 
spectra (ex=560nm) were recorded before ( _ _ ) and after ( - - -) addition of 
Triton X-I00 (1 % v /v) . From Hoekstra et ai, 19B4. 
Figure 4. Fusion of reconstituted Sendai virus envelopes (RSVE) with H9 
cells, monitored by the RIB assay. (A) 261!g RSVE interacting with lxl06 H9 
cells in PBS. (B,C,O) 131!g RSVE with 5xl05 H9 cells. (B) The virus was 
pretreated with 100 I!g (ll!g/l!i) trypsin for 2 hours at 37° C. (C) The virus was 
treated with 1 mg Fetuin (10I!g/l!i). (0) The virus was suspended in two ml's 
of media with serum. 
Figure 5. Schematic representation of RIB diffusion during viral fusion. 
Figure 6. Summary of selected literature values for viral fusion inhibition. 
Figure 7. Summary of some of my own experimental values for viral fusion 
inhibition . 
Figure B. Comparison of the extent of dequenching of uninhibited and 
trypsinized samples at different ratios of Sendai virus to target ghost 
erythrocyte. In all cases 120 I!g of ghos t erythrocytes were used as the target 
cells. 5 I!I of virus contained 9 I!g of Sendai protein. 
Figure 9. Comparison of effects of order of trypsin treatment, RIB labeling, 
and purification on dequenching. 
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Figure 10. Comparison of dequenching after overnight incubation of R18 
labeled virus with and without trypsin treatment. 10 ~g of mumps (a) or 
Sendai (b) were incubated with various amounts of erythrocyte ghosts for 18 
hours . 
Figure 11. Schematic representation of F protein hydrophobic terminus 
serving as a bridge between membrane bilayers. 
Figure 12. Spectrum of R18 incorporated into the viral bilayer. 
Figure 13. Structures of the fluorescent lipid probe pair NBD-PE and Rd-PE. 
Figure 14. (a) Excitation (- - -) and emission ( __ ) spectra in 
phosphatidylserine vesicles containing 1 mol % fluorescent analogues. (A) 
Spectra of NBD-PE; (B) Spectra of Rh-Pe. 
(b) Efficiency of energy transfer as a function of the number of energy 
acceptors per phospholipid molecule (surface density). The molar ratio of 
NBD-PE to total phospholipids (1 :99) was kept constant while the amount of 
Rh-PE was varied to give the indicated surface densities. 
From Struck et al. ,1981. 
Figure 15. Quenching of NBD-PE by Rd-PE at two different ratios of acceptor 
to donor. Chloroform solutions containing the fluorescent lipid probes and 
egg phosphatidylcholine (PC) were mixed at set ratios, dried, and resuspended 
in phosphate buffered saline (PBS) as multilamellar vesicles (MLV's). 
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Fluorescent reading before and after the addition of Triton X-I00 were 
compared to determine the % Quenching (%Q = 1- (Initial 
Fl uorescence /Triton Fluorescence). 
Figure 16. Summary of the behavior of lipid probes and of the corresponding 
fluorescence in the probe mixing assay (A) and the probe dilution assay (B) . 
Figure 17. Dequenching profiles of NBD/Rd labeled and R18 labeled RSVE 
interacting with erythrocyte ghosts. The erythrocyte ghost amounts are 
shown as the underlined number and represent ~ of ghost added where 10 ~ 
of ghosts contains 13 Ilg of ghost protein. 
Figure 18. Comparision of the extent of dequenching observed with R18 
versus that observed with NBD/Rd in interaction of RSVE with ghost 
erythrocytes. 
Figure 19. Five kinetic curves obtained from reaction of labeled Sendai virus 
(from experiment 1 of figure 8 , i.e., native virus) with various amounts of 
ghost erythrocytes. 5 III of virus was equivalent to 9.0 Ilg of viral protein and 
40 III of ghost erythrocytes was equivalent to 96 Ilg of erythrocyte ghost 
protein. (a) Two raw data curves and (b) three smoothed data curves are 
presented to provide the reader with a perspective on the difference between 
raw and smoothed fluorescence data. 
Figure 20. Kinetic fits to data from Figure 17 using the simple bimolecular 
model. 
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Figure 21. Kinetic fits to data from Figure 8 using the simple bimolecular 
model. 
Figure 22. Kinetic fits to data from Figure 19 using the simple bimolecular 
model. 
Figure 23. Three mass action fits to a pair of data curves from Figure 17. The 
constants used to fit these two curve were: 
A- k1=.S2 x109, k2= .00223, k3= .002; 
B- k1= 1 x109, k2= .00223, k3= .00078; 
C- k1= 5 x109, k2= .00223, k3= .0002. 
Figure 24. Kinetic data from Figure 17 with curve fits provided by the rate 
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Figure 3b. 
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Figure 6. 
Author System Inhibitor % Uninhibited 
Chejanovsky et al.(1986) 
NBO RSVE/FELC Trp 20.5 
RSVE/FELC Trp 16 
" OTT 6.3 
" PMSF 15 
" Neuroaminidase 21 
NBO-Cl Sendai/FELC OTT .4 
Trp 2.3 
Neuro. 8 
" PMSF 2.1 
RSVE/FELC OTT 5.5 
" Trp 11.8 
Neuro. 17.4 
PMSF 17.4 
Chejanovsky et al. (1988) 
RI8 Sendai/HELA OTT 9.6 
Trp 15.3 
" PMSF 15.3 
Sendai/Ghost OTT 12 
" HN 12 
" F 16 
" HN-F 104 
Citovsky et al. (1985) 
NBO RSVE/Ghost Trp 5 
RSVE/HTC Trp 7.6 
RSVE/PC Trp 14.2 
RSVE/PC+ Trp 13.3 
Citovsky et al. 1988) 





Date System Time Inhibitor Fusion Notes 
7/2/f57 Mumps/Ghosts 1 hr None 7.7 R18 
" Trp 0 
" " OTT 0 
" 8 hr None 22.7 R18 
" Trp .7 
" " OTT 9.4 
4/1/89 Mumps/Ghosts 27 min None 17.7 R18 
" Trp 5.6 
4/11/90 Mumps/Cells 15 min None 25.0 R18 
Trp 4.0 
5/24/90 Mumps/Cells 15 min None 12.0 R18 
" Fet 6.0 
6/16/f57 RSVE/Ghost 15 min None 12.5 R18 
" " Trp 8.3 
" OTT 6.2 
6/24/f57 RSVE/POPC 15 min None 11.2 R18 
" Trp 9.0 
" OTT 3.0 
6/25/f57 Sendai/Ghost 15 min None 6.3 R18 
" Trp 3.8 
" OTT 0.5 
6/25/f57 Sendai/POPC 15 min None 12.4 R18 
" " Trp 13.1 
" OTT 7.5 
10/5/f57 RSVE/Ghosts 2000 sec None 7.4 R18 
" Trp 2.8 
" Pro 1.4 
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1O/7/fr7 RSVE/Ghosts 2000 sec None 24.1 NBD/Rd 
" Pro 1.7 
RSVE/PBL 600 sec None 37.1 
" " Fet 4.6 
" Trp 2.1 
3/14/90 RSVE/Ghost 1000 sec None 24.0 Rd-PE 
" Fet 11.2 
" " Trp 2.9 
4/2/90 RSVE/PBL 900 sec None 23.0 Rd-PE 
" " Fet 4.0 
" Trp 15 
" " Serum 0 
4/5/90 RSVE/H9 900 sec None 20 Rd-PE 
" " Trp 4 
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Trypsin Digestion Controls 
Procedures 
1. Normal Uninhibited- Label with RIB, Purify by Centrifugation 
2. Inhibited- Trypsinize, Label with RIB, Purify by Centrifugation 
3. Inhibited- Trypsinize, Label with RIB, Purify with G50 column 
4. Inhibited- Label with RIB, Trypsinize, Purify by Centrifugation 
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A. 9 ~g Sendai I 192 ~g Ghosts 
B. 9 ~g Sendai I 48 ~g Ghosts 
400 600 800 
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• / .... 
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a 200 400 600 800 
t (Seconds) 
RSVE(~g) Ghost (~I) Vo (M) Go (M) nGo (M) k 
1 .1 10 1.86e-12 2.0ge-14 1.81e-12 2.24e+8 
1 .1 20 1.86e-12 4.17e-14 3 .63e-12 2.27e+8 
1 .1 40 1.86e-12 8.30e-14 7.27e-12 2.08e+8 
1 .1 80 1.86e-12 1.60e-13 1.45e-11 1.82e+8 
1 .1 160 1.86e-12 3 .30e-13 2.90e-11 6.80e+7 
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Figure 21 . 
V (M) V act (M) Go (M) 
3.85e-12 5.77e-13 1.7ge-13 
9 .63e-12 1.44e-12 1.7ge-13 
2.8ge-11 4.33e-12 1.7ge-13 
Figure 22. 
Sendai (~g) Ghosts (~g) V (M) x 1e-12 
9 .0 96 1 .73 
18.0 192 3.46 
9.0 192 1 .73 
4 .5 48 8 .66 
9.0 48 1 .73 
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Chapter 3: The Reconstitution of Mumps and Sendai virus 
I. Introd udion 
For a tissue to be infected with a virus it must be exposed to that virus 
and it must be capable of supporting a complete virus replication cycle. 
These two factors determine viral tissue tropism, i.e., selective tissue 
infection. 
Entry pathways (skin, respiratory tract, gastrointestinal tract, etc.) 
determine initial cellular exposures, while bodily transport systems and 
viral infection pathways determine later cellular exposures. For example, a 
virus which is directly injected into the blood (by an insect, a wound, a 
needle, etc.) will be initially exposed to lymphoid and erythroid cell lines as 
well as those endOthelial cells lining the blood transport system. A virus 
could then infect the capillary linings and bud prodigy virus into the gut 
organ tissue. 
For a virus to successfully infect a cell, it must transport its replicative 
material to the cellular interior, all replication proteins must be active in 
the cell, functional viral proteins and nucleic acid must be produced, and 
the progeny virus must successfully exit the cell. 
Entry phase behavior is moderated by the proteins on the surface of the 
virus. A binding ligand is necessary on the viral surface for the virus to 
become associated with a cell. The viral surface proteins can confer direct 
specificity for certain cells by the recognition of factors on the surface of the 
cells. A tissue specific drug delivery system could be developed if this 
targeting behavior could be incorporated into an artificial delivery system. 
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The paramyxovirus mumps was chosen to test the feasibility of this idea, 
due to its infective properties and tissue tropism. 
Mumps only known natural host is man, where the infection is located 
in the T celilyrnphocytes, the respiratory tract, the kidneys, the pancreas, the 
salivary glands (the swelling in the parotid salivary gland gives mumps its 
name) and, most significantly, the central nervous system (CNS) (Wolinsky 
et al.,1985).1 Mumps can be detected in the CNS of 50% of infected humans 
(Wolinsky and Server, 1985). The infection of the CNS in humans is 
usually benign although meningitis is a common complication and 
encephalitis occurs rarely, which can result in terminal illness or 
permanent brain damage. The virus has been adapted to cell lines, chicken 
eggs and newborn hamsters (Cantell, 1961). In the newborn hamsters certain 
mumps viral strains will cause terminal encephalitis within 5 days of 
infection. The mechanism by which mumps enters and infects the CNS is 
unclear. Infection appears to cross into the brain at the choroid plexus, as 
shown by infection of these tissues and antibody staining of infected 
hamster brains. 
Drug delivery to the CNS of humans is an unresolved pharmaceutical 
problem, due to the existence of a blood brain barrier. This barrier is due to 
tight junctions existing between the endothelial cells lining the brain 
capillaries. For material to cross into the brain it must be selectively 
transported across the barrier or be highly hydrophobic and diffuse across 
the barrier via the lipid bilayers. The possibility of CNS targeting was one 
incentive for researching the mumps system. 
The mumps virus is made up of 6 proteins, a single stranded RNA, 
and a lipid outer membrane. The six regular proteins are the Large (L), 
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NucleoCapsid (NC), Polymerase (P), Matrix (M), Fusion (F) and 
Hemagglutination- Neuraminidase (HN) proteins (Jensik and Silver, 1976). 
The last two are glycoproteins and based on Sendai parallels are responsible 
for cell entry behavior (Tsao and Huang, 1986; Hoekstra and Klappe, 1986). 
The HN protein contains two activities, a Neuraminidase activity by which 
it can cleave terminal sialic acids from sialated glycosylations and a 
Hemagglutination activity, which is a binding activity that allows the 
agglutination of red blood cells. The F protein initiates fusion between host 
and viral membranes. The fusion protein (Fo) is cleaved upon appearance 
of the virus on the infected cell surface before viral budding to give a 
disulfide associated pair of proteins called FI (containing the 
transmembrane sequence and a highly hydrophobic N terminus) and F2 
(containing the signal sequence)(Herrler and Compans, 1983; Merz et aI., 
1983). Under examination by electron microscopy, these proteins appear on 
the surface of the virus as spike-like projections with knobbed heads and are 
often refered to as "spike proteins." 
Mumps virus belongs to a group of viruses that enter the interior of a 
cell by fusion with the exterior cell membrane bilayer in a pH independent 
manner, as opposed to viruses like influenza which enter the cell interior 
by fusing with the walls of a lysosomal compartment at low pH (White et 
aI., 1983). Fusion with the cell surface leaves the fusion and binding 
proteins on the surface of the infected cell. These proteins might then cause 
the formation of syncytia or giant cells by causing cells to fuse with one 
another. The other possibility for syncytial formation is the simultaneous 
fusion of a virus with two cells. The target on the cell surface for the 
mumps virus is most likely a negatively charged ganglioside, as the HN 
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protein naturally has a neuraminidase activity for such residues. The 
neuraminidase activity and binding activity appear to be located in the same 
site in the HN protein (Klamm, 1980; Server et ai., 1982) . In the related 
paramyxovirus Sendai it has been shown that the primary target is the 
ganglioside GQlb, with the ganglioSides GOla and GTlb as secondary targets 
(Markwell et ai., 1981). The N terminus of the F protein is highly 
hydrophobic and may playa direct role in membrane fusion by disrupting 
or bridging opposed viral and cellular bilayers. 
Mumps virus has evolved into a multitude of strains which can be 
divided into two classes, based upon their behaviors (Wolinsky and Stroop, 
1978; McCarthy et aI., 1980). The first class causes little syncytia formation or 
cell-to-cell fusion, has low pathogenicity in animal models, and contains a 
high ratio of neuroaminidase activity to hemagglutination activity. The 
second class of mumps strains causes a high rate of syncytia formation, is 
highly pathogenic and neuroinvasive and has a low ratio of 
neuroaminidase to hemagglutination activity (Merz and Wolinsky, 1981). 
The neuroinvasive activity of the virus can be related to the activities of the 
HN protein (Server et aI., 1982; Wolinsky et aI., 1985). Further evidence that 
the neuroinvasive properties are caused by the HN protein rather then the 
F protein is provided by the fact that the F protein is conserved in sequence 
across the strains while the HN protein varies in sequence and size, from 
75,000 daltons to 80,000 kilodaltons (Server et aI ., 1985a&b; McCarthy and 
Johnson, 1980). The other mumps virus proteins also show conservation in 
size across the strains. 
The reconstitution of the lipid and glycoprotein viral envelope has 
been previously accomplished for several viruses, including the influenza 
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virus, Semliki Forest virus, vesicular stomatitus virus and Sendai virus. 
The mumps virus is closely related to Sendai virus, another 
paramyxovirus, whose glycoproteins have been reconstituted into artificial 
membranes and tested for activity with ghost erythrocytes (Harmsen et aI., 
1985). The activity of Sendai virus glycoproteins has been examined in 
reconstituted "virosomes" or RSVE (Reconstituted Sendai Viral 
Envelopes)(Harmsen et aI., 1985; Vainstein et aI., 1984). The glycoproteins 
or membrane associated proteins are separated from the internal core of the 
virus and placed into a lipid bilayer made up of natural viral lipids or some 
synthetic lipids. A reconstituted system is noninfectious and allows one to 
study the behavior of the surface proteins. The reconstituted vesicles might 
carry drugs or markers in various in vitro (Uchida et aI., 1979) or in vivo 
(Vainstein et aI., 1983) delivery schemes. See Figure 1 for a schematic 
representation of a RSVE drug delivery to a target cell. 
It was my hope in beginning this project that one might successfully 
reconstitute the mumps glycoproteins HN and F in a similar fashion to that 
of Sendai. With such a system one could look at the tissue targeting 
behavior of the glycoproteins in vitro and in vivo in order to demonstrate 
whether tropism is determined by viral surface constraints. Of greatest 
interest in the in vivo animal studies was the possible interaction of the 
reconstituted vesicles with the central nervous system. The in vitro 
interactions of the vesicles with cells and ghost erythrocytes could also be 
studied by physical techniques in order to better understand the interaction 
of the viral proteins with the cell surface, and any conformational 
properties or changes in the viral protein structure created by interaction 
with a target cell surface. 
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II. Initial Reconstitution Studies with Mumps 
Introduction 
Initial reconstitution attempts were made with the mumps virus based 
on a method used previously with Sendai. The detergent reconstitution 
technique using octyl glucoside developed by Harmsen et al. was first 
examined (Harmsen et ai., 1985). Octyl glucoside has a high critical micelle 
concentration (CMC) giving it the desirable property of easy removal via 
dialysis. The general protocol of detergent reconstitution calls for the 
addition of detergent to the virus, dissolving surface glycoproteins and 
lipids. The interior proteins and nucleic acids are then removed by 
centrifugation. When the detergent is dialyzed away vesicles can form with 
the glycoproteins incorporated into their membranes. These vesicles can 
then be physically characterized and assayed for activity. 
Methods 
Virus- 3H Leucine labeled Kilharn strain of mumps virus was grown 
in CV-1 cells in roller bottles at the University of Texas Department of 
Neurology by Neal Waxham and associates (Server et ai., 1982). The virus 
was purified on a discontinuous 25/50 sucrose gradient and then frozen at -
800 . All work with live virus was performed at the viral facilities run by Dr. 
John Zaia at the City of Hope Hospital. 
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Reconstitution- In a series of experiments a variety of reconstitution 
methods were attempted, the conditions are summarized in Table 1. 
Procedures were very similar in form. The virus was washed in a 100,000 g 
centrifuge spin. The virus pellet was resuspended in buffer and octyl 
glucoside detergent was added to the solution. The solution was incubated 
for one hour at room temperature and then nondissolved material was 
pelleted out at 100,000 g. Dialysis was performed to remove the detergent 
octyl glucoside. The dialysed solution was centrifuged at 100,000g and the 
product pellet was resuspended in appropriate buffer. 
Five different reconstitutions were performed. Reconstitutions #1 and 
#2 were based on the method of Harmsen et ai. (Harmsen et ai., 1985). 
Reconstitution #3 used CV-l cells as target membranes for the reconstituted 
products in the fluorescent fusion assay. Reconstitution #4 involved 
running a parallel set of experiments using Sendai virus. Half of the 
reconstitutes used high pH/high salt conditions, based on work by Jensik 
and Silver showing a higher rate of protein solvation using these 
conditions Oensik and Silver,1976). Reconstitution #5 focused on the 
physical characterization of the products. Reconstitution was done in the 
presence of 20 mM magnesium as other reconstitution studies have 
indicated that magnesium facilitates the proper insertion of membrane 
proteins during reconstitution (Levitzki, 1985). 
Lipid and Protein Assays- Modified Lowry (Peterson,1977) and Bartlett 
(Itoh et ai.,1986) assays were used to determine the protein and lipid 
contents of the samples at various times. Protein concentrations could also 
be correlated to the amount of Tritium in a sample. 
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Transmission Electron Microscopy- 10 ~l of sample at various 
concentrations (-300~g protein/mi) was applied to carbon covered glow 
discharged grids and allowed to dry. 10 ~ of stain was then applied. 1% 
Phosphotungstic acid, 1 % Uranyl Acetate, and 2% Ammonium Molybdate 
were used as stains. The samples were examined at the Caltech Biology EM 
facility using the Phillips EM201 transmission electron microscope. 35 mm 
photos were processed in the lab used the Ectamatic film photo 
development system. 
Sucrose gradients- Sucrose gradients were prepared by the method of 
Luthe (Luthe, 1983). Gradients from 0-25% density were formed with a 50% 
bottom cushion. Reconstituted vesicles, vesicles treated with trypsin, and 
vesicles treated with pronase were placed on the surface of the gradient and 
centrifuged for 5 hours at 150,000 g. The gradient was removed from the 
centrifuge tube by puncture of the bottom of the tube and fractions were 
collected. The fractions were monitored for Tritium counts. 
Ghost Preparation- 0+ and A + human erythrocyte ghosts were 
prepared by the method of Steck (reviewed by Steck and Kant, 1974). 
Cell Line- Attached Green Monkey Kidney endothelial CV-1 cells were 
obtained from Neal Waxham and from the Cal tech cell culture facility (run 
by Norm Davidson). The cells were grown in Eagle's Minimum Media 
with 10 % Fetal Calf Serum. Cells were passed every 4-5 days. 
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Fluorescent Fusion Assays- All fluorescent measurements were made 
on a SLM 4800 fluorimeter attached to an IBM AT computer using SLM 
software. Two sets of fluorescent indicators were used in the fluorescent 
fusion experiments. 
NBD-PE and Rd-PE resonance energy transfer probes were 
incorporated into reconstituted vesicles by addition to the viral solution 
during detergent solvation (Struck et aI., 1981). Probe concentration was 
based on lipid content of the viral vesicles: NBD-PE and Rd-PE were added 
at 1.5 mole % and 2 mole % of the lipid content respectively. In a 
fluorescent fusion assay 5-25 mg of viral protein were placed with 2 ml 
buffer in a quartz cuvette. An emission prescan was made, exciting at 470 
nm and monitoring emission between 500 and 600 nm. Kinetic data were 
acquired by monitoring emission at 530nm (NBD emission) with the 
addition of ghost erythrocytes or CV-I cells to the cuvette. After acquiring 
kinetic data, a post-fusion scan of emission wavelengths was taken. The 
solution was then brought to a concentration of 1 % Triton X-IOO so that 
maximal NBD fluorescent output could be determined. The NBD emission 
value with Triton X-IOO represents maximal NBD fluorescence. 
The RI8 self quenching fluorescent probe was added directly in an 
ethanol solution to the reconstituted vesicles (Hoekstra et aI., 1984). 
Unincorporated RI8 was removed by passing the sample over a G50-IOO 
Sephadex 5 ml chromatography column. RI8 was added at 2 mole % of the 
lipid content. In the RI8 system the excitation wavelength was 560 nm 
while the emission at 590 nm was monitored. Kinetic data was acquired 
previous to and after the addition of ghost erythrocytes or CV-I cells to the 
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sample cuvette. Maximal emission was determined by adding Triton X-100 
to the solution. 
Hemagglutination Assay- Hemagglutination was assayed for by 
method of Salk (Salk, 1944). Serial dilutions of the virosomes were made 
and mixed with .5% 0+ red blood cells in a conical bottomed titer plate. 
Readings were made after several hours at room temperature . 
Hemagglutinated cells settled uniformly across the bottom of the plate 
while non-agglutinated cells settled into a dark spot at the bottom of the 
conical well. 
Fluorescence Microscope Studies- NBD/Rd labeled vesicles were 
applied to PBS rinsed CV-1 cell monolayers grown on cover slips. The 
mono layers were observed under a Nikon fluorescent microscope using 
NBD and Rd emission and excitement wavelength based filters . 
Light Scattering Studies- Measurements were made using a Malvern 
4700c photon correlation spectrometer equipped with a 455nm 5 watt 
Spectrophysics laser attached to an ATT PC with Malvern software. Most 
measurements were made at 900 with no size bias and maximum modal 
distribution parameters. Measurements at other angles were made to check 
for any major amplitude variations. Size bias parameters were inserted 
after initial data collection to further clarify size distributions. 
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Results 
Fluorescent Fusion Studies- In order to determine whether the fusion 
protein was still functional after reconstitution, the fluorescent resonance 
energy transfer probes NBD-PE/Rd-PE were added to several of the 
reconstituted systems. If fusion were to occur one would expect to see 
increased emission from the NBD probe as the spacing of the probes in the 
bilayer will increase and the rhodamine absorption effects will lessen due to 
the dilution of the virus associated probe into the target membrane (Struck 
et ai., 1981). The distance dependency behavior of resonance energy transfer 
is 1/r6, and therefore small changes in probe density can be detected by this 
method. RMVE were added to CV-l cells and human ghost erythrocytes 
(0+ and B+) . In no case was there any evidence of probe dequenching . 
The probe R18 was also used as a monitor of fusion by observation of 
lipid transfer . Transfer of the R18 probe to the target bilayer is indicated by 
increased fluorescence as the self quenching probe is diluted into the target 
bilayer (Hoekstra et ai., 1984). Transfer of the R18 probe was observed in 
every reconstituted mumps experiment where it was used, even in cases 
where trypsin or DTT was added in order to inhibit protein mediated 
fusion. Table II presents some of the results found with the labeled products 
of reconstitution #4. There would appear to be a base line transfer of probe 
through solution without bilayer fusion . With reconstituted Sendai 
systems a higher rate of dequenching (-12%) was seen that was affected by 
DTT and trypsin, being brought down to baseline transfer levels (-5%). 
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Hemagglutination assay and Fluorescence Microscope Studies- The 
Hemagglutination assay showed a high amount of binding activity in the 
reconstituted systems, requiring between 2 and 10 ng of glycoprotein to 
agglutinate 50!!1 of .5% red blood cells. Fluorescence microscopy showed 
CV-l cells with hundreds of glowing points attached to them, even after 
several buffer rinses, indicating that the virus readily bound to the CV-l 
cells. 
Electron Microscopy, Sucrose Gradient and Light Scattering- Initial 
studies with the electron microscope using PTA as a stain showed many 
>150 nm vesicles. Surface features were poorly contrasted with this stain. 
Upon usage of 2% Ammonium Molybdate, surface features became clear. 
Three different populations of reconstituted products became apparent. The 
first population was composed of large liposomes lacking surface 
projections and ranging between 250 and 400 nm in size. The second 
population was composed of small liposomes covered with surface protein 
projections, between 50 and 90 nm in size. These vesicles were similar to 
the reconstituted vesicles shown in the reconstitution paper of Harmsen. 
The third population consisted of filamentous protein aggregates . These 
elongated structures were covered with viral protein spikes and appear very 
much like a caterpillar in form. The aggregates ranged from 40-70 nm in 
length and 15-20 nm in width. Light scattering data also indicated that two 
size populations existenced, a large 250-400 nm population and a smaller 50-
100 nm population. 
Sucrose gradients showed three populations of products, a population 
which floated on the surface of the gradient and two populations in the 
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gradient which settled to 25% and 20% sucrose concentrations in the 
gradient, see Figure 2. These two populations disappeared from the middle 
of the gradient and appeared on the surface of the gradient upon addition of 
trypsin or pronase to the RMV£, indicating that these populations may 
have been protein aggregates digested into smaller less dense fragments or 
proteins cleaved from the surface of vesicles. Protein free vesicles are of low 
density and will float near the surface of the gradient. 
Conclusions 
Multiple reconstitution procedures to functionally reconstitute the 
fusion activity of the mumps virus were tried. While some fusion activity 
could be seen with Sendai via this octyl glucoside procedure, mumps failed 
to produce any protein dependent fusion activity. The lack of fusion 
activity might be due to the products observed by light scattering and 
electron microscopy, mainly protein aggregates rather then protein covered 
vesicles. 
Some parallels can be drawn between these results and experiments 
done by Helenius and collaborators with the alphavirus Semliki Forest 
virus. The Semliki Forest virus has two large glycoproteins (£1 and E2) and 
one small glycoprotein on its surface (£3). Helenius reports that when the 
Semliki Forest virus E proteins were solubilized in Triton X-I00 the three 
proteins remained in the form of a complex (Helenius and Soderland, 1973, 
Helenius et aI., 1977) but were dissociated when treated with 50S or 
deoxycholate (Helenius et aI., 1976; Becker et al.,1975) . When the E proteins 
were purified and reconstituted into synthetic membranes using octyl 
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glucoside as a detergent, Helenius et aI. found that El formed vesicles with 
the protein inserted, E2 formed protein aggregates and E3 precipitated out of 
solution (Helenius and Kartenbeck, 1980). They also reported that with 
parainfluenza, influenza, and Sendai virus, protein aggregates were the 
predominant octyl glucoside reconstitution product (Helenius et aI., 1981). 
Hsu, Scheid, and Choppin also experimented with the introduction of 
isolated Sendai glycoproteins into artificial bilayers (Hsu et aI., 1979). They 
found that at low ratios of lipid to F protein, protein aggregates were 
formed. At a high ratio of lipid to F protein, vesicles with incorporated 
protein spikes were formed. Vesicles with incorporated protein were 
formed at all concentrations attempted with the HN protein. In Harmsen's 
reconstitution paper using octyl glucoside he reports "Occasionally, thin 
filamentous structures were seen, entirely surrounded by spikes" (Harmsen 
et aI., 1985). 
My results show that the major fate of the viral proteins in octyl 
glucoside dialysis is protein aggregation. The highly hydrophobic N 
terminus of the Sendai and mumps Fl protein may cause the Fl to 
preferentially form protein aggregates. This in agreement with all of the 
above cited literature. 
Helenius attributes incorporation of glycoproteins into vesicles to be 
dependent on a number of factors, one of which is the rate of detergent 
removal (Helenius et aI., 1981). It is useful to have a detergent that is easily 
removed in dialysis, i.e., a detergent with a high CMC. However, in several 
viral reconstitutions in the literature and in my work with mumps, the 
rapid removal of octyl glucoside appears to be non-beneficial as some viral 
proteins do not preferentially incorporate into the lipid bilayer but rather 
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form protein aggregates. A detergent with a lower CMC will dialyse away at 
a slower rate but may give the protein more time to incorporate itself into 
the lipid bilayer. 
In order to avoid the formation of the protein aggregates, alternative 
detergent systems were tested and compared to the octyl glucoside products 
(section III). The detergents Triton X-IOO and C12E8 were used based upon 
their lower CMCs and the success of other workers using these detergents 
for reconstitution. The experiments were done with the model system 
Sendai, due to the ease and availability of working with Sendai, compared 
with the difficulties of working with and scarcity of the mumps virus. 
Careful examination to the actual reconstituted product forms were made. 
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III. Reconstitution Studies on Sendai Virus Using Octyl Glucoside, Triton X-
100, C12ES. and Short Chain Lipids 
Introduction 
Reconstitution of Sendai using either octyl glucoside or Triton X-100 
has been reported in the literature (Harmsen et aI., 1985; Vainstein et aI., 
1984). Harmsen et al. reported successful reconstitution of the virus based 
upon successful fusion of the vesicles with erythrocyte ghosts. They 
reported that Triton X-100 reconstituted vesicles were defective in fusion 
ability. Vainstein et al. have reported a Triton X-100 reconstitution of 
Sendai and upon the basis of hemolysis activity maintain that Triton X-100 
reconstituted vesicles were functional while octyl glucoside vesicles were 
defective in fusion ability. The use of SN-2 Biobeads to remove the Triton 
X-100 selectively from solution allows the use of Triton X-100 as an 
alternative detergent to octyl glucoside (Holloway, 1973). The Harmsen 
vesicles were reported to be 75nm in diameter while the Vainstein vesicles 
were lOO-300nm in diameter. A larger vesicle may be of more use in drug 
delivery of aqueous drugs as it has a much larger volume of encapsulation. 
Both reconstitutions were repeated in order to test the literature statements. 
A third detergent, C12E8, has been used to reconstitute vesicular 
stomatitis virus (VSV)(Metsikko et aI ., 1986). The effects of this detergent in 
Sendai reconstitution were also examined. In addition the usage of 
shortchain lipids was investigated in reconstitution (Gabriel and Roberts, 
1984, Gabriel and Roberts, 1986, Roberts and Gabriel, 1987). 
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The rigorous NBD/Rd fusion assay was used to determine vesicle 
fusion. It has been documented (Duzgunes, 1987) and shown in our lab that 
this probe system gives the most consistent results in other systems less 
complex than viral fusion, such as Ca++ induced PS fusion and freeze-thaw 
induced SUV fusion (Goodrich and Baldeschwieler, 1988). 
Methods 
Virus- Sendai virus was propagated in 10 day old fertilized chicken 
eggs. The virus was injected into the allontoic cavity of the eggs and 
allowed to grow for three days. The allontoic fluid was then harvested and 
the virus was purified by centrifugation, alternating between spins of 5,000g 
and 15,000g to pellet debris and virus respectively (Scheid and Choppin, 
1976). The virus was stored at -800 . 
Reconstitution-In all reconstitution methods the product was stored on 
ice and used in assays within 48 hours. If the products were frozen and then 
thawed before any assays were performed, hemagglutination activity was 
preserved while fusion activity was destroyed. 
Octyl glucoside reconstitution was performed by the method of 
Harmsen et a!. (Harmsen et a!., 1985). 1 mg of virus was pelleted at 100,000 g 
for 1 hour and resuspended in 140 mM NaCl, 10 mM Hepes, 50 ~M PMSF, 
and 50 mM octyl glucoside. The solution was incubated for one hour at 
room temperature (RT) and nondissolved material was removed by 100,000 
g centrifugation for 1 hour. The sample was dialyzed against 25 ml buffer 
for 1 hr at RT. The dialysis was repeated and then the sample was dialyzed 
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against 50 ml buffer for 2.5 hr at room temperature. Dialysis was completed 
by 3 six hour dialysis periods against 250 ml of buffer at 40 C temperature. 
The products were then collected by centrifugation at 100,000 g for 1 hr. 
Triton X-I00 reconstitution was performed by the method of Vainstein 
et ai. (Vainstein et ai., 1984). 1 mg of virus was pelleted and resuspended in 
20 1.11 of 100 mM NaCi, 50 mM Tris-HCL, .1 mM PMSF, and 10% Triton 
buffer. The solution was shaken for 1 hr at RT. Nondissolved material was 
removed by centrifugation at 100,000 g for 1 hr. 15 mg of SN-2 Biobeads 
were added to the solution. The solution was incubated for 4 hours while 
shaking. An additional 15 mg of Biobeads was then added along with 20 ~ 
of 160 mM NaCi /20 mM Tris-HCI buffer. This solution was shaken for 14 
hours at room temperature. The cloudy solution was removed from the 
beads via a Hamilton syringe and the products were isolated by pelleting at 
100,000 g for an hour. 
C12E8 reconstitution was based on the above Triton reconstitution and 
Metsikko's work on reconstitution of VSV with C12E8 (Metsikko et ai., 
1986). 2 mg of virus was pelle ted at 100,000 g for Ihr. The pellet was 
resuspended in 70 ~ of 100 mM NaCi/50 mM Tris/ .5 mM EDTA/ .s ~ 
PMSF/ 100 mM C12E8 ' The solution was shaken for 1 hr at RT. The 
nondissolved material was removed by centrifugation at 100,000g for 1 hr . 
20 mg of SN-2 Biobeads were added and the solution was shaken for 2 
hours. Shaking was resumed for 14 hours after the addition of 20 mg more 
biobeads. The product was removed by Hamilton syringe and collected by 
centrifugation at 100,000 g for a Ihr. 
Short chain lipid reconstitution was based on the work of Gabriel and 
Roberts (Gabriel and Roberts, 1984, Gabriel and Roberts, 1986,Roberts and 
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Gabriel, 1987). Virus was collected by centrifugation at 100,000 g and 
resuspended in 450~1 of 100 mM NaCl/50 mM Tris/.5 mM EDTA buffer. To 
this a 50 ~l solution of 20mM Diheptanoyl-PC was added. The short chain 
lipid solution was prepared by vortexing dried short chain lipid with buffer. 
The ratio of viral lipid to short chain lipid was 1:2 at this point. This 
solution was shaken for 1 hr at RT and then centrifuged for 40 minutes at 
100,000 g. The supernatant was added to a 100~ solution of 50 mM DPPC 
ML V's. The mixed solution was vortexed for several minutes and then 
shaken at RT for 4 hours. The DPPC MLV's were prepared from a dried 
solution of DPPC which was vortexed with buffer for several minutes and 
bath sonicated for 1 minute. The DPPC solution was exposed to a 460 bath 
for 20 seconds in order to disperse aggregates of DPPC. The product of the 
reconstitution was then collected by centrifugation at 100,000 g for Ihr. 
Fluorescent Monitoring of Fusion- The resonant energy pairs of probes 
of NBD-PE and Rd-PE were used to monitor fusion in these systems (Struck 
et a!., 1981). Each of the probes was added at 1.5 mole % of the lipid content 
of the reconstituted vesicles. The probes were added to the detergent 
dissolved virus in the octyl glucoside, Triton X-I00 and C12E8 
reconstitutions and were incorporated into the DPPC MLV's in the 
shortchain lipid reconstitution. Fluorescent measurements were made on a 
SLM 4800 using SLM software in an attached IBM AT computer. The 
reconstituted virus was excited at 470 nm and prescanned for emission 
between 500 nm and 600 nm. Kinetic data was collected by monitoring at 
530nm. A+ human erythrocyte ghosts were used as the target membranes 
in all cases. Post fusion scans were made with and without the addition of 
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Triton X-lOO. The fluorescence at 530 after the addition of .5% Triton was 
treated as maximal fluorescence for NBD, after correction for Triton 
quenching. 
Fluorescence Microscope studies, Transmission Electron Microscopy, 
Hemagglutination Assay, Light Scattering Measurements- Performed as in 
Section II. 
Animal Studies-Virus was reconstituted by the Triton X-I00 method 
and loaded with ll1In. Reconstitution buffers included 10 mM NTA. 
Nonencapsulated NTA was removed by centrifuging at 100,000g through 
NT A free buffer twice. 1 0 ~l 111 In was dryed under a heat lamp and 
resuspended in 10 ~l HCl by vigorous vortexing. 100 ~l buffer was added to 
the 111In solution along with 3 III of ACAC. This loading buffer was then 
added to the NTA filled virosomes. The solution was incubated at 370 or 
RT for 1 hr; both temperatures led to satisfactory loading (Beaumier and 
Hwang.,1982). Nonencapsulated ll1In was then removed by centrifuging 
the sample three times at 100,000g for 40 minutes through 5 ml of Indium 
free buffer. Serum stability studies were performed on the vesicles by 
monitoring the <G22> of the 111 In by PAC for up to two days (Hwang et aI., 
1980). Alternately 200 ~l samples of 2 mg starting virus were injected into 
the tail vein of female adult BalbC mice. At two time intervals mice were 
sacrificed by heart puncture and their organs were counted for distribution. 
<G22> values were taken for organs with enough counts to monitor using 
the PAC device. 
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Results 
Light Scattering and EM Data- Sendai virus appeared as polyploidal 
objects with spike projections on the viral surface. The virus ranged 
between 330-400nm in size. See Figure 3 for size distributions. 
Octyl Glucoside dissolved virus consisted of micelles less than 2.4 nm 
in diameter and mostly less then 1.4 nm in diameter. 
Three products were formed after detergent dialysis . The majority of 
the volume was made up of large protein-free or "bald" vesicles between 
300-400 nm in size. Light scattering showed a second set of particles between 
50-130 nm, see Figure 4. EM revealed this to be made up of two populations, 
protein-covered or "spiked" liposomes and protein aggregates. These 
aggregate structures were filamentous with spike-like projections, appearing 
in form like a caterpillar. The aggregates tend to be no longer than 70nm 
long and 20 nm wide. The protein aggregates make up the majority of the 
visible products under the electron microscope. 
RSVE's prepared by the Triton X-I00 method also showed two 
populations by light scattering. The large population ranged between 250-
600nm, with the majority of vesicles between 300 and 400 nm, while the 
small population ranged from SO-170 nm (see Figure 5). Under examination 
in the electron microscope both populations consisted of vesicles covered 
with viral protein spikes. The large population made up 90% of the total 
mass and 30% of the total number of particles. 
RSVE's prepared with C12ES appeared as fairly uniform viral spike-
protein-covered vesicles under EM examination. Light scattering showed a 
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major population between 300 and 500nm with a shoulder of vesicles 
tailing down to 160nm (Figure 6). 
Protein-free large liposomes 300-500nm in size were observed when 
the short chain final products were examined. Protein-spiked vesicles were 
found, however, in the pelleted non short chain lipid dissolved material. 
These "Jumbosomes" ranged between 600 and 2500 nm, the majority being 
between 6S0 and 1200 nm in size, see Figure 7. Viral spikes covered both 
their external and internal surfaces. 
Fusion monitored by Fluorescent quenching release- The products of 
octyl glucoside, Triton X-IOO, and C12ES reconstitution all showed protein 
dependent fusion with target A+ ghost human erythrocytes. Some kinetic 
investigation into the C12ES fusion was made, see Figure S. This binding 
curve was created by using various ratios of reconstituted virus to ghost 
erythrocytes. A saturation of the available fusion sites can be seen with a 
limit of approximately .5 ~g viral protein per ~g ghost protein. Fusion 
activity was destroyed by freezing the reconstituted product at -700 C. 
Hemagglutination assay- The Triton X-IOO vesicles required a 
minimum of 4-6 ngs of protein to agglutinate 50 ~l of .5% A+ red blood 
cells. 
Fluorescence Microscope Observation- RSVE's produced by octyl 
glucoside, Triton X-IOO, or C12ES could be observed bound to the surface of 
CV-I cells. Some glowing auras could be detected around the cells which 
could be interpreted as probe released by fusion into the cellular membrane. 
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Animal Injections- The distributions of lllIn radiation in mice are 
shown in Figure 9. The bars shown are calculated by dividing the counts in 
an organ by the weight of the organ in grams and then dividing by the total 
counts injected into the animal. The material was fairly stable in the blood 
and accumulated in the reticuloendothelial organs, i.e., liver and spleen. 
Conclusions 
While octyl glucoside, Triton X-IOO and C12 E B detergent 
reconstitutions of Sendai all produced products that were functional in 
binding and fusion activity, the sizes and shapes of the reconstituted 
products differed greatly. The octyl glucoside procedure gave three 
populations, protein-free 300nm vesicles, protein-spike-covered 100nm 
vesicles and 60nm protein aggregates. The Triton X-IOO reconstitution 
procedure gave two populations, a smaller 100 nm protein-spike-covered 
vesicle population and a larger 300nm protein-spike-covered vesicle 
population. The C12EB reconstitution gave one broad set of 250nm protein-
spiked vesicles. 
Octyl glucoside is considered to be a "strong" detergent, i.e., a detergent 
that will break up protein subunits and replace lipids tightly associated with 
a glycoprotien. This property and its high CMC make it a useful detergent 
for many chemical examinations of glycoproteins, including X-ray 
crystallography. However, for purposes of functional reconstitution a 
"weak" detergent such as Triton X-IOO may function much better, allowing a 
glycoprotein to stay associated with local lipids and other protein subunits. 
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Usage of these detergents was in response to the early results with 
mumps. In the next section the results of using these detergents with 
mumps is examined, as the Sendai work indicated that the detergents 
Triton X-I00 and C12E8 might be more useful in reconstitution. 
The reconstitution using short chain lipids gave rather different results 
then those expected in designing the experiment. Proposed was a solvation 
of the virus lipids and glycoproteins in a short chain lipid detergent 
micelles. These micelles would normally form spontaneously large 
unilamellar vesicles upon the addition to a solution containing 
multilamellar vesicles of DPPC (Gabriel, 1984&1986; Roberts, 1987). By this 
means, protein might be incorporated into a large unilamellar vesicle. 
Instead initial solvation was only partial and very large vesicles (> 600nm in 
diameter) that had lost their viral core material were pelleted by 
centrifugation. These vesicles showed proteins oriented on both sides of the 
lipid bilayer. 
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IV. Reconstitution and Animal Studies with Mumps Virus 
Introd uction 
Having completed a survey of reconstitution with the Sendai virus, 
repetition of the detergent reconstitution methods using mumps was 
attempted. Similar reconstitutions were performed and tested for fusion 
and binding activity and were characterized physically by light scattering and 
electron microscopy. In addition the tissue distribution of reconstituted 
mumps injected into infant hamsters was investigated, with emphasis on 
penetration into the central nervous system. 
Materials and Methods 
Virus- The Kilham strain of virus was again used as obtained from 
Neal Waxham at the university of Texas. 
Reconstitution- Octyl glucOSide, Triton X-IOO and Cl2ES 
reconstitutions were prepared in the same manner as described in section 
III, substituting mumps for Sendai virus. All samples were prepared with 
NBD-PE and Rd-PE fluorescent probes being added to the detergent solution 
in amounts equivalent to 1.5 mole % and 2 mole % of the total lipid 
content, for NBD and Rd respectively. 
A Triton X-IOO reconstitution with lipid supplement was also 
performed. lmg of mumps virus was peUeted at 100,000g for one hour. 40 
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~l of 10% triton buffer with NTA was then added, the pellet was 
resuspended and shaken for 1 hour. The undissolved material was 
removed by centrifugation at 100,000g for one hour. To the detergent 
solution 40 ~ of buffer containing 1.5 mg of DSPC and .5 mg of cholesterol 
was added. 30 mg of SN-2 Biobeads were then added and the mixture was 
shaken 4 hours at RT. An additional 30 mg of biobeads were then added 
along with 40 ~l of 160 mM KCl/20 mM Tris buffer. The solution was 
shaken for 14 hours, the solution removed from the beads by a Hamilton 
syringe and then again centrifuged at 100,000g for one hour to pellet out the 
prod uct vesicles. 
Fluorescent Fusion Studies- Fluorescent fusion studies were performed 
in the same manner as described in Section III with the modification that 
0+ ghost erythrocytes were used as fusion targets. 
Fluorescence Microscope Studies, Electron Microscopy, 
Hemagglutination Assays, and Light Scattering Measurements- All these 
assays were performed as described in section II. 
Animal Studies- Reconstituted vesicles were prepared and loaded with 
111In as discussed in Section III. Newborn Syrian hamsters between 4 and 6 
days of age were injected intraperitoneally with 200 ~l of vesicles containing 
the reconstituted product from 1 milligram of starting mumps viral protein. 
Animals were sacrificed by heart puncture and their organs removed and 
counted with a gamma counter with windows for l11In. A summary of the 
recovered radioactivity is given in figures 13 and 14, based upon % of total 
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recovered/g tissue, corrected for the blood within each organ (Hwang et al., 
1980). 
Results 
Product Recovery- 3H protein counts showed that 8.5% of the initial 
viral protein was reconstituted in the Triton X-l00 procedure. 18% of the 
protein was recovered using the C12E8 method and 9% recovered using the 
octyl glucoside method. A maximal recovery of surface glycoproteins 
should be about 20%. 
Fluorescent Fusion Assays- NBD-PE and Rd-PE labeled vesicles were 
monitored for fusion after the addition of 0- ghost erythrocytes. No fusion 
activity was seen with any of the reconstituted products. 
Hemagglutination Assay-All reconstituted vesicles showed 
hemagglutination ability. The minimum required protein amounts to 
agglutinate 50 J.ll of .5% 0+ erythrocytes are shown in Table ill. 
Fluorescence Microscopy-Binding to CV-l cells was observed under 
the fluorescent microscope. All reconstituted vesicles showed strong 
binding tendencies, as observed as glowing points attached to the surface of 
the cells. 
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Light Scattering Data- Triton X-lOO reconstituted vesicles showed a 
wide distribution of vesicle sizes between 200nm and 700nm in size, the 
majority of vesicles being between 250 and 400 nm in size (Figure 10). 
C12E8 reconstituted vesicles also showed a wide distribution of sizes 
between 200 and 700 nm in size with the majority of vesicles being 250nm to 
400 nm in size. Larger sized vesicles were less frequent in the C12E8 
reconstitution products as compared to the Triton X-I 00 reconstitution 
produet.(Figure 11). 
Oetyl glucoside reconstituted vesicles showed two populations by light 
scattering. The smaller population was between 90 and 200 nm in size 
while the larger population was between 250 and 500nm in size. See Figure 
12. 
The Triton X-I00 reconstituted vesicles supplemented with lipid were 
between 460 and 1200nm in size with a fairly even distribution of numbers 
across this range. 
Animal Studies- As the binding protein of the reconstituted virus 
appeared to be functional in hemagglutination and fluorescence microscope 
studies, some preliminary animal experiments were performed. As 
mentioned in the introduction, the binding or HN protein structure 
correlates with the ability of the virus to be neuroinvasive. The literature 
animal system of baby syrian hamsters was used ( Kilham and Overman, 
1953, Kilham and Murphy, 1952). The animals were injected 
intraperitoneally, the only available avenue, besides intracerebrally, in 
animals of their size. The first experiments showed 111 In counts in the 
brain after correction for blood associated counts, due poSSibly to some blood 
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brain barrier penetration, see Figure 13. Also observed was a large 
association of radioactivity with the backbone and spine. The experiments 
were repeated with a second batch of animals where mumps virus and 
control DSPC/Cholesterol liposomes were also injected, see Figure 14. It 
became apparent that much of the blood brain penetration was due to some 
amount of leakiness in the brains of these animals as some control 
liposomes also penetrated into the brain. The association of the 
reconstituted vesicles with the spine and ribs is strong in these animals. 
The RMVE containing native viral membrane appear to have a higher 
blood stability than the DSPC/Chol supplemented or plain DSPC/Chol 
vesicles. 
Conclusions 
In no case was there evidence that the fusion protein of the mumps 
virus was reconstituted functionally . Several possible reasons for this 
inactivity were tested. Early experiments involved reconstituted virus that 
had been stored at -700 . We have found with Sendai virus that freezing and 
thawing the reconstituted virus results in loss of fusion activity. In the case 
of mumps experiments no activity was seen with refrozen virosomes or 
nonrefrozen virosomes. Multiple reconstitution methods were undertaken 
in the hope that under certain detergent or buffer conditions activity could 
be preserved, yet no conditions proved successful in preserving fusion 
activity. One possibility reason for this failure in reconstitution was that the 
whole virus did not contain membrane fusion activity. The starting 
material was prepared in another lab and was not tested for activity before 
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conducting these experiments. To test the fusion ability of native mumps, 
one can label whole virus with RIS and look for fusion via fluorescent 
assay, but, as previously noted this assay tends to give spontaneous non-
protein-dependent transfer. This experiment was attempted twice, the first 
time showing some protein mediated RIS transfer, while the second time 
no activity was observed (see Chapter 4 Appendix, 1.). When the virus is 
grown, the Kilharn strain of mumps causes a great deal of syncytia and cell 
disruption. For this reason the virus is purified on a sucrose gradient. This 
gradient can cause the virus to lose 99% of its infectivity. This loss might be 
due to a irreversable conformational change in the fusion protein, making 
reconstitution functionally a difficult task. 
Two other possibilities existed for the lack of fusion activity. While 
attachment is seen to the surface of the target ghost erythrocytes and CV-I 
cells, some other target site for the fusion protein might have been missing. 
There was also the possibility that the virus had a much slower fusion 
activity than Sendai and that fusion occured at a rate undetectable by the 
fluorescent methods «2% fusion per hour). The fusion activity of the 
native virus had not yet been determined. 
The structure and size of the reconstituted products are described in the 
results section. Reconstitution by Triton X-IOO or C12ES has an advantage 
over octyl glucoside reconstitution in that the formation of protein 
aggregates is avoided. Both Triton and C12ES reconstitution gave a single 
population of vesicles with mumps, C12ES vesicles being slightly more 
homogeneous in distribution. Comparison of mumps reconstituted 
products with Sendai reconstituted products show that the octyl glucoside 
and C12ES reconstitution products are very similar with both viruses. The 
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Triton X-I00 reconstitution, however, gave a much more homogeneous 
population of vesicles with mumps. Further experiments used vesicles 
prepared by Triton X-I00 and C12ES methods rather than the octyl glucoside 
method . 
Studies with the preferred literature animal system in terms of 
targeting to the central nervous system were inconclusive. In any event 
there was no dramatic targeting to the brain by the mumps envelopes. 
Future experiments should seek an infectable candidate with a known rigid 
blood brain barrier. Full grown mice contract a slow infection of the virus 
and might be used (Overman et aI., 1953, Kristensson et aI., 1984) 
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v. Reconstitution with "Caitech/City of Hope" Mumps 
Introduction 
In order to exam the activities of whole mumps virus and determine if 
alternative starting material could lead to successful reconstitution, Kilharn 
strain mumps virus was prepared. The whole virus was examined for 
activity (see Chapter 4) as was Triton X-I00 reconstituted virus. 
Methods 
Mumps Growth and Purification- CV-l cells were grown in MEM media 
with 10% FCS in 150 cm2 bottles until confluent and then transferred to 800 
cm2 roller bottles. The cells required 4-6 days to become confluent in these 
larger bottles. The medium was then removed and the cells washed with 
Hanks solution. Seed solution of mumps virus (2 to 5 m!) was then added 
to the roller bottle along with Hanks buffer to bring the total volume up to 
10 ml per bottle. The bottles were then incubated for 2 hours at 37° while 
rotating. The inoculum was aspirated and new media was added, 
containing 20 mM Hepes as buffer. Alternatively the bottles were gassed 
with 5% C02 for 60 seconds. After 3 to 4 days large scale destruction of the 
cell monolayer was apparent and the medium was removed. The media 
could be frozen at this point for use as "seed" virus in future viral 
preparations. Cell debris was removed by pelleting at 1500 rpm for 10 
minutes in a lab top centrifuge using 50 ml conical tubes. The supernatant 
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was transferred to high density tubes and centrifuged in a SS-34 rotor for 40 
minutes at 15,000 rpm (= 2s,000g). The pellet was resuspended in PBS and 
used for later experiments or stored by freezing in liquid nitrogen after the 
addition of 10% glycerol. This preparation was run on a small scale to 
prepare "seed virus" and on a larger scale to prepare experimental virus. 
Plaque and Cell Death Assays- Plaque and cell death assays were run on the 
seed and experimental virus in order to determine viral infectivity. Serial 
dilutions of the virus in 1 ml Hanks buffer were added to six well plates (10 
cm2/well) containing confluent CV-l cells (media removed) and incubated 
at 37°C for 2 hours. The inoculum was then removed. The cells were then 
covered with media in the cell death assay. For the plaque assay agar/media 
or methylcellulose/media were used to cover the cells. To prepare the agar 
overlay, agar was dissolved in boiling water and mixed with 2X media. 
Upon cooling to 35°C, serum was added to the mixture and the overlay was 
placed on the cells. The methylcellulose overlay consisted of a 1:1 mixture 
of 2X media and 2% methylcellulose. 
Preparation of RMVE-
Short term fusion experiment- Five roller bottles were used to produce 
virus that was purified and resuspended in 14 ml PBS. Two reconstitutions 
w ere conducted on 4 ml samples of this preparation. The virus was pelleted 
at 100,000g for 1 hour in the SWsO.l rotor . The mumps pellet was then 
resuspended in 100 ~l of Triton X-I00 (in 100 mM NaCl, 50 mM Hepes) or 
140 ~l of C12ES. The mixture was shaken at room temperature for 2 hours 
and then centrifuged at 100,000g for 40 minutes to remove undissolved 
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material. The fluorescent probes NBD-PE and Rd-PE were added to the clear 
supernatants in the amounts of 6 ~g NBD-PE and 8 ~g Rd-PE to the Triton 
X-IOO mixture and 12 ~g NBD-PE and 16 ~g Rd-PE were added to the C12E8 
mixture. 100 mgs of SN-2 biobeads were then added to the mixture, the 
solution was vortexed, and then shaken for 4 hours. An additional 100 mg 
of SN-2 Biobead were then added along with 100 ~l of solution A (160 mM 
NaCI, 20mM Hepes) . After shaking at room temperature for an additional 
15 hours the cloudy RMVE were removed from the beads with a Hamilton 
syringe, the beads were washed, and the product was pelleted by 
ultracentrifugation (lOO,OOOg for 40 minutes) . Lowry protein measurements 
gave yields of 125 ~g RMVE from the Triton X-IOO reconstitution and 95 ~g 
from the C12E8 reconstitution. 
Long term fusion experiment- From a seven bottle mumps preparation 
2 ml (~460 ~g mumps protein) PBS suspended product were used in the 
reconstitution. The same general procedure as described above was used 
with: 100 Ili Triton X-IOO used to dissolve the virus, 1 ~g NBD and 1.2 ~g 
Rd-PE being used to label the virus, 50 mg biobeads used in initial dialysis, 
50 mg biobeads and 50 ~l solution A used after the 4 hour incubation. The 
preparation yielded 50 ~g of RMVE. 
Serum Stability Experiment- RMVE were prepared from the mumps 
preparation described above in the short term fusion experiment. 1.8 ml of 
virus solution (~ .2 mg) was pelle ted and reconstituted as described above 
with: 50 Ili Triton X-IOO used to solvate the virus, 50 mg biobeads used in 
initial dialysis, 50 mg biobeads and 50 ~l solution A used after the 4 hour 
incubation. All solutions contained 10 mM NTA, a chelate for the 111In 
loading. After pelleting the final product the sample was resuspended in 
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100 ~l PBS without NT A. The 111 In was prepared by drying 10 ~l of 111 InCI 
(= .1mCi) and then serially adding 10 ~l 3 mM HCI, 100 ~ PBS, and 3 ~l 
ACAC, with vortexing between each addition. The RMVE were then mixed 
with this solution and incubated at RT for 1.5 hours. A large volume of PBS 
was added (4 ml) and the RMVE were pelleted by ultracentrifugation. The 
wash was repeated. The RMVE were found to contain =45% of the added 
111 In, as measured by radiation output (geiger counter). 
Whole virus 1251 Labeling Experiment- One tube out of eleven from a 
10 roller bottle preparation was labeled with 1251 and then reconstituted. 
The method of reconstitution was as detailed above with the following 
parameters: 100 ~l Triton X-I00 used to solvate the virus, 70 mg biobeads 
used in initial dialysis, 70 mg biobeads and 100 ~l solution A used after a 3 
hour incubation. 
Reconstituted Sendai labeling experiment- One tube out of eleven 
from a 10 roller bottle prep was reconstituted and then labeled with 1251. 
The method of reconstitution was as detailed above with the following 
parameters: 50 ~l Triton X-I00 used to solvate the virus, 50 mg biobeads 
used in initial dialysis, 50 mg biobeads and 50 ~l solution A used after a 6 
hour incubation. 
Labeling with 1251_ Disposable glass test tubes were coated (10 ~g for a small 
tube, 30 ~g for a large tube) with Iodogen reagent and dryed. Mumps virus 
or RMVE were placed inside the coated test tube and 5 ~l Nal25I was added. 
The reaction was allowed to procede on ice for one hour. The sample was 
removed from the tube, the tube washed and the virus or RMVE was then 
pelleted by ultracentrifugation. The pellet was washed with PBS. 
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Perturbed Angular Correlation Spectroscopy Serum Stability Studies( PAC)-
PAC was conducted on 111 In loaded RMVE to measure <G22> values in the 
absence and presence of serum. The PAC was calibrated to give a <G22> 
reading of .671 for a mixture of l11In and NTA and a reading of .198 for a 
mixture of 111 In and serum. 
Fluorescent Fusion Assay, Protein Assay, Ghost Preparation- Conducted as 
described in section II. 
Results 
Comments on virus growth and purification-
Initial attempts at virus growth ran into a number of problems, 
primarily caused by repeated contamination of cell culture. Fungal 
contamination was present in a number of the seed cultures used to grow 
virus. Cells were grown to high densities and tended to be very susceptible 
to contamination when the media became very acidic. After inoculation 
with virus, the roller bottle cultures are sealed to the external atmosphere 
and must be buffered by adding external C02 to the bottle or by adding 
HEPES buffer to the media. I found the first method to be very susceptible 
to error in providing proper pH balance for the cells. 
Purification without the use of sucrose gradients was easily achieved. 
The sucrose gradients were originally used to remove fragmented cellular 
material from the growth supernatant. Gel elecrophoresis examination of 
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the protein products showed that little material other than virus and BSA is 
purified by differential centrifugation. 
The one persistent contaminant during purification is bovine serum 
albumin (BSA) which is a major component of the fetal calf serum (FCS) 
used as a supplement to the cell growth mixture. This protein is only 66 kD 
MW and should be separated from the virus by ultracentrifugation but most 
likely sticks to the centrifuge tube and perhaps to the virus. Quantification 
of virus amount is aggravated by the presence of this contaminant. 
Presence of BSA during purification procedures is difficult to detect as it has 
a very similar apparent molecular weight to the mumps NC protein, the 
most abundant protein in the virus. Multiple ultracentifuge purification 
cycles were conducted to remove the BSA and determine the amount of 
virus present. One additional cycle of ultracentrifugation appears to 
remove the majority of the BSA. Under standard growth conditions, 
approximately 250 ~g ± 50 ~g were prepared per 800 cm2 roller bottle. 
Fluorescent fusion assays-
Short term- Kinetic measurements were made of the fusion of virus 
with erythrocyte ghosts using the NBD/Rd probe pair system. Fluorescent 
dequenching was apparent providing evidence for successful reconstitution 
with Triton X-I00 (Figure 15). 
Long term- Overnight incubation of RMVE with ghost erythrocytes 
was conducted. As the amount of target membrane was increased fusion 
increased and then leveled at ~28% (Figure 16). Thus only a limited 
number of reconstituted envelopes contained fusogenic activity. 
Approximately 350 viral receptors were available per cell. 
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Serum Stability- PAC spectroscopy was used to observe the stability of 
RMVE. As vesicles are destabilized and disrupted by serum their NT A 
chela ted 111 In becomes exposed to serum and tightly bound by serum 
proteins. This produces a comparatively low <G22> (.2) to that of the 
loosely bound l11In/NTA complex (.67). The loaded RMVE gave a <G22> 
value of (.53±.03) . This lower value may be due to interaction of the 111 In 
with the viral proteins. In serum, 30% of the vesicles degraded over 60 
minutes (Figure 17). The rest of the vesicles were less susceptible to 
degradation, with 15% degraded over the next 8 hours. 
125 I /abeling- For purposes of binding studies with human brain epithelial 
capillary tissue, RMVE was labeled with 1251. Two methods of labeling were 
attempted, labeling before and after reconstitution. For the recovered 
product of 20 Ilg RMVE, labeling before reconstitution gave a specific 
activity of 44,500 cpmlllg while labeling after reconstitution gave a much 
higher specific activity, 5.5xl06 cpml Ilg. In the experiment where 
reconstitution occurred after labeling, much of the 125r label may have been 
lost to residual BSA, as no ultracentrifugation purification was conducted 
on the sample until after labeling. The experiments for which these 
samples were prepared for were not conducted due to a lack of enthusiasm 




The mumps virus can be successfully purified without the use of 
sucrose gradients. Use of this virus allowed successful reconstitution of 
fusion active RMVE. RMVE vesicle stability in serum was reasonable with 
30% of the vesicles being lost in one hour and the rest appearing to be stable 
for many hours. 
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VI. Conclusions 
This initial work on mumps reconstitution by detergent dialysis 
methods concentrated on the recovery of the virus glycoproteins in a form 
in which the protein's interactions with target membranes could be 
surveyed. The products given by octyl glucoside detergent dialysis 
reconstitution were undesirable as any behavior exhibited by the 
reconstituted virus may be attributed to any of the three different 
reconstituted products, including protein aggregates. Triton X-lOO and 
C12ES reconstitute products are better defined in size and character and 
exhibit all the glycoprotein properties of the native mumps and Sendai 
virus . 
The reason for the lack of mumps fusion activity in the early 
reconstitutions is unclear. The sucrose gradient run during the initial 
purification of this virus may have been responsible for destruction of the 
fusion acti vi ty as this gradien t will cause loss of infecti vi ty. Al terna ti vel y, 
storage at -1960 C in the presence of a cryopreservative may have preserved 
viral activity better than storage at -SO° C. Reconstitutions which involved 
mumps virus grown in cell culture at the City of Hope Hospital gave fusion 
functional reconstitutes. 
Animal studies with reconstituted Sendai and mumps virus showed 
that these vesicles acted in principle very similarly to liposomes in 
circulation behavior. Uptake of the "virosomes" occurred primarily in the 
reticuloendothelial system, i.e., liver and spleen. The uptake of the mumps 
by the brain of the hamsters was near background blood levels and too near 
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the "noise" level of the assay to draw any conclusive positive results. As an 
experimental system it was unclear whether these animals had a complete 
blood brain barrier. In general the vesicles had reasonable stability in serum 
and good circulation time in the blood. 
VII. Future Potentials 
Given that the mumps and Sendai HN protein activities are preserved 
in all reconstitutions and the Sendai F protein activity is generally 
preserved, a combination of mumps and Sendai viral proteins in a 
reconstituted system could have unique properties. The binding protein of 
mumps could provide the tissue specific behavior while the Sendai fusion 
protein allows for entry of the virosome contents into the target cell. 
Isolation of the individual glycoproteins from both Sendai and mumps is 
feasible via sucrose gradients or immunoaffinity columns (Hsu, 1979). 
Reconstitution with other more specific binding moieties should also be 
feasible. Such a combination of viral targeting and fusion proteins could 
represent the first generation of tissue tropic drug delivery liposomes. 
I Abbreviations Used-CNS- Central Nervous System, F-Fusion Protein, FI & F2 -Fusion 
protein cleavage products, HN- Hemagglutination-Neuroaminidase Protein, RSVE-
Reconstituted Sendai Viral Envelope, RMVE- Reconstituted Mumps Viral Envelope, CMC-
Critical Micelle Concentra tion, NBD-PE - N-(7-nitro-2,1,3,-benzoxadiazol-4-yl)-
phosphatidylethanolamine, Rd -PE N-(lissamine Rhodamine B sulfonyl)-
phosphatidylethanolamine, RIB- Octadecyl Rhodamine B chloride, 011- Dithiothreitol, 
PS- Phosphatidylserine, PC- PhosphatidyJcholine, Octyl Glucoside- I-O-n-octyl-Beta-D-
glucopyranoside, PMSF- Phenylmethylsulfonyl Fluoride, DPPC-Dipalmitoyl 
phosphatidyJcholine, DOPC- Dioleoyl Phosphatidylcholine, EM- Electron Microscopy, 
SUV- Small Unilamellar Vesicle, LUV- Large Unilamellar Vesicle, MLV- MultiLamellar 
Vesicles, ACAC- 2,4-Pentanedione, POPC- I-Palmitoyl-2-0Ieoyl PhosphatidyJcholine, 
MEM- Minimal Essential Media, FCS- Fetal Calf Serum. 
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Figure 1. Schematic representation of Reconstituted Sendal Viral Envelope (RSVE) 





Number 1 2 3 4 S 
Wash 
140mM NaCI 140mm NaCI 140mM NaCI r-ble r-ble 
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10mM Hepes 10mM Hepes 10mM Hepes 
pH 7.4 10:1 pH7.4 10:1 pH 7.4 10.1 
Viral 
.66 mg/ml 1.32 mg/ml .66 mg/ ml A. lmg/ml Core. 1.32 mg/ml B. 2 mg/ml 
Main 
140mM NaCI 140mM NaCI 140mM NaCI 10mM tris A&B.l0mM Hepes 
Buffer 
10mM Hepes 10mM Hepes 10mM Hepes l00mM NaCI 140mM NaCI 
pH 7.4 pH 7.4 pH 7.4 See notes below 
B. +20mM MgCI 
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250ml 6hr 4 C 250ml Shr 4C 250m I Shr 4C 250ml Shr RT 
250ml 6hr 4 C 250ml Shr 4C 
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B+ ghosts- Trypsln+_ 0+ ghosts 0+ ghosts 0+ ghosts 
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on controls specific fusion No Fusion 
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RMVE- used 
Notes buffer pH 7.4 
RMVE+ used 
buffer pH 10.0 
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Bicarbonate 
+ 2M KCI 
Legend: (-) Protein activity deficient; (+) Protein activity presant; RMVE- Reconstituted envelopes 
prepared in normal buffer (l00mM) and pH conditions (7.4); RMVE+ Reconstituted vesicles prepared 
in high salt (2M) and high pH conditions (10.0) . 
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Figure 11 . 
C12E8 RMVE Size Distribution 
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Chapter 4; Membrane Fusion of Mumps Virus with Ghost Erythrocytes 
and CV-l Cells 
ABSTRACT 
The octadecyl rhodamine (RI8) fluorescent dequenching assay was 
used to examine membrane fusion between mumps virus and cells. Rapid 
fluorescent dequenching, indicative of fusion, was observed with both ghost 
erythrocytes and CV-l cells. After fifteen minutes a saturation limit of 18 
virus per erythrocyte ghost and 6400 virus per CV -1 cell was observed. 
Fetuin was found to inhibit viral fusion, indicating a role for sialic acid in 
viral binding to the cells. Two de quenching processes were observed of 
which the faster process is thought to be membrane fusion and the second 
process thought to be probe proximal transfer. The most rapid dequenching 
occurred at a rate of 3 (±1) x 109 M-l sec-I, demonstrating that the interaction 
of mumps virus with the target membrane is a rapid process. 
INTRODUCTION 
Mumps virus is a paramyxovirus of the genus paramyxovirus 
whose only natural host is man. The virus is tropic for a number of visceral 
organs and the central nervous system (for a review, see Wolinsky and 
Server, 1985). Mumps is structurally related to other paramxyoviruses, 
including Send ai, in terms of protein structure, protein size, and viral size. 
Paramyxoviruses bind to the target cell by using a Hemagglutination/ 
Neuraminidase (HN) protein and fuse their membrane with the cell 
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membrane at neutral pH by means of the Fusion (F) protein (for reviews, 
see White et al., 1983; White,1990). This allows the genetic material to enter 
the cellular interior. 
A wide variance in neurotropism and neuroinvasiveness has been 
observed in the various strains of isolated virus (Wolinsky and Stroop, 
1978), which can be correlated with differences in function and structure of 
the HN protein of the virus (Merz and Wolinsky, 1981). A long term goal of 
these experiments is the explanation of the mechanism of neuroinvasion 
and neurovirulence. Since neurovirulence appears to be related to the viral 
entry mechanism, we have begun examining this process. For our 
experiments, we used Kilham strain mumps, the most neurotropic and 
neuroinvasive strain known (Kilham and Overman, 1953). In this paper 
we examined the fusion of mumps virus with ghost erythrocytes and CV-l 
cells. 
Sendai virus has served as a model system for studying 
paramyxovirus fusion (Knutton, 1977; Ohnishi, 1988; Loyter et al., 1988a) 
The fusion activity of Sendai with erythrocyte ghosts has been examined 
quantitatively (Hoekstra and Klappe, 1986). These experiments with Sendai 
virus led us to examine the interactions of mumps with ghost erythrocytes. 
A fluorescent assay using a self-quenching probe can be used to 
monitor membrane fusion events as discussed in Chapter two. The probe 
octadecyl rhodamine (RI8) inserts spontaneously into a membrane and 
exhibits linear fluorescent quenching from 0 to 10% molar concentration 
(Hoekstra et aI., 1984). The advantages of using this system to study 
membrane fusion have been discussed elsewhere (Loyter et aI., 1988b). 
Upon fusion of the fluorescently labeled virus with a target membrane, the 
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probe rapidly redistributes into the target membrane and will dequench, 
resulting in an increase in fluorescent intensity. This provides a direct 
measurement of the fusion of the viral membrane with the cell membrane. 
Short term fusion of the virus with target cells was monitored using this 
probe. 
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MATERIALS AND METHODS 
Cells and Erythrocyte Ghosts 
CV-1 cells (ATCC#CCL70) were grown in Minimal Essential Media 
(MEM) with 10% fetal calf serum (FCS). Sealed, right side out erythrocyte 
ghosts of A+ human blood were prepared by standard methods (Steck and 
Kant, 1974). 
Mumps Virus 
Kilham strain mumps virus was grown in 800 cm roller bottles of 
cultured CV-1 cells with 50 ml MEM with 10% fetal calf serum. When the 
cells reached confluence, they were washed with Hank's balanced salt 
solution and inoculated with 0.1 to 1 plaque forming units/cell or with 
1/25th of a previous preparation for 2 hours. The cells were then grown in 
MEM with 10% FCS with 20mM Hepes or in OptiMEM with 20 mM Hepes. 
Syncytia and cell death were highly evident by the third day. Virus was 
harvested on the fourth day by removing the media and pelleting out cell 
debris at 1500g for 10 minutes. The virus was pelleted by centrifugation at 
25,000g. The virus was resuspended in PBS with 10% glycerol and frozen in 
a liquid nitrogen freezer. BSA was the only major contaminant in the 
purification procedure and was removed by ultracentrifugation washes 
(lOO,OOOg, 40 minutes) of the virus before experiments. Seed stocks of virus 
and procedures were provided by Neal Waxham at the University of Texas 
Medical Center. Virus was grown in the viral facilities of Dr. John Zaia at 
the City of Hope Hospital. 
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Size of Virus 
A Malvern 4700c photon correlation spectrometer was used to 
measure the virus size. The system is equipped with a 488 nm tuned 3 watt 
Spectra-Physics 2020 laser attached to an IBM compatible PC with Malvern 
software. Most measurements were made at 90° to the beam with no size 
bias and maximal modal distribution parameters. Measurements at other 
angles were made to check for any major amplitude variations. In some 
instances size bias parameters were inserted after initial data collection to 
further clarify size distributions. 
Virus and Ghost numbers 
For purposes of conversion of microgram protein quantities of 
mumps and erythrocyte ghosts to numbers of particles in the results section 
and figures, it was assumed that 1 Ilg of ghost protein equaled 1.8xl06 ghosts 
(Chi and Wu, 1990) and 1 Ilg of mumps virus protein equaled 1.3xl09 viral 
particles. The molecular weight of the mumps virus is between 5 and 7xloB 
with 70% of the weight being protein (Kingsbury et aI., 1978). This is 
equivalent to 1.22-1.72xl09 viral particles per Ilg protein . 
For surface area calculations, the mumps virus was treated as having 
an average surface area of .282 112 (radius of 150 nm) and an erythrocyte 
ghost was treated as having an average surface area of 125 112 (Chi and Wu, 
1990; Westermann et ai., 1961). 
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Fluorescent labeling 
The fluorescent probe R18 has been used by a number of other 
workers to examine viral fusion (Loyter et al., 1988b). The R18 probe will 
spontaneously insert into a membrane and will rapidly equilibrate 
throughout a membrane when fusion does occur (Rubin and Chen, 1990). 
Due to the overlap of the emission and excitation fluorescence bands the 
probe self-quenches, the excited electronic state decaying by trivial 
mechanisms. In dilute concentrations «10% of the lipid content), the 
fluorescent quenching is linearly proportional to the concentration of the 
probe in the membrane. The surface area of the viral particles is much 
smaller than the surface area of the ghost erythrocytes or cells. Upon fusion 
of virus with ghost, the probe in the viral lipid bilayer dilutes into the target 
membrane and dequenches. 
A fresh solution of 1 mM R18 was prepared and an amount equal to 
2-6 mole percent of the viral membrane lipid (276 nanomoles lipid/mg 
viral protein) was added to a 1 ml solution of 250 ~g virus, while vortexing. 
A smaller mole percentage (3%) was found to be most useful for the 
fluorescent assays as this amount is still highly quenched (50%) and emits 
more fluorescence, which is useful in increasing the signal to noise ratio. 
The solution was allowed to sit in the dark for half an hour and then the 
unincorporated R18 was removed by running the sample over a G75 
Sephadex column or by pelleting the virus by ultracentrifugation (100,000g 
in a SW50.1 rotor). 
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Fusion Measurements 
Fluorescent measurements were made in a SLM4800 fluorimeter by 
monitoring the emission at 590 nm with a excitation wavelength of 560 nm 
and a Schott OG550 type filter in the emission path. For kinetic 
experiments, virus was preincubated at 37°C in the cuvette with 2 ml of 
phosphate buffered saline (PBS). The sample was stirred in the sample 
chamber by a magnetic stirrer. Fluorescence data was collected digitally and 
stored on disk by an IBM AT computer using SLM4800 software. Data 
collection was initiated and after a baseline had been established, ghosts or 
cells were added to the virus using a Hamilton syringe for the ghosts or a 
pipette for the cells. The fluorescence of control aliquots of virus was 
measured with and without 1 % Triton, to determine fluorescent quenching, 
and baseline scatter was determined with a solution of ghosts or cells. 
Graphic presentation of the kinetics data in this paper was smoothed with 
the Igor data processing program (WaveMetrics). 
For overnight experiments the components were mixed in a 2ml 
solution of PBS and incubated in the dark at 37°C. Control aliquots were 
used to determine the initial fluorescence of the virus and the dequenching 
obtained upon addition of 1 % Triton. 
For kinetic experiments with CV-1 cells, the cells were cleaved from 
the surface of the culture flask by using a solution of 2mM EDTA in PBS. 
An equal volume of medium was added to the suspension and the cells 
were pelleted. The cells were then resuspended in a small volume of PBS, 
from which aliquots were added to the fluorimeter cuvette during a kinetic 
experiment. 
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To show that the mumps dequenching was F protein mediated, 
samples were treated with trypsin. Trypsin cleaves the F protein but not the 
HN protein. Virus (l00 ~g protein) was incubated with 100 ~g of trypsin for 
one hour at 37°C in 100 ~l volume. The reaction was stopped by the 
addition of soybean trypsin inhibitor. This virus was subsequently used in 
the kinetic fusion assay. 
Some CV-l cells were treated with cytochalasin B to disrupt the 
cellular cytoskeleton and inhibit endocytosis. Cytochalasin B (50 ~g) was 
added to each well of a six well plate (lxl06 cells). The cells were incubated 
for 40 minutes at 37°C. They were then washed with PBS and fresh media 
was added. After 30 minutes at 37°C the media was removed, and PBS and 
labeled virus were then added. After 3 hours the cells were cleaved from 
the plates with 2 mM EDTA and the fluorescence of cells and supernatant 
was measured. 
Calculation of Fusion 
Fusion of the virus was calculated using the formula: 
%Fusion=(Fluor·final -Fluor. initial )/(Fluor·maximum- Fluor.initial)· 
For kinetics experiments Fluor.final and Fluor.initial represent 
values taken from the data plots. The Fluor.maximum value was 
determined by taking a solution of labeled virus and adding Triton X-I00 to 
1 % v lv, allowing the RIB to totally dequench. 
For overnight experiments Fluor.final was measured with the 
fluorimeter, and Fluor'initial was determined from control experiments 
using set amounts of labeled virus without ghosts. The ratio of fluorescence 
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with and without Triton (correcting for dilution) in the control experiment 
was used to determine Fluor.maximum : 
Fluor·maximum 
Fluor. initial 
= '(""C'o-n"'tC"r-o'l ';oF "I u- o-re- s-c-e-n-c':"e':"/"C:;-o':"n-O'tr"'o"I"'F""IC"u-o-r-e-s-ce-n-ce-+--;:;T;-r-:-:i t-o-n') 
Protein determination, Gel Electrophoresis, Transmission Electron 
Microscopy 
Protein contents of the virus and ghosts were determined by using 
the Peterson assay (Peterson, 1977) with omission of the TCA precipitation 
step. Fraction V BSA (Reheis Chemical Company) was used as a protein 
standard. The BCA protein determination kit (Sigma) was also used. 
Acrylamide gel electrophoresis was used to confirm the presence of 
virus and to check virus purity. Ten percent separating gels were run with 
six percent stacking gels. Biorad protein standards were used. Gels were 
silver stained using the Biorad Silver Stain Kit. 
Virus samples (10 ~l) at various concentrations (about 250 ~g 
protein/ml) were applied to carbon-covered glow-discharged grids and 
allowed to dry. 10 ~l of stain was then applied and allowed to sit for various 
time periods. 1 % Phosphotungstic acid, 1 % Uranyl Acetate, and 2% 
Ammonium Molybdate were used as stains. The samples were examined 
using a Phillips EM201 TEM. 
Kinetics Modeling 
Computer programs were written in the BASIC and C language to do 
numerical integration to solve the multiple differential equations involved 
in the following viral interaction schemes: 
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A)The mass action kinetic model 
k1 
Virus + Binding Site. • Virus. Binding Site k3 • Fused Virus 
k2 
B) The exchange mechanism 
k1 
Virus + Binding Site. • Virus. Binding Site 
k2 
Virus + Fusion Site k3 • Fused Virus 
C) The two fusion site mechanism 
Virus + Fusion Site 1 k 1 • Fused Virus 
Virus + Fusion Site 2 k2. Fused Virus 
0) The receptor recycling mechanism 
Virus + Fusion Site k 1 • Fused Virus k2. Fusion Site 
To reduce errors in the solutions, the Runge-Kutta method was employed 
to do the calculations (Boyce and Oi Prima, 1977). Fluorimeter data were 
loaded directly into the program. A fitting parameter measuring the 
absolute differences between the data and a fit was minimized by using an 
"evolutionary" fitting subroutine to optimize fitting. After initial rate 
guesses were inserted into the program the minimization subroutine would 
make ten random guesses at new kinetic values by varying the old values by 
0-10%. The best fit of these guesses was displayed and the fitting cycle was 




Purification and Size of Virus 
After initial purification, about 250 ~g of Mumps virus and 550 ~g of 
BSA were obtained from each roller bottle. This corresponds to about 3250 
virus produced per cell, a 25-fold increase over the 130 virus / cell 
inoculation. An additional ultracentrifugation resulted in removal of the 
BSA. As an alternative approach in reducing BSA contamination, cells 
were grown in serum free OptiMEM during the viral infection. A more 
productive infection was achieved with syncytial destruction of the 
monolayer by the third day. The yield of virus was also higher, ~ 500 ~g 
viral protein per roller bottle. 
Figure 1 shows the size distribution from a typical batch of Kilham 
mumps virus obtained by light scattering measurements. The diameter of 
the virus, 310 nm ± 100nm, is somewhat larger than previously reported 
(Cantell, 1961) . The virus is known to be pleomorphic from EM studies. 
Electron microscopy showed that the virus was intact and contained the 
spike glycoprotein structures. 
Gel electrophoresis showed the presence of the Nucleocapsid, Fusion, 
Polymerase, and Matrix proteins. Three larger protein bands were also 
evident which may represent the Large protein or multimers of the HN 
protein. 
Short Tenn Fusion of Virus with Ghosts 
The kinetic de quenching of virus interacting with ghost erythrocytes 
was observed directly for short time periods. Figure 3 shows a number of 
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kinetic curves from mumps-erythrocyte ghost fusion experiments. As the 
ratio of ghost erythrocyte to virus increased, the percent of virus fusing 
increased due to the increased availability of viral receptor sites. Under 
conditions where a large number of ghosts were available the fusion 
kinetics appeared to be biphasic, with a rapid burst of initial dequenching 
and a slow secondary dequenching. 
The ratio of virus to ghost determined the amount of virus 
dequenched after 14 minutes, see Figure 4a. The maximum number of 
possible fusion events can be calculated by using a reciprocal Scatchard-like 
plot of the fusion data, Figure 4b. After 14 minutes, a maximum of about 
.025 mg of virus protein per 1 mg of ghost protein was able to fuse. This is 
equivalent to about 18 viral particles per ghost. 
In control experiments the viral fusion can be strongly inhibited by 
trypsin pretreatment. This is evident from both a kinetic profile, Figure 3 
and from the final fusion values, Figure 4a. Trypsin selectively cleaves the 
F protein, thus allowing binding but no fusion. As discussed in Chapter 
two, the inhibition is not complete and a residual proximal transfer of R18 
occurs. 
pH and Temperature Data 
Over the temperature range studied, mumps virus interaction with 
ghost erythrocytes was maximal at 37°C, see Figure 2a. No pH dependence 
was seen in the interaction of the virus with ghosts, see Figure 2b. The pH 
profile was nearly identical to that observed with Sendai virus (Ohnishi, 
1988). This is consistent with viral entry through the cell membrane as well 
as the endocytotic compartments. 
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Saturation of Fusion sites 
In order to determine the maximum number of virus that might 
bind with an erythrocyte ghost, various ratios of fluorescently labeled virus 
and ghosts were mixed and the fluorescent dequenching after 18 hours was 
observed. An 18 hour kinetic profile of mumps with ghost erythrocytes 
showed that dequenching was complete at this time and equilibrium had 
been reached (data not shown) . Figure Sa shows the amount of virus 
dequenched over an 18 hour time period as related to the amount of virus 
added per erythrocyte ghost. Due to the proximal transfer of the probe, this 
dequenching represents virus that have fused with the ghost surface and 
particles which are bound to the ghost surface. As virus which have fused 
over a long time course are indistinguishable from those which are bound, 
the generic term "interacted" is used to describe this assembly of events. 
Also shown is data from Hoekstra and Klappe (Hoekstra and Klappe, 1986) 
on Sendai virus fusion with erythrocyte ghosts. The binding activity of the 
viruses appears to be similar at set ratios of viruses and ghosts; however, 
less of the total mumps preparation appeared to be active. Up to 75% of the 
mumps virus was able to interact with the ghosts. 
A reciprocal plot was used to calculate the saturation of the binding 
sites on the ghost surface, see Figure 5b. The Sendai data is from Hoekstra 
and Klappe. Using a fit of the reciprocal plot, approximately 570 ~g of 
mumps protein can interact with 1 ~g of ghost protein; this is equivalent to 
about 410 mumps virus per ghost. The reciprocal plot is highly linear until 
more than 200 viral particles interact per ghost. The curve then turns 
downward as it approaches the y axis indicating that a greater number of 
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virus can interact when the system is highly saturated. Under such 
conditions, a large number of fusion events with the ghosts could change 
the ghost's surface composition and its ability to fuse. 
The mumps saturation is compared to the data of Hoekstra and 
Klappe on Sendai fusion. Mumps virus can undergo a greater number of 
interaction events per erythrocyte ghost than the Sendai virus: 410 events 
versus 240 events. 
Virus Fusion with CV-l cells 
While ghost erythrocytes serve as interesting model membranes, we 
also wished to observe the interactions of the virus with cultured cells. CV-
1 cells were used as they represent the growth cell line for the Kilham strain 
of virus. Long term saturation experiments were not performed as cell 
viability would become questionable before completion of the experiment. 
Short term kinetics curves of mumps fusion with CV-1 cells were recorded, 
Figure 6. A biphasic behavior is observed in the interaction of virus with 
the cells. The reCiprocal plot, Figure 7, shows the saturation of fusion as the 
number of viruses per ghost are increased. Under the conditions of the 
experiments about 6400 virus were able to fuse per cell after 900 seconds and 
14,840 virus after one hour. 
To determine if sialic acid plays a role in the viral fusion process, 
fetuin was added to the solution to serve as a binding site competitor. A 
large inhibition of fusion was observed, indicating sialic acid as having a 
role in the viral entry process. 
In a control experiment, cells in 6 well plates treated with 
cytochalasin B were compared to untreated cells in terms of fusion 
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susceptibility. Cytochalasin B caused some disruption or rounding of the 
cellular skeletal structure, as observed under a light microscope, and should 
partially inhibit endocytosis. No difference in fusion was seen between the 
fusion with treated and untreated cells (see appendix, experiment 4.). 
Kinetic Modeling 
Four different kinetic models were used to fit the data on mumps 
erythrocyte interactions. 
A binding site competition model was tested that gave curves of 
proper character but was most dependent on the ratio of binding to fusion 
si tes in determining ex ten t of fusion. 
The two site model used a set of available fast fusion sites and a 
second, more numerous, set of slow fusion sites. The number of fast and 
slow fusion sites was estimated from the previous kinetic and equilibrium 
experiments and then adjusted during calculations to give the best possible 
data fit . For optimal fitting of the fusion of mumps with erythrocyte ghosts, 
the number of fast fusion sites was 6 ( ±2) per ghost and the number of slow 
sites was 400 (±SO). The observed fast rate, kl' for fusion with erythrocyte 
ghosts was 3 ( ±1) x 109 M-l sec-I. This rate was slowed with high ratios of 
virus to ghost, due to the negative cooperation mentioned above in the 
short term virus ghost fusion section. The slow rate, k2' was about 8 ( ±I) x 
105 M-l sec-I. 
An alternative model to fit the data used a small number of receptors 
per cell which were "recycled" for usage. The number of receptors was 6 ( 
±2) per ghost erythrocyte. The fusion rate, kl' was 3 (±I) x 109 M-I sec-I, as 
observed with the two site model. The rate of receptor recycling was 4 ( ±1) x 
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10-4 sec-1. This model is likely faulty on two accounts. The slow rate was 
uninhibited by trypsin and was likely due to proximal probe transfer rather 
than receptor recycling. Secondly, there is no evidence for receptor recycling 
in ghost erythrocytes although receptors used in viral fusion could become 
available at the completion of the event. 
The mass action model did not effectively fit the data as it was 
impossible to achieve steep initial rates in conjunction with a second slower 
rate. When the second slow rate was removed by subtracting it out, the 
optimal fit given by the model is one where k1 = 3 (±1) x 109M-1sec-1, k2 = 0 
sec-1, and k3= 1 sec-1 with 27 percent viral activity and 25 receptors per 
ghost. These constants indicate that fusion occurs much more rapidly than 
binding, i.e., that binding is the rate limiting step. The reaction form is 
essentially V + BS~ ( V· BS~) Fused. The dequenching curves appear to 
be of simple exponential form, reduction of the k3 to a value below one 
gives the curves a sigmoidal character. Acquisition of binding data would 
support the hypothesis that binding was rate limiting but binding rates 
proved to be very difficult to acquire (experiments not shown). 
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DISCUSSION 
No previous quantitative studies on the fusion ability of mumps 
virus have been conducted. We have quantitatively examined the fusion of 
mumps virus with ghost erythrocytes and CV-l cells. The virus was treated 
as a neutral pH fusing agent with an optimal activity at 37°C. The virus was 
found to fuse with the model membrane ghost erythrocytes, similar to the 
behavior of Sendai virus. 
The fusion of mumps virus is a rapid process, under non-saturating 
conditions 20+ % of the virus can fuse in 3 minutes. Although a pH 
dependent fusing virus such as influenza fuses more rapidly than mumps 
(White,1990), it must first undergo endocytosis which requires a number of 
minutes. Evolution has chosen a quick viral entry which should allow 
avoidance of the multiple clearance pathways. 
The amount of mumps virus which can fuse with an erythrocyte 
ghost differs greatly from the amount which can fuse with the CV-l 
membrane surface. After 15 minutes a saturation limit of about 20 virus 
can fuse with each ghost and 6000 virus with each CV-l cell. Considering 
the surface area of the erythrocyte ghost to be about 125 J.lm2 and CV-l cell 
surface area to be 2000 J.lm2 (105 cells/ cm2), fusion saturation is about one 
virus per 7 J.lm2 of erythrocyte membrane surface and 0.32 J.lm2 of CV-l 
membrane surface. For the CV-l cells this is about the area displaced by 
placing a virus on the surface of the cell. For the longer overnight 
experiment, an erythrocyte can also undergo a large number of interaction 
events, one every 0.3 J.lm2. The sites for viral interaction are abundant on 
the cellular surface in both systems, indicating a common molecule as the 
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receptor site. A difference in lipid composition between the two cell type 
bilayers may determine this apparent difference in fusion propensity. 
Although the cell receptor for mumps has not been identified, it is 
likely that the sialic acids on gangliosides or a common sialoglycoprotein 
would function as a binding site. The HN protein of Sendai has been 
shown to use gangliosides as a cellular receptor (Markwell et at., 1981). The 
identified activities of the mumps HN are hemagglutination, the binding of 
red blood cells, and neuraminidase activity, the cleavage of sialic acid from 
fetuin; the efficiency of these activities vary from strain to strain and can be 
directly correlated to neuroinvasiveness. Both these activities appear to 
reside in the same domain of the protein structure (Merz and Wolinsky, 
1981). Gangliosides are common to most cells, allowing the virus to enter a 
number of cell types. The larger number of virus interaction events with 
the cell surface is also indicative of a common cell surface moeity. Highly 
sialated fetuin was shown to inhibit viral cell fusion in these experiments. 
The kinetic profiles of virus interacting with ghost erythrocytes or 
CV-l cells are very similar. The dequenching of mumps appears to be 
biphasic. The initial fast dequenching most likely represents F protein 
induced membrane fusion. The second slower dequenching is uninhibited 
by trypsin and likely represents a proximal transfer of the R18 probe. As 
discussed in Chapter two, although the dequenching of R18 is usually 
attributed to fusion of the membrane bilayers, it is difficult to prove that 
fusion is actually occurring without a contents mixing assay. Proteases 
which cleave both HN and F (Protease K) totally inhibit dequenching (data 
not shown), while some slow dequenching still occurs after trypsin 
treatment, which only cleaves the F protein. If spontaneous R18 transfer 
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does occur, it requires binding of the virus to the surface of the cell. A 
fusion protein mediated non-fusion transfer of the R18 probe is nearly 
impossible to rule out, but control experiments have been conducted in this 
lab (Chapter 2, DiSimone and Baldeschwieler, 1991) that show that with 
reconstituted Sendai viral envelopes the kinetics of fusion are nearly 
identical when measured with the R18 assay or a NBD/Rhodamine 
phosphatidyl ethanolamine resonance energy transfer assay (Struck et aI., 
1981). The probes in the NBD/Rhodamine system are much less likely to 
transfer spontaneously to another membrane. In a different viral fusion 
system, Sarkar et al . observed similar kinetics for the contents mixing of 
NBD-taurine and membrane mixing of R18 when fusing erythrocyte ghosts 
with influenza HA-expressing fibroblasts (Sarkar et aI., 1989). 
Comparison of the long term interactions with ghosts by Sendai or 
mumps shows that the viruses are similar in activity but not identical. For 
short term fusion of Sendai with ghosts, a reciprocal plot analysis of data 
from Citovsky et al. (Citovsky et ai, 1985) shows a saturation of about 16 
Sendai virus per ghost over 30 minutes, similar to the 18 mumps viral 
fusion events seen in our experiments. Though there is some conservation 
of the F protein across the paramxyoviruses, the binding protein HN varies 
in size and function even within the various mumps strains. 
It is unclear why a virus would develop which will fuse with a 
erythrocyte, as this would seem to be a dead end in viral replication. To the 
virus the erythrocyte must appear so similar to the target cellular surface 
that the virus binds and fuses with the surface. The virus appears to be 
rapid but fairly unspecific in its cellular interactions. Mumps can probably 
fuse with most cells types, including erythrocytes. 
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The mechanism by which the mumps virus is neuroinvasive and 
neurotropic is still unclear. In mice, penetration of the infection into the 
neurons is determined by replication (Kristensson e/ ai., 1984; Love e/ ai., 
1987). In hamsters, neurotropic and nonneurotropic strains are both able to 
penetrate as far as the ependymal cells by crossing into the cerebrospinal 
fluid at the choroid plexus (Wolinsky e/ aI., 1974). Given that the virus 
fuses with a diverse array of cells, virus-cell fusion would not playa key role 
in neurotropism but would only allow a widespread dissemination of the 
virus. Infection of the neurons may be more closely linked to cell-cell 
fusion and viral budding, other viral activities partially controlled by the 
glycoproteins. Propagation of virus into the neurons by virus-cell fusion 
may be difficult due to restricted diffusion of the virus into the neuronal 
interstitial spaces, while cell-cell fusion would allow infection of nearest 
neighbors and continued penetration of the neuronal matter. It is also 
possible that in the neuroinvasive mumps strains the HN or F glycoprotein 
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Figure 1. Size distribution of mumps particles as measured by light 
scattering. 
Figure 2. (a). Temperature dependence of mumps dequenching with 
erythrocyte ghosts. Erythrocyte ghosts (66 Ilg) were added to 2.5llg of RIB 
labeled mumps in PBS at 37°C. Kinetic measurements were made as 
described in methods. Initial rate was measured both by hand and by 
taking the first derivative of the spectra. Both methods gave the same 
rate within 2%. (b). Effect of pH on the fusion of mumps. RIB labeled 
mumps virus (5 Ilg) was incubated with 65 Ilg of erythrocyte ghosts in 
PBS adjusted to the various pH's for 30 minutes as 37°C. The fraction 
fused was determined as described in methods. 
Figure 3. Kinetic profiles of mumps virus de quenching interaction with 
erythrocyte ghosts. Erythrocyte ghosts (260 Ilg) were added to various 
amounts of RIB labeled virus and the kinetics of dequenching were 
measured. One hundred percent virus de quenching was calculated as 
described in methods. 
Figure 4. (a). Extent of dequenching of mumps with ghost erythrocytes after 
14 minutes. Erythrocyte ghosts were mixed with RIB labeled virus in 
PBS at various ratios. Kinetic profiles were obtained as in figure 3. Final 
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extent of dequenching as calculated in the methods is plotted against the 
ratio of ghosts to virus. (b). A reciprocal plot was used to calculate the 
maximum number of deequenching events after 14 minutes. 
Figure 5. (a). Long term dequenching interaction of mumps with 
erythrocyte ghosts. R18 labeled mumps virus (16-23 ~g) was added to 
varied amounts of erythrocyte ghosts. Dequenching was measured after 
an 18 hour incubation at 37°C. Sendai data is from Hoekstra and Klappe, 
1986. (b). A reciprocal plot of the data shown in Figure 3a used to 
calculate the saturation of dequenching events. 
Figure 6. Kinetic profiles of dequenching interactions of mumps with CV-l 
cells. CV-1 cells (6.5xl06) were added to various amounts of R18 labeled 
mumps virus in PBS. Kinetics were observed as described in methods. 
Figure 7. Saturation of dequenching sites on CV-1 cells. A reciprocal plot of 
the amount of virus added to 6.5 x 106 CV-l cells versus the amount of 
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Appendix to Chapter 4- Additional Mumps Fusion Experiments 
Introduction- A number of kinetic experiments monitoring mumps virus 
fusion were conducted which are not detailed in Chapter 4. The details of 
these experiments and kinetic traces are given below. 
1. Two fusion experiments were run with the mumps grown by Neal 
Waxham at the University of Texas (see Chapter 3) . In both of these 
experiments whole virus was labeled with the RIB probe and allowed to 
incubate with erythrocyte ghosts. The fusion was measured for separate 
samples at set time points. 
Kilham mumps virus (264 ~g, 400 ~l) was labeled with 2.41 nmoles RIB 
(7 ~l EtOH). The virus was purified by column and assayed for protein 
content. 100 ~l (=29 ~g) aliquots of mumps virus was mixed with 15 ~l 0+ 
ghosts (56 ~g) and allowed to incubate. Two of these virus aliquots had been 
pretreated with OTT or trypsin in order to inhibit fusion . Initial and triton 
fluorescent values were determined from control aliquots of virus. The 
following dequenching amounts were observed: 
! Untreated Trypsin OTT 
0 0 0 0 
Ihr20min 7.7 0 0 
2hr20min 12.1 0 4.3 
Bhr40min 22.7 .7 9.4 
24hr 32.0 .6 22.4 
A second experiment was run with a different mumps preparation sent 
from Texas. 726 ~g of virus were labelled with 6 ~g ' of RIB, purified by 
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column chromatography and then mixed in various ratios with ghost 
erythrocytes . No change in sample fluorescence was apparent after an 
overnight incubation. 
2. One ml out of 3.3 ml mumps preparation (841 ~g/ml protein, 
mumps + BSA) from one roller bottle was labeled with 5 nmoles RI8 and 
purified by column chromatography. The labelled virus fraction contained 
278 ~g of purified virus per ml with a volume of 450 ~l. Kinetic fluorescent 
fusion experiments were conducted with various amounts of erythrocyte 
ghosts (6.8 mg/ml) (Figure 1) . The extents of dequenching from this 
experiment were used in Figure 4a in Chapter 4. 
3. One ml out of 10 ml mumps preparation (795 ~g/ml protein, 
mumps + BSA) from four roller bottles was labeled with 5 nmoles RI8 and 
purified by column chromatography. The labeled virus fraction contained 
230 ~g of purified virus. Kinetic fluorescent fusion experiments were 
conducted with various amounts of erythrocyte ghosts (5.75 mg/ml) (Figure 
2). For the trypsinization experiment, 23 ~g of mumps virus was treated with 
20 ~g of trypsin for one hour at 37" C and then the digestion was halted by the 
addition of 10 ~g of trypsin inhibitor. The extents of dequenching from this 
data were used in Figure 4a in Chapter 4. 
4. One ml out of 10 ml mumps preparation (795~g/ml protein, mumps 
+ BSA) from four roller bottles was labeled with 5 nmoles RI8 and purified by 
column chromatography. The labeled virus fraction contained 237 ~g of 
purified virus. Six well plates containing =9.6xIOS CV-I cells per well were 
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used in this experiment. Some of the plates were treated with cytochalasin B 
prior to viral addition. 5 mg of cytochalasin B was added to 200 ~l of DMSO to 
form a stock solution from which 2 ~l were added to each plate well. The 
cells were incubated for 40 minutes and then the media were removed and 
the cells washed with PBS. The cells were allowed to incubate in PBS for 30 
minutes, washed again and covered with PBS. Various amounts of labeled 
virus were then added. The virus were allowed to react with the cells for 
three hours at which time the cells were cleaved from the plate by the 
addition of 1 mM EDTA. The cells were then removed and fluorescence 
measurements made on the samples. Control aliquots of virus with and 
without Triton X-lOO were used to determine fluorescent quenching, initial, 
and maximal fluorescence values. The observed dequenching (Figure 3) was 
corrected for baseline scatter of light due to the introduction of cells into the 
fluorescent light path. 
5. A single kinetic experiment was run on virus labeled mumps virus 
from the prep described in 4. above. One ml (209 ~g) of virus was labeled 
with 5 nmoles of R18 and purified by pelleting twice by ultracentrifugation. 
9.6x105 CV-1 cells were mixed with 25 ~l of labeled virus in 2 ml PBS. After 
1100 seconds 13.2% de quenching was observed, with correction for baseline 
light scatter. Separation of bound and unbound material was accomplished 
by centrifugation and showed that 20.0% of the fluorescent probe was found 
associated with the cells. Emission and excitation spectra were taken before 
and after the fusion experiment and showed no apparent shifts in 
wavelength maxima. 
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6. 1.4 ml out of 16 ml mumps virus preparation (750llg/ml protein, 
mumps + BSA) from ten roller bottles was labeled with 1.3 Ilg RIB and 
purified by ultracentrifugation. The labeled virus fraction contained 250 Ilg of 
purified virus. Kinetic measurements were made of the labeled virus 
interacting with ghost erythrocytes (Figure 4). 
7. One ml out of eleven rnl from a ten roller bottle mumps preparation 
was labeled with 1 Ilg of RIB and purified by ultracentrifugation. Various 
amounts of the labeled virus (500 Ilg/mi) were mixed with 1.63xl06 CV-l 
cells and fusion kinetics were recorded (see Figure 5). 
B. One ml out of eleven rnl from a ten roller bottle mumps preparation 
was labeled with 2 Ilg of RIB and purified with ultracentrifugation. Various 
amounts of labeled virus were mixed with 1.41xl06 CV-l cells and the 
kinetics recorded. Over the range of virus concentration tested (5 Ilg to 25 Ilg) 
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Mumps fusion with CV-l Cells 
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Chapter 5: Fusion of Sendai Virus and Reconstituted Sendai Virus with H9 
and Peripheral Blood Lymphocytes. 
Christopher Di Simone1, Delilah A. Stephens2, John A. Zaia2, and 
John D. Baldeschwieler1-
IDepartment of Chemistry and Chemical Engineering 
California Institute of Technology 
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2Division of Pediatrics 
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Abstract 
We have examined the membrane fusion of Sendai virus and 
reconstituted Sendai virus (RSVE) with H9 cells and peripheral blood 
lymphocytes (PBL) . By using two fluorescent assays we were able to 
determine the rate and extent of fusion. The fusion of virus and RSVE with 
the cells was inhibited by fetuin, indicating sialic acid residues as the binding 
site on the cellular surface. The fusion was also inhibited by trypsin 
cleavage of the fusion (F) protein, indicating that the fusion was F protein 
mediated. The number of fusion events with each cell was high, we 
estimated a saturation limit of 12,000 RSVE were able to fuse with each PBL. 
Up to 40% of the RSVE were able to fuse with the PBL in 15 minutes. The 
RSVE may serve as a drug delivery system to these cells. 
- Corresponding Author 
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Introduction 
Sendai virus is a pneumotropic murine paramyxovirus of the genus 
Para myxovirus. The viral lipid coat contains two glycoproteins, the fusion 
protein (F)1 and the hemagglutination/neuraminidase protein (HN) which 
are responsible for entry of the viral interior into the cellular cytoplasm (for 
reviews of viral fusion, see 11, 21, 19, 34). The virus can bind via the HN 
protein to gangliosides, as shown with ganglioside labeled lipid vesicles (9), 
with terminal sialic acid residues serving as a receptor for viral binding to 
cells (18). The fusion of the virus membrane with the cell is mediated by 
the F protein and is pH independent, indicating that fusion can occur with 
the cell membrane without the endocytosis required for pH dependent 
viruses such as influenza. The F protein contains a highly hydrophobic 
region at its N terminus which has been directly implicated in the fusion 
process (20). 
Detergent reconstitution of the virus envelope produces particles 
similar in size and activity to the native virus but lacking any interior 
components (31). In fact, the vesicles can be loaded with drugs, receptors, or 
nucleic acids and these contents delivered to cellular targets by the same 
mechanism by which the virus delivers its own genome (2, 8, 14, 17, 32, 33). 
Some work has been done on using reconstituted Sendai viral envelopes 
(RSVE) as a system for transfection with a limited number of cells lines (3, 
16,30). 
We wished to examine the interactions of Sendai and RSVE with H9 
and Peripheral Blood Lymphocytes (PBL) as these cell systems serve as 
models and hosts of HIV infection (23) . RSVE's might serve as a drug 
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delivery system for various AIDS therapeutics, including phosphorylated 
AZT, antisense DNA (35) , and HIV cleaving Ribozymes (26). 
Two fluorescent assays using self-quenching probes were used to 
monitor membrane fusion events. The probe octadecyl rhodamine B (R18) 
inserts spontaneously into a membrane and can be used to monitor the 
fusion of whole virus membranes with target cell membranes The 
advantages of using this system to study membrane fusion have been 
discussed elsewhere (5, 15). In addition, reconstituted virus was labeled 
with a fluorescently labeled phospholipid analog, Lissamine Rhodamine B 
Sulfonyl Phosphatidylethanolamine (Rd-PE), which can be incorporated 
into the RSVE during the reconstitution process. This labeling procedure 
represents a novel use of rhodamine's self-quenching fluorescent behavior. 
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Materials and Methods 
Virus Preparation-
Strain Z Sendai virus (200JlI at 2Jlg/ml) was inoculated into the 
allantoic compartment of 10 day old chicken eggs. After three days the eggs 
were cooled to near O°C and the allantoic fluid was removed and cell debris 
pelleted by centrifugation at 5000 g for 30 minutes. The virus was pelleted at 
15,000 g for 40 minutes and resuspended in PBS (1mg/ml, each egg yielding 
~.3 mg) . The virus was then filtered through 1.2 and .8 Jlm filters to remove 
aggregates and bacteria. The purified virus was checked for HA activity (25) 
and flash frozen in liquid nitrogen. Ten percent glycerol was added to the 
virus before freezing as a cryopreservative (1). 
H9 Cells and PBL Cells -
H9 cells were maintained in RPM! 1640 supplemented with 10% fetal 
bovine serum (RPM! 10). 
Lymphocytes were prepared by the general method of Boyum (4) . 
Buffy coat from human blood was diluted three fold with phosphate 
buffered saline and then placed on top of a cushion of Ficoll-paque 
(Pharmacia) . After centrifugation for 30 minutes at 400g the cells at the 
serum/Ficoll-paque interface were removed and washed twice with Puck's 
salt solution. The cells were resuspended at a concentration of about 2xl06 
per ml in RPM! medium with 20 % fetal bovine serum . 
Phytohemagglutinin P (Pharmacia) was added at a concentration of 0.8 
Jlg/ml. Cells were expanded for three days prior to being used in 
experiments. 
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Determination of Virus Size-
A Malvern 4700c photon correlation spectrometer was used to 
measure the virus size. The system is equipped with a 488 nm tuned 3 watt 
Spectra-Physics 2020 laser attached to an IBM compatible PC with Malvern 
software. Most measurements were made at 90° to the beam with no size 
bias and maximal modal distribution parameters. Measurements at other 
angles were made to check for any major amplitude variations. In some 
instances size bias parameters were inserted after initial data collection to 
further clarify size distributions. 
Virus Reconstitution-
Reconstituted virus envelopes were prepared by the general method 
of Vainstein e/ a/. (29) with a few variations in protocol. One milligram of 
virus was pelleted by ultracentrifugation (l00,000 g) for one hour and then 
resuspended in 50 ~l of a 10% Triton X-IOO solution (l00 rnM NaCl, 50 rnM 
Hepes, 2 mM EDTA, pH 7.4). Pierce Surfact-AmpsTM X-IOO purified 
detergent was used. The solution was then shaken for two hours at 20° C. 
The nucleocapsid was removed by 40 minutes of ultracentrifugation 
(lOO,OOOg) and the supernatant removed to an 1.5 ml eppendorf microfuge 
tube. Fluorescent probes were added to the detergent supernatant. SM-2 
Biobeads were then added at 1 mg biobeads/~l detergent solution. After 
four hours of shaking, 50 ~l of buffer A (l60 rnM NaCI/20 mM Hepes, pH 
7.4) and an additional 50 ~g of Biobeads were added to the solution. After 
shaking for 12 hours at room temperature the RSVE were removed from 
the beads with a Hamilton syringe and the beads washed three times with 
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buffer A. The RSVE were pelleted by ultracentrifugation (lOO,OOOg, 40 
minutes) and resuspended in PBS (500 ~l) . 
One milligram of biobeads should absorb one ~l of the given 
detergent solution in 4 hours (l3). As the beads absorb some viral lipid as 
well as detergent, one should use the least amount of detergent possible to 
solubilize the virus (13) . In later experiments the amount of Triton X-lOO 
solution used was reduced to 30 ~l. 
Fluorescent labeling-
The fluorescent probe RIB has been used by a number of other 
workers to examine viral fusion (l5). The RIB probe will spontaneously 
insert into a viral membrane and will rapidly equilibrate into a target 
membrane when fusion does occur (24) . The probe self-quenches by 
resonant energy transfer and subsequent trivial decay mechanisms due to 
the overlap of the emission and excitation fluorescence bands. In dilute 
concentrations «10% of the lipid content), the fluorescent quenching is 
linearly proportional to the concentration of the probe in the membrane. 
The surface area of the viral particles is much smaller than the surface area 
of the cells. Upon fusion of virus with the cells, the probe in the viral lipid 
bilayer dilutes into the target membrane and dequenches. 
A fresh solution of 1 mM RIB (Molecular Probes) was prepared and 
an amount equal to 2-6 mole percent of the viral membrane lipid (276 
nanomoles lipid/mg viral protein) was added to a 1 ml solution of 1 mg 
protein Sendai virus, while vortexing. A smaller mole percentage (3%) was 
found to be most useful for the fluorescent assays as this amount is still 
highly quenched (50%) and emits more fluorescence, which is useful in 
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increasing the signal-to-noise ratio. The solution was allowed to sit in the 
dark for half an hour and then the unincorporated RIB was removed by 
either running the sample over a G75 Sephadex column or by pelleting the 
virus with ultracentrifugation (100,000 g in a SW50.1 rotor). 
Reconstituted virus were labeled by using the fluorescent labeled 
lipid Rhodamine-phosphotidyl ethanolamine (Rd-PE). Previous workers 
have measured fluorescent resonance energy transfer between NBD-PE and 
Rd-PE in order to monitor fusion (27). We have found that fusion can be 
monitored by just using the self-quenching properties of the Rd-PE, similar 
to the RIB experiment described above. 
Rhodamine PE (Avanti Polar Lipids) was dried from chloroform and 
resuspended in the Triton X-100 reconstitution solution. The probe was 
then added to the reconstitution as described above so that the total amount 
of lipid added equaled 5 mole percent of the total lipid. 
Fusion Measurements-
Fluorescent measurements were made in a SLM4BOO fluorimeter by 
monitoring the emission at 590nm with an excitation wavelength of 560nm 
and a Schott OG550 or OG570 type filter in the emission path. For kinetic 
experiments, Sendai virus or RSVE were preincubated at 37°C in the cuvette 
with 2 ml of PBS. The sample was stirred in the sample chamber by a 
magnetic stirrer. Fluorescence data were collected digitally and stored on 
disk by an IBM AT computer using SLM4BOO software. Data collection was 
initiated and after a baseline had been established, cells were added to the 
virus using a pipette. The fluorescence of control aliquots of virus was 
measured with and without 1 % Triton, to determine quenching, and 
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baseline scatter was determined with a suspension of cells. The kinetic data 
was smoothed with the Igor data processing program (WaveMetrics). 
The H9 or PBL cells (lxlOS to Ix 106) were pelleted from media and 
resuspended in a small volume of PBS (l00~l), and then added to the 
fluorimeter cuvette during a kinetic experiment. 
To show that the Sendai virus or RSVE fusion was F protein 
mediated, samples were treated with trypsin. Trypsin cleaves the F protein 
but not the HN protein. Virus (l00 ~g protein) was incubated with 100 ~g of 
trypsin for one hour at 37°C in 100 ~l volume. The reaction was stopped by 
the addition of soybean trypsin inhibitor. This virus was subsequently used 
in the kinetic fusion assay. 
For binding competition experiments fetuin was preincubated with 
the labeled virus for 30 minutes at 37°C. The entire solution was then 
added to the PBS cuvette and cells were added as described above. 
Calculation of Fusion-
Fusion of the virus was calculated using the formula: 
Fluor·(final) - Fluor ·(initial) 
%Fusion= -= __ ---'c=='--_---;:;-;-'c:..:..:.:.:..:.::..:.c. __ x 100. 
Fluor ·(maximum) - Fluor.(initia/) 
For kinetics experiments Fluor·(fina/) and Fluor.(initia/) represent 
values taken from the fluorescent data plots. The Fluor.(maximum) value 
was determined by adding Triton X-IOO at 1% v/v to a solution of labeled 
virus, allowing the R18 to totally dequench. 
A control experiment showed that the fluorescence of RIB labeled 
virus + 1% Triton X-I 00 approximately equaled the fluorescence of an 
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infinite dilution of the probe, without a correction factor for the fluorescent 
environment. Phosphatidyl choline (PC) vesicles were labeled with RIB 
and measured for fluorescence. In a mock fusion experiment, additional 
unlabeled PC vesicles were then added and co-sonicated. As dilution of the 
probe increased, the fluorescence linearly approached an infinite dilution 
value. This infinite dilution value was equivalent to the fluorescent value 
given after the addition of 1 % Triton X-IOO to the original labeled PC 
vesicles . 
Conversion of virus protein to number of particles-
To relate quantities of Sendai viral protein to the number of viral 
particles it was assumed that 1 ~g of Sendai virus equaled 1.3 x 109 viral 
particles. This is based on the data given by Hoekstra and Klappe (10) and 
the MW measurement and size of the Sendai virus (12) . To determine the 
number of RSVE particles it was assumed that 30 % of the viral protein was 
glycoprotein. Assuming that the virus and RSVE are similar in size, 1 ~g of 
RSVE protein would be equal to 3.9 xI09 RSVE particles. 
Protein determination, Gel Electrophoresis, Transmission Electron 
Microscopy-
Protein content of the virus was determined by using the Peterson 
assay (22) with omission of the TCA precipitation step. Fraction V BSA 
(Reheis Chemical Company) was used as a protein standard. The BCA 
protein determination kit (Sigma) was also used. 
Polyacrylamide gel electrophoresis was used to ·confirm the presence 
of virus proteins and to check viral purity. Ten percent separating gels were 
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run with six percent stacking gels. Biorad protein standards were used. Gels 
were silver stained using the Biorad Silver Stain Kit. 
Virus samples (10 Ill) at varying concentrations (about 250 Ilg 
protein/ml) were applied to carbon-covered glow-discharged grids and 
allowed to dry. 10 III of stain was then applied and allowed to sit for various 
time periods. 1 % Phosphotungstic acid, 1 % Uranyl Acetate, and 2% 
Ammonium Molybdate were used as stains. The samples were examined 
using a Phillips EM201 TEM. 
Fluorescent Microscopy-
A Nikon inverted fluorescent microscope was used to examine the 
cells after addition of fluorescently labeled virus and RSVE. Virus and 
RSVE were fluorescently labeled as described above. Virus and cells were 
incubated at 37° for 30 minutes and then pelleted and washed with PBS to 
wash away unbound and unfused material. The samples were then placed 




The size distribution of Sendai virus and RSVE was determined by 
photon correlation spectroscopy light scattering measurements (Figure 1). 
The viral particles had an average diameter of 300 nm. Reconstituted virus 
envelopes contained two populations of particles, one with a diameter 
around 90 nm and the other with a diameter around 300 nm. 
Electron microscopic examination showed that the Sendai virus and 
the RSVE were intact vesicles and contained the spike glycoproteins HN 
and F. Gel electrophoresis showed the presence of the Large, HN, 
Polymerase, Nuclear Protein, F, and Matrix proteins in the whole virus and 
only the HN and F glycoproteins in the RSVE. 
Fusion of Sendai with H9 cells-
The fusion of the whole virus with H9 cells was tested in a 
preliminary experiment. Whole virus was labeled with the R18 fluorescent 
probe as described in the methods. Dequenching kinetics were monitored 
continuously for one hour using a number of different ratios of virus to 
cells (Figure 2). As virus numbers were increased a reduction in the 
percentage of virus dequenching was observed as the receptor sites on the 
cell surface were saturated with virus. Under the least saturating 
conditions, 4 % of the viral particles were able to interact with the H9 cells 
in 14 minutes. Under highly saturating conditions up to 2500 viral particles 
0.9 ilg viral protein/ Ix 106 cells) were observed to interact with each cell 
after 14 minutes. A reciprocal plot analysis (0.98 r squared fit) of the fusion 
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values showed a saturation maximum of about 2600 fusion events per cell 
(2 IJ.g viral protein per 1x106 cells) . 
Fusion of RSVE with H9 Cells-
The kinetic interaction of RSVE with H9 cells was then examined. 
RSVE were labeled with the self quenching Rd-PE probe rather than R18 
since the Rd-PE probe should be less likely to transfer spontaneously to a 
target membrane (see discussion). Again, as the amount of viral protein 
was increased the percentage of particles fusing went down while the 
absolute number of fusing particles increased, see Figure 3a. Up to 40% of 
the RSVE were observed to fuse, with up to 6 IJ.g of viral protein observed 
fusing per 106 cells. 
Trypsin has been shown to cleave selectively the F protein of Sendai 
virus (28). Fusion was inhibited 75 % by trypsin treatment of the virus 
indicating a large role for the F protein in the fusion process, see Figure 3b. 
Fetuin is a highly glycosylated protein which should compete with 
the cellular binding sites for the virus due to the multitude of sialic acid 
residues on the fetuin protein surface. When fetuin was added to the RSVE 
before addition of the virus to cells, fusion was inhibited by 93 %. In 
addition, no fusion was observed (97% inhibition) when the fusion assay 
was conducted in medium with serum rather than in PBS. Fetal calf serum 
contains fetuin which should have inhibited fusion. 
Fusion of RSVE with PBL-
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Experiments were also conducted to determine if RSVE virus could 
fuse with Peripheral Blood Lymphocytes. Over a time span of 14 minutes 
up to 40 % of the reconstituted virus could fuse with the PBL, see Figure 4a. 
A reciprocal plot Scatchard type analysis of the extents of fusion showed a 
saturation of about 2.9 Ilg viral protein per 106 cells in 14 minutes, Figure 5. 
As preparations of PBL may vary in content, the experiments were repeated 
with a second preparation of PBL. Similar behavior was observed with a 
saturation of about 2.7 Ilg viral protein per 1x106 cells. 
Fusion was highly inhibited (95%) by trypsinization of the virus, see 
Figure 4b. Fetuin or serum also strongly inhibited fusion (80-85% and 99%, 
respectivel y). 
Fluorescence Microscopy-
Peripheral blood lymphocytes were examined under the fluorescent 
scope to qualitatively examine the virus binding to the cellular surfaces. 
The PBL were covered with fluorescent points indicating a multitude of 
virus binding to the cells (data not shown). The virus appeared to be surface 
associated and not located in endocytotic or lysosomal compartments. 
Addition of fetuin to the media previous to viral addition resulted in 
almost complete inhibition of viral binding. No virus were observed 




In collaboration with Sean Sullivan (Vestar) , Roy Chang and John 
Rossi (City of Hope Hospital), RSVE were tested for the ability to encapsulate 
intact ribozyme. In a preliminary experiment, RSVE were incubated with 
ribozyme and then the ribozyme was examined by column chromatography 
to confirm the intactness of the ribozyme. No degradation of the RNA was 
caused by the RSVE. 32p labeled ribozyme (140 mer) was then encapsulated 
into RSVE (30 ~g ribozyme in 2 mg of Sendai protein) and the encapsulated 
product examined by gel electrophoresis. 50 % of the radiolabel was found 
associated with the vesicles . The material appeared intact by gel 
electrophoresis. The loaded RSVE were able to bind to the target H9 cells. 
An experiment was designed to determine if ribozyme was being 
delivered to the cellular interiors by the RSVE. Trypsin treated RSVE are 
able to bind to the H9 cellular surface but are not fusogenic, because trypsin 
cleaves the F protein but not the HN protein. After incubation of trypsin 
treated and untreated vesicles with H9 cells we had hoped to remove 
unfused vesicles from the cellular surface by treatment with protease K. 
Unbound virus was easily separated from the H9 cells by centrifuging 
through a layer of silicon oil. Unfortunately the treatment with protease K 
made no difference in the amount of material associated with the H9 cell; 
either the protease K was ineffective in removing the virus from the surface 
or all the RSVE, trypsin treated or not, were taken up by the cells. 
An attempt was made to transfect the H9 cells with the pXGH5 
plasmid which contains the human growth hormone under the mouse 
metallothionein-l promotor. The Allegro™ assay from Nichols Institue 
was used to determine if any transient expression was detectable. Little 
expression above background was found. The H9 cells are refractive to 
180 
other mechanisms of transfection. The DNA may be delivered to the 




After determining that Sendai virus was able to fuse with H9 cells, we 
found that reconstituted virus was able to fuse with both H9 and PBL cells. 
The majority of fusion occurred over a time span of thirty minutes and 
presented a simple single exponential kinetic profile, indicating that only 
one type of fusion event was occurring. Fusion of the virus with the cells 
was saturable, with a maximum number of binding receptors or fusion sites 
available. The process could be blocked by competing for the binding site 
sialic acids with fetuin or by preventing fusion by cleaving the F protein 
with trypsin. A large number of fusion events were observed with each cell; 
for the PBL approximately 2 Ilg of viral protein were observed to fuse with 1 
x 106 cells, equal to about 2600 whole virus per cell or 7,800 reconstituted 
virus per cell. The receptor for the Sendai virus, sialic acid, is common to 
many cells and fairly numerous in the cell membrane, providing a large 
number of binding sites for the virus to interact with the cells. It is likely 
that most mammalian cell lines are susceptible to fusion with the Sendai 
virus . 
We have used a new fluorescence assay to monitor membrane fusion 
in this paper. For examining the fusion of reconstituted systems or 
liposomes the self quenching probe Rd-PE can be incorporated into the 
membrane. Previous workers have used the resonance energy transfer pair 
NBD-PE/Rd-PE to monitor fusion (27). The Rd-PE probe system produces 
more fluorescent signal than the NBD/Rd system (data not shown) and is 
not subject to some of the artifacts seen in the NBD/Rd system (7). The Rd-
PE probe has an advantage over the R18 probe as Rd-PE has two 
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hydrocarbon tails rather than RIB's one and thus is less likely to 
spontaneously transfer out of the membrane. RIB is still the preferred 
system for labeling whole virus due to its ability to insert into the intact 
virus envelope. 
Reconstituted virus may provide a method for drug delivery to cells. 
The ability of the reconstituted virus to maintain contents is critical to 
delivery and is undergoing current examination. AZT loading may require 
phosphorylation to prevent the drug from crossing the viral membrane. 
Literature procedures used to load nucleic acids into these reconstituted 
vesicles have produced very low rates of loading in our hands. The vesicles 
may be more valuable for the delivery of membrane components and pro 
drugs; the delivery of Epstein Barr receptors to receptor-negative cells has 
previously been demonstrated (32). 
I-Abbreviations used- Rd-PE, LissamineRhodamine B Sulfonyl Diacyl 
Phosphatidylethanolamine; RIB, Octadecyl Rhodamine B; PBL, Peripheral 
Blood Lymphocyte; RSVE, Reconstituted Sendai Viral Envelope 
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Figure Captions 
Figure 1. Light scattering size analysis of Sendai virus and RSVE. 
Figure 2. Fusion of Sendai virus with H9 cells. Cells were added to R18 
labeled Sendai virus as described in Methods. Viral amounts are described 
in terms of micrograms of viral protein. H9 cells were injected after 100 
seconds. 
Figure 3a. Fusion of RSVE with H9 cells. H9 cells were added to Rd-PE 
labeled RSVEs after 60 seconds. Two milliliters of H9 cells contained 6.4 x 
105 cells. 3b. Inhibition of fusion. In each experiment 6.4 x 105 H9 cells were 
used. 
Figure 4a. Fusion of RSVE with PBL cells. Various amounts of viral protein 
were mixed with 4.8 x 10 6 PBL cells. 4b. Inhibition of RSVE fusion with 
PBL cells. Again, 4.8 x 106 PBL cells were used. 
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Figure 3(a). 
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ABSTRACT 
DNA plasmids (=5000 base pairs) were loaded into Triton X-I00 
reconstituted Sendai prepared by the general method of Vainstein et a!. 
(Vainstein et a!., 1984). Examination by gel electrophoresis of DNAase 
treated vesicles revealed that the vesicles encapsulated <1 % of the input 
DNA. Protamine, polylysine and lysozyme were used to enhance 
encapsulation. All three proteins enhanced loading to between 4 and 10 % 
DNA encapsulated. Accurate values for DNA encapsulation with 
protamine were difficult to determine as the protamine afforded the DNA 
some DNAase protection. Transfection experiments using luciferase 
expression as a marker gave positive results for Cos cells and negative 
results for HL60 cells. 
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INTRODUCTION 
The paramyxovirus Sendai contains two glycoproteins, HN, which is 
responsible for viral binding to host cell receptors (sialic acid), and F, which 
is responsible for fusion of the viral membrane with the cellular 
membrane. These proteins can be reconstituted into vesicles by solubilizing 
the viral lipids and glycoproteins in detergent, removing the interior 
proteins and viral nucleic acid by ultracentrifugation, and dialyzing away 
the detergent. These reconstituted Sendai viral envelopes (RSVE) maintain 
the functions of the native viral glycoproteins and thus can be used to 
deliver material to the interior of a cell. A variety of substances have been 
encapsulated and delivered using these vesicles (Loyter et aI., 1983, Loyter 
and Volsky, 1982, Vainstein et aI., 1983). 
We are investigating the use of RSVE in transfecting certain cell lines 
which are difficult to transfect by normal mechanisms (calcium phosphate, 
electroporation, lipofection, DNA loaded liposomes). We would like to 
effiCiently load DNA into these viral vesicles and deliver DNA to cellular 
interiors. In preparing loaded vesicles we found that the loading was highly 
inefficient. Work by Jay and Gilbert on DNA loading into phospholipid 
vesicles (Jay and Gilbert, 1987) suggested that positively charged proteins 
might serve to enhance DNA loading into the reconstituted viral 
envelopes. 
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MATERIALS AND METHODS 
Materials 
Sendai virus was grown in 10 day old embryonic eggs and prepared by 
differential centrifugation. The virus was further purified by filtration 
through 1.2 ~m and .8 ~m filters. Plasm ids were prepared by standard 
methods . The proteins used in the coencapsulation experiment were 
protamine sulfate (Salmon type 11), poly lysine hydrochloride (MW 17,300), 
and lysozyme (egg white) . 
Reconstitution 
A modification of the Triton X-110 reconstitution method of Vainstein 
et al. (Vainstein et ai., 1984) was used in preparation of the vesicles. One mg 
of viral protein was pelle ted at 100,000g for one hour in a SWSO.1 rotor. The 
virus was dissolved in 30 to 50 ~l of 10% Triton X-100/l00 mM NaCl/SO 
mM Hepes/2 mM EDTA pH 7.4 buffer. The sample was shaken for 4 hours 
at room temperature and then the non-dissolved nucleocapsid material was 
pelleted out with the ultracentrifuge, again at 100,000g. 
External DNA, proteins, and fluorescent markers were added to the 
detergent solubilized lipid and proteins after removal of the nucleocapsid. 
In general, 5-10 ~g of DNA were used with 1 mg of Sendai viral protein. 
Exact starting DNA ratios are given in the figures and results . 
Coencapsulated protein was vortexed with the DNA before addition. A ten 
to one gram/gram ratio of protein to DNA was generally used (50-100 ~g 
protein) . Other ratios were also tested. The resonance energy transfer 
probes NBD-PE and Rd-PE were added at 1.5 mole % of. the total lipid. 
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After addition of materials to be encapsulated, SM-2 Biobeads (30-50 
mg) were added to absorb the detergent and the solution was shaken at 
room temperature for 4 hours. Thirty to fifty milligrams of additional SM-2 
biobeads and 30 to 50 ~l of 160 mM NaCI/lO mM Hepes solution were then 
added. The sample was shaken at room temperature for 12-14 hours. The 
solution was removed from the beads with a Hamilton syringe and the 
beads were washed three times with the high salt buffer. The RSVE were 
pelleted by ultracentrifugation and resuspended in PBS. 
Fluorescent Fusion Assay 
The RSVE were labeled with the resonance energy transfer probes 
NBD/Rd, described previously (see Chapter 2; Struck et aI., 1981), and 
fluorescent fusion assays were conducted to determine if the reconstituted 
vesicles retained the fusogenic activity of native viral particles and to 
determine if the RSVE were able to fuse with target cell lines. In brief, 
labeled virus were mixed with target cells in a 370 cuvette in a SLM 4800 
fluorimeter. The emission of the NBD at 530 nm was monitored 
continuously while exciting at 470 nm. An increase in NBD fluorescence 
occurs upon viral fusion due to the diffusion of the fluorescent probes into 
the membrane of the target cell which reduces energy transfer from the 
NBD to the Rd. The % of the virus which have dequenched can be 
determined continually upon mixing of virus and target lipids. 
DNAase digestion 
Non encapsulated DNA was removed by DNAase digestion. Samples 
were adjusted to 5 mM MgCl2 and DNAase was added to 20 ~g/ml. 
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Samples were incubated at 37°for one hour. Digestion was stopped by 
addition of EDT A to 10 mM. 
Gel Electrophoresis 
To prepare the encapsulated DNA for electrophoresis, both DNAase 
treated vesicles and untreated vesicles were disrupted with .5% 50S. The 
samples were treated with .1 Ilg of Protease K for 6 to 20 hours at 37° to 
digest viral and added proteins. To remove digested protein, samples were 
phenol extracted twice, chloroform extracted once, and ether extracted. The 
DNA was precipitated overnight at -70° with 10% volume sodium acetate 
and 200% volume ethanol. After pelleting the DNA and drying in a spin 
vacuum centrifuge, the DNA was resuspended in TBE with bromophenol 
blue dye. 
Standard 1 % agarose slab gels were run on the samples with ethidium 
bromide staining. Photographs were taken and band intensities measured 
by a LKB scanning densitometer. The peak areas in the densitometry scans 
were measured by hand. 
Light Scattering Size Measurements 
A Malvern 4700c photon correlation spectrometer was used to measure 
the virus size. The system is equipped with a 488 nm tuned 3 watt Spectra-
Physics 2020 laser attached to an IBM compatible PC with Malvern software. 
Most measurements were made at 90° to the beam with no size bias and 
maximal modal distribution parameters. Measurements at other angles 
were made to check for any major amplitude variations. In some instances 
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size bias parameters were inserted after initial data collection to further 
clarify size distributions. 
Cell Extract Preparation and Luciferase Assays 
The cells to be transfected were incubated with loaded RSVE for 30 
minutes at 37°C in PBS. The cells were then grown for several days. Cell 
extracts were prepared by thrice washing the cells with PBS (no Ca or Mg), 
adding 1 ml of extraction buffer (0.1 M KP04, 1 mM OTT, pH 7.8) to each 10 
cm2 region of cells and then scraping the cells from the surface into an 
eppendorf tube. Cells were pelleted at 4° C for 2 minute in an eppendorf 
centrifuge. Suspension cells were simply pelleted. The cell pellet was 
resuspended in .1 ml of extraction buffer, vortexed, and freeze-thawed three 
times from 37° C into liquid nitrogen and back again. The extracts were 
centrifuged for 5 minutes in a eppendorf centrifuge (4° C) and the 
supernatant was used for a luciferase assay. 
Balb c mice were injected with loaded RSVE intravenously in the tail 
vein or in traperi toneall y. The animals were sacrificed and the tissues 
frozen in liquid nitrogen. For luciferase experiments with animal tissue the 
tissue was ground in a dounce homogenizer in the presence of .5 ml 
extraction buffer and the cell debris was pelleted from the cytoplasm extract 
by centrifugation. 
For a measurement of luciferase activity 10-25 ~l of cell extract were 
mixed with 330 ~l of glycylglycine buffer (25 mM glycylglycine pH 7.8, 15 
mM MgS04) and 20 ~l of 100 mM ATP. The sample was placed in the 
luminometer and 100 ~l of 1 mM luciferin were injected at the start of a 
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Encapsulation of naked DNA is low 
In our initial experiments, 32p labeled plasmid DNA was used as 
reporter of encapsulation. Plasmid loaded RSVE were prepared and treated 
with DNAase to remove non encapsulated plasmid DNA. A large number 
of radioactive counts were found associated with the RSVE (see Figure 1). 
Unfortunately, when these samples were run on agarose gels very little 
DNA was observed «1 % of the starting material) . It is likely that the 
artificially high counts were given by digested DNA tightly bound to the 
surface of the RSVE. 
This experiment was repeated using various ratios of DNA plasmid to 
Sendai protein but in all cases the observed encapsulation was less than 1 %. 
An example of one of these experiments is shown in Figure 2. This 
experiment was performed multiple times as a control for later experiments 
and did not ever show any encapsulation above 1 % plasmid DNA 
Polylysine and Lysozyme enhance loading 
When DNA was encapsulated along with polylysine or lysozyme a 
substantial increase in loading was observed. The agarose gels shown in 
Figures 3a and 3b were quantitatively analyzed for the intensity of bands 
using densitometry. Reference lanes of set amounts of the plasmid 
encapsulated were run to establish a calibration curve and the intensities of 
the samples were compared to this curve. About 3% of the DNA/lysozyme 
200 
mixture and 8% of the DNA/polylysine mixture were encapsulated as 
compared to less than one percent in the naked DNA sample. To determine 
if the proteins or the vesicles afforded any protection to DNA not in the 
interior of the RSVE, control digestion experiments were run with 
preformed RSVE and DNA/protein complexs. These experiments show 
that virtually no protection was afforded to the whole plasmid, <1 % of the 
starting material was found in the supercoiled, nicked and linear bands. 
Some protection was afforded to the smaller fragments as evidenced by a 
long smear in the gel. Naked DNA was completely digested. As a further 
control DNA was digested in the presence of empty RSVE, in order to 
determine if RSVE could afford any protection to the DNA. The presence of 
empty RSVE's made no difference on the DNAase digestion. 
Various degrees of efficiency were seen in the encapsulation of the 
DNA/protein complexes. In general 4 to 10 % of the DNA was found to be 
encapsulated when complexed with positively charged proteins. 
Protamine Loading effects are difficult to quantitate 
The positively charged protein protamine was our initial choice as a 
coencapsulation agent as it might not only serve as a packaging protein for 
the DNA but also as a transport mechanism to the interior of cells 
(Weinhaus et aI., 1987). Unfortunately protamine was found to afford some 
protection to whole plasmid, making it very difficult to quantitate the 
amount of plasmid encapsulated. In control digestion studies with 
protamine-DNA complexes, linear and nicked circle bands were observed. 
No super coiled plasmid was observed in the control digestion. Supercoiled 
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plasmid was observed in the RSVE encapsulated DNA gel lanes indicating 
that enhancement of DNA encapsulation was occurring. In Figure 4 
approximately 3% of the initial DNA was found inside the vesicles in 
supercoiled form. 
Properties of the Reconstituted vesicles 
A summary of the size distribution of the reconstituted vesicles is 
given in Figure 5. The reconstitution procedure normally produces a 
bimodal distribution of particles with one set of particles with a mean 
diameter of about 100 nm and the second set having a diameter of about 300 
nm. The addition of DNA/protein complexes to the reconstitution had 
little effect on the reformation of vesicles, although the number of vesicles 
in the larger population increased. Some of this size increase may have 
been due to aggregation of the viral particles . Electron microscopy 
observation showed that the RSVE were normal in character, covered by the 
spikelike F and HN proteins. 
The activities of the F and HN protein were tested by a fluorescent 
fusion assay and a hemagglutination assay. Fusion was observed with ghost 
erythrocytes even when vesicles were loaded with DNA and protamine 
(Figure 6) . Fusion activity did not appear to be affected by the presence of 
added DNA. Hemagglutination also appeared to be unaffected. 
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Observation on RSVE interactions with cells 
In order to determine if the RSVE were able to deliver their contents to 
the cells in question a number of different materials were loaded into the 
vesicles and surveyed for delivery to target cells by fluorescent microscopy. 
RSVE labeled with NBD-PE and Rd-PE lipid probes were observed to be 
bound to HL60 cells with both punctilate and diffuse fluorescence on the cell 
surface. Some signs of receptor "capping" were observed, with bound virus 
preferentially accumulated at one end of the cells. Cells treated with trypsin 
were still able to bind RSVE. 
RSVE loaded with ethidium bromide were added to cells and observed 
under a fluorescent microscope. No direct observation of EtBr was possible; 
this may have been partially due to a high background fluorescence and 
improper excitation of the EtBr. However, the cells were all dead within 24 
hours, providing some evidence for delivery of the EtBr to the cell interiors. 
RSVE loaded with carboxy fluorescein aqueous probe were added to 
cells and a diffuse fluorescence was observed in the interior of the HL60 
cells, although this fluorescence was photobleached more rapidly than it 
could be recorded by photography. RSVE loaded with trypan blue and a 
EtBr /DNA complex were added to cells but no observation of these contents 
markers was made in the cell interiors. 
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Transfection experiments with the reconstituted vesicles 
With some evidence that the RSVE were able to interact with the HL60 
cells, transfection experiments were conducted in order to determine the 
efficiency of the RSVE as carriers of DNA into the cells. Plasmids with the 
luciferase gene under various promotors were loaded into RSVE vesicles 
and the vesicles were allowed to interact with HL60, U937 and Cos cells. 
The luciferase gene product can be detected by mixing cellular extracts with 
luciferin and ATP, the resulting reaction producing light photons ( em = 560 
nm)(OeWet et aI., 1987), 
luciferase + luciferin + ATP f---t luciferase-luciferyl-AMP +PPi 
luciferase-luciferyl-AMP + 02 -t luciferase + oxyluciferin + AMP + 
C02 + hv. 
Previous attempts to transfect HL60 cells with calcium phosphate, 
electroporation, and OOTMA (lipofection) have been unsuccessful (T. 
Amatruda, personal communication). 
Four promotors were used, an early promotor from the SV40 virus 
(SV40 or SV2), a Rous sarcoma virus promotor (RSV), and two early 
promo tors from cytomegalovirus (CMV and COM). 
Under no circumstances was transfection of the HL60 or U937 cells 
observed with the loaded RSVE (see Figures 7a-e) . In one experiment 
(Figure 7b) a southern blot analysis was performed on nuclear extracts 
prepared from the HL60 and Cos cells in order to look for the presence of 
plasmid in the cellular nucleus (gel not shown). A small amount of 
plasmid material was present in all of the nuclear extracts from the Cos cells 
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with the uncomplexed DNA appearing to be the least degraded. Large 
amounts of DNA, much of it degraded, appeared in the HL60 cell nuclei for 
the RSVE where the DNA was complexed with polylysine or protamine. 
No DNA was apparent in the nuclei of the HL60 cells where naked DNA 
was delivered to the cell. It should be noted that the procedures for 
preparation of nuclear extracts are not very clean and material stuck to the 
surface of the nucleus or the cell could contaminate the preparation. 
The Cos cells were consistently transfected. In general DNA complexed 
with protamine gave higher transfection then naked DNA (Figures 7c and 
7d). Some inconsistency was observed in the transfection efficiencies from 
experiment to experiment, and in one anomalous result a large amount of 
expression was seen with the naked DNA loaded into the RSVE ( Figure 7b). 
When compared to electroporation for efficiency of transfection, the RSVE 
were one to two orders of magnitude less efficient then the transfection 
with electroporation (Figure 7c,e) . In terms of promotor efficiency in 
expression in the COS cells, the following order of activity was observed: 
CDM > SV40 > CMV, RSV. 
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DISCUSSION AND CONCLUSIONS 
Theoretical encapsulation 
A range of reconstituted vesicle sizes from 150 to 400 nm in diameter 
was observed. For a reconstituted vesicle having a diameter of 200 nm, 4/3 
1t x 10-21 m3 of volume is encapsulated (3.37 times this value for a 300 nm 
diameter). The volume used in a typical reconstitution is 1 x 10-7 m3 with 
1:3x1012 reconstituted particles being formed . Thus approximately 5.4 % of 
the volume is encapsulated by the particles (18% for 300 nm particles). For a 
small neutral particle this is the amount of material we would expect to 
encapsulate. 
A number of methods can be used to estimate the size of the plasmids 
used in these experiments. For a 5000 bp plasmid(n=5000) a maximum 
radius of 850 nm for a rigid rod conformation (.34 nm (L) per base pair) can 
be calculated. As a rigid circle this radius is reduced to 283 nm. If the DNA 
is treated as a neutral totally flexible random coil the radius can be 
determined using the formulas, 
(;/nxL) 
Rg = ...[6 
or 
(;/nxL) 
Rg = -{3 , 
which give radiuses of 9.85 and 13.88 nm, respectively. 
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A more realistic analysis of DNA plasmid size uses the persistence 
length, a measure of flexibility for large macromolecules. This parameter, b, 
is about 70 nm for normal B form DNA. For a linear length of DNA, 
" (h
2
) = " L x b 
which gives a radius of 140 nm. The radius of a relaxed circular plasmid can 
be estimated to be this amount divided by the -{2 to give a radius of 100 nm. 
To compare the radius of a piece of relaxed circle DNA versus a piece 
supercoiled DNA the centrifugation diffusion constants (5) of the respective 
forms can be compared where 
1 
Rg oc 5 . 
cent 
For 5V40 DNA the relaxed circle has a 5 value of 16.5 versus 21 for 
supercoiled (Bauer and Vinograd, 1968). Thus the supercoiled plasmid 
should have a radius 1.27 times smaller than the nicked circle, giving a 
value of 80 nm for a 5000 bp plasmid. 
This calculation indicates that the plasmid DNA is comparable in 
radius to the radius of the reconstituted virus envelope (DNA radius of 140 
nm, 100nm, and 80 nm for linear, nicked circle, and supercoiled respectively 
versus reconstituted virus envelope radius of 75-200 nm) . 
The native virus encloses a number of proteins and a 15,000 nucleotide 
single stranded RNA. 
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Effects of charge repulsion, condensation 
The addition of basic proteins during reconstitution was effective in 
enhancing encapsulation. The proteins may have served to reduce 
electrostatic repulsion of the DNA from the Sendai lipids and proteins, in 
general the presence of phosphatidyl serine in natural bilayers gives them a 
net negative charge at neutral pH. In addition, the basic proteins may have 
reduced internal DNA repulsion and resulted in a condensation of the 
plasmid DNA into a more compact package. Packaging of chromosomal 
DNA is accomplished by the presence of positively charged histone proteins. 
Literature reports on encapsulation 
A number of other workers have loaded nucleic acids into RSVE. In 
general no quantitation of the amount of encapsulated material was 
undertaken. In several cases radiolabeled DNA was used as an indicator of 
encapsulated material, leading to a false reportation of the efficiency of 
encapsulation. In two cases, gel electrophoresis evidence was published 
within a paper that contradicted data on encapsulation determined by 
radiolabeled DNA given within the same paper. 
In the first paper (Vainstein et aI., 1983), rates of encapsulation of 6.5% 
(pBR322), 5.5% (pBR322) and 2% (pMB9) for ratios of DNA to protein 
(~g/mg) of 4, 10 and 10, respectively, were determined using 3H DNA as a 
tracer. Gel electrophoresis of the recovered product from DNA digestion of 
150 ~g of pTKx1 DNA loaded into 10 ~g of Sendai is shown next to a control 
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lane containing 3 ~g pTKx1 DNA. A loading efficiency of 5% should be 
equivalent to 3 ~g of encapsulated DNA being loaded onto the gel (the same 
as the control lane). However, virtually no DNA was visible in the lane to 
which the reconstituted encapsulated product was added, as compared to the 
control lane. 
A similar observation was made in the second paper (Loyter et aI., 
1983). Encapsulation rates up to 10% are reported at ratios of 10 ~g SV40-
DNA to 1 mg sendai protein. For ratios of 40 ~g of sV40-DNA to 1 mg 
sendai protein rates of encapsulation of 2-4% are reported by 3H 
radiolabeled DNA digested with DNAase. The encapsulated product was 
run on gel electrophoresis next to a control lane containing 1 ~g of SV-40 
DNA and appears much fainter in intensity. For the materials started with, 
120 ~g DNA with 3 mg Send ai, one would expect a much brighter band of 
2.4-4.8 ~g of encapsulated DNA to appear on the gel given the 2-4% 
encapsulation rate. 
These literature data support my observations that radiolabeled DNA 
can overreport the amount of material trapped by RSVE. 
HL60 Cells and Transfection 
The HL60 cell line is derived from a promyelocytic leukemia and 
proliferates continually in suspension tissue culture (unlike other isolated 
myeloid leukemia cells) . The HL60 cell is essentially a myeloid cell which is 
arrested in its differentiation to mature cell type and transformed into a 
cancerous cell. Of significant experimental interest is the ability of these 
cells to differentiate into mature cell types upon the addition of external 
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stimulating factors (Collins, 1987). These cells can differentiate into 
granulocytes (neutrophils), monocytes, macrophage-like cells and 
eosinophils. See Table 1 for a listing of the factors that induce this 
differentiation. Thus, these cells serve as a model system for hematopoietic 
differentiation and gene regulation as well as a model for leukemia cells. 
As transformed cells, they also provide information on the mechanisms by 
which oncogenes control cellular division. 
Insertion of exogenous genes could provide a number of insights into 
cellular control of gene expression and differentiation. The expression 
levels of "neutral" genes with various promotors and enhancers before, 
during and after differentiation would provide information on the 
interaction of cellular transcriptional factors with these cis acting elements. 
The effects of increasing or decreasing proteins integral to the differentiation 
process could also be investigated (Concannon et a!., 1985). In our 
experiments transfection was desired in order to study the effects on the 
differentiation process of having mutated G proteins in the phospholipase 
phosphoinositol signalling pathway (Morgan, 1989). 
Although there are many interesting possibilities for transfected HL60 
cells, there are virtually no references to gene transfer into these cells in the 
literature. Our experiments and previous experiments (T. Amatruda) have 
shown that these cells are particularly refractory to transfection by calcium 
phosphate, electroporation, lipofection, or reconstituted Sendai viral 
envelope DNA delivery. There was one literature report of calcium 
phophate transfection in 1985 but it gave a low yield ( 2 x 10-5 ) and has not 
been reproducible (Concannon et a!., 1985). There "is also one meeting 
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abstract on electroporation of these cells, but the abstract does not give any 
information on the success rate of transfection (Ikeda et al., 1988) 
There is one significant report of retroviral gene transfer in the 
literature by the discoverer of HL60 cells, Steve Collins, in which he 
reported that expression in HL60 cells of the retrovirus N2 was low 
compared to other hematopoietic cell lines (30-40% in K562 cells versus <5% 
in KG-1 and HL-60 cells)(Collins, 1988a). Southern blots analysis showed 
virtually no viral DNA was present in the HL60 cells in unintegrated form 
(24 hours post infection) or integrated form (5 days post infection). In 
contrast the KG-1 cells contained unintegrated but no integrated DNA, 
while the K562 contained unintegrated and integrated DNA. Collins 
suggests three mechanisms for this: 1) the presence of relatively few 
retrovirus receptors on the HL60 cell surface, 2) inhibi tion of reverse 
transcriptase, or 3) enhanced degradation of unintegrated DNA. In an 
accompanying paper Collins showed that those HL60 cells which were 
transfected showed enhanced transcription of retroviral mRNA when the 
cells were stimulated to differentiate (Collins,1988b). No further 
investigations have been made into the mechanism of resistance ( S. 
Collins, personal communication). 
In our experiments there appear to be receptors for viral interaction 
with the cells and DNA is delivered directly to the cells, eliminating the 
requirement for any reverse transcriptase activity. A cellular DNAase 
activity could be responsible for the expression resistance or the promotor 
sequences used in our plasmids may not be active in these cells. It is 
interesting to note that in the southern blot experiment done on cell nuclei 
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after RSVE transfection, protected DNA (protamine associated) was found 




Under normal Triton X-100 reconstitution conditions the 
encapsulation of DNA is very low, <1 %. Radiolabeled DNA does not give 
valid encapsulation values when compared to direct gel analysis. 
Polylysine and lysozyme greatly increase the amount of encapsulated 
material to between 3 and 10%. This amount of encapsulated material is 
approximately equivalent to the amount one would expect to find for the 
encapsulation of a small, neutral molecule. The enhancement in 
encapsulation may be due to a charge neutralization of the DNA and a 
condensation of the mean size of the DNA. The protein/DNA complex 
may also serve as a site of formation for the reconstituted virus, similar to 
the process of viral budding from the cell. 
Protamine may also enhance encapsulation but quantitization was 
difficult. Protamine partially protected the DNA from digestion. Protamine 
does not appear to protect supercoiled plasmid from nicking and 
supercoiled material was observed in the RSVE/DNA/Protamine samples. 
Transfection was feasible using the reconstituted virus with luciferase 
protein being expressed in Cos cells. The efficiency of transfection was no 
better than already available techniques. No expression was observed in 
HL60 cells. Experimental evidence supports a hypothesis that material can 
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FIGURES 
Note- For those who are not familiar with agarose gel electrophoresis, this 
technique is used to separate large pieces of nucleic acids. In terms of 
mobility in the gel media of equal length pieces of DNA, supercoiled DNA 
travels most rapidly, due to its compact structure, while linear DNA travels 
second in speed and nicked circle travels the slowest, as the linear material 
is more able to "snake" through the gel matrix than the nicked circular 
material. A control "ladder" of digested material can be run to determine 
fragment length for linear pieces, our control ladder consisted of lambda 
DNA cut by HindIII restriction endonuclease giving fragments of 23 kb, 9.4 
kb, 6.6 kb, 4.4 kb, 2.3 kb, 2 kb, .6 kb, and .1 kb. 
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Figure 1- Radiolabeled DNA is a poor reporter of encapsulation 
32p labeled DNA was used as a reporter of encapsulation. RSVE were 
prepared and treated with DNAase as in methods. No coencapsulation 
proteins were used in these experiments. 
Exp. 1,2,3: 1.2 mg Sendai virus protein, 32p DNA (1.45xl06 cpm) 
Exp 1: 1 Ilg sheared salmon sperm DNA 
Exp 2: 10 Ilg sheared salmon sperm DNA 
Exp 3: 40 Ilg sheared salmon sperm DNA 
Exp. 4: 3 mg Sendai, 40 Ilg RSVL plasmid DNA (=5000 basepairs) 
Recovery of 32p DNA 
BioBeads Wash DNAase Wash RSVE Total 
exp 1 439722 51450 12000 5850 609200 (54%) 1118000 (77%) 
exp2 733028 11500 24760 8010 348720 (31 %) 1125000 (77%) 
exp3 664425 33600 75780 14130 607200 (44%) 1392000 (96%) 
These numbers seemed quite high (17.6 Ilg in expo 3). An agarose gel was 
run (Figure la) on the samples to visually confirm these numbers. 
Lane 1- 30 ng SV2Lux DNA 
Lane 2- 500 ng SV2Lux DNA 
Lane 3- 4% RSVE 
Lane 4- 10% RSVE 
Lane 5- Other Samples (DRV's) 
Lane 6- Other Sample (DRV's) 
Lane 7&8- Empty 
Unfortunately, very little of the DNA was encapsulated. The DNAased 
material most likely can bind to the RSVE, giving artificially high 
encapsulation numbers with the radiolabeled DNA. 
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Figure 2- Normal Encapsulation of DNA is very low 
Multiple experiments confirmed that little DNA was loaded into 
the vesicles using the general procedure. The data from such an experiment 
is shown below. 
1.2 mg of Sendai starting protein was reconstituted with 10 ~g, 30 
~g, and 50 ~g plasmid DNA (4 kilobases). 80% of the RSVE samples were 
treated with DNAase. 
Lanes 1-6: other Samples 
Lane 7: 100 ng Plasmid 
Lane 8: 250 ng Plasmid 
Lane 9: 1 ~g Plasmid 
Lane 10: 5 ~g Plasmid 
Lane 11 : 20% 10 ~g DNA/RSVE 
Lane 12: 20% 30 ~g DNA/RSVE 
Lane 13: 20% 50 ~g DNA/RSVE 
Lane 14: 64% 10 ~g DNA/RSVE +DNAase 
Lane 15: 64% 30 ~g DNA/RSVE +DNAase 
Lane 16: 64% 50 ~g DNA/RSVE +DNAase 
=250 ng (=1%) 






Figure 3- Polylysine and lysozyme enhance loading 
a) 3.6 ~g of HE6 DNA (about 5000 bp) and .75 mg Sendai Protein 
were used in the reconstitution experiments. 
Reconstituted vesicles were prepared and DNAased as in methods. 
The encapsulation experiments used plain DNA, DNA plus 32 ~g lysozyme, 
and DNA plus 20 ~g polylysine. 
Three experiments were conducted as controls of DNAase activity 
and lack of protein protection from such activity. DNAase digestion control 
experiments were conducted with .8 ~g DNA and 250 ~g of preformed 
RSVE in the presence of 20 ~g lysozyme, 5 ~g polylysine, or nothing. 
Densitometry 
Lane 1: 400 ng HE 6 Plasmid 
Lane 2: 40 ng HE6 Plasmid 
Lane 3: Lysozyme/DNA RSVE + DNAase 
Lane 4: Polylysine/DNA RSVE + DNAase 
Lane 5: Plain/DNA RSVE + DNAase 
Lane 6: DNA/Lysozyme+DNAase 
Lane 7: DNA/Polylysine+DNAase 
Lane 8: DNA + DNAase 
Lane 9: 100 ng HE6 
Lane 10: 10 ng HE6 
Lane 11: 200 ng HE6 
Lane 12: Hindill Lambda Ladder 
100 ng (3.1 %) 
260 ng (8.1 %) 
<10 ng 
~10 ng (1.2%) 
~10 ng (1.2%) 
<10 ng 
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b) 5 ~g of HE6 DNA (about 500 bp) and .78 mg Sendai Protein were 
used in the reconstitution experiments. 
Reconstituted vesicles were prepared and DNAased as in methods. 
The encapsulation experiments used plain DNA, DNA plus 50 ~g lysozyme, 
and DNA plus 20 ~g polylysine. 
Three experiments were conducted as controls of DNAase activity 
and lack of protein protection from such activity. DNAase control 
experiments were run with 2 ~g DNA and 250 ~g of preformed RSVE in 
the presence of 20 ~g lysozyme, 8 ~g polylysine, or nothing. 
Densitometry 
Lane 1: 400 ng HE 6 Plasmid 
Lane 2: 80 ng HE6 Plasmid 
Lane 3: 20% Lysozyme/DNA RSVE 
Lane 4: 20% Polylysine/DNA RSVE 
Lane 5: 20% Plain/DNA RSVE 
Lane 6: Hind III Ladder 
Lane 7: 80% DNA/Polylysine RSVE +DNAase 
Lane 8: 80% DNA RSVE+ DNAase 
Lane 9: 80% DNA Lysozyme+ DNAase 
Lane 10: Polylysine/DNA + DNAase 
Lane 11: Lysozyme/DNA + DNAase 
Lane 12: DNA + DNAase 
Lane 13: 40 ng HE6 
Lane 14: 10 ng HE6 
Lane 15: 800 ng HE6 
150 ng (3.75%) 
<lOng «.1%) 
260 ng (6.5%) 
<10 ng «.5%) 











Figure 4- Protamine loading effects difficult to determine 
Protamine was the first protein used in this study, mainly due to its 
ability to enhance transport of DNA into the nucleus. Protamine may 
enhance DNA loading but the loading is difficult to assay as protamine 
protects the DNA from digestion. 
10 ~g of Plasmid DNA (~5000 basepairs) was loaded into vesicles 
formed from .77 mg Sendai virus starting protein. 100 ~g of protamine or 
lysozyme were used. For control lanes, 4 ~g of DNA and 40 ~g of protamine 
or lysozyme were digested with DNAase. 
Gel Lanes 
Lane 1: 80 ng HE6 Plasmid 
Lane 2: 100 ng HE6 Plasmid 
Lane 3: 200 ng HE6 Plasmid 
Lane 4: 50% Protamine/DNA RSVE + DNAase 
Lane 5: 50% Protamine/DNA + DNAase 
Lane 6: 50% Lysozyme/DNA + DNAase 
Lane 7: 50% Lysozyme/DNA RSVE + DNAase 
Lane 8: 10 ng HE6 Plasmid 
Lane 9: 400 ng HE6 Plasmid 
Lane 10: 20 ng HE 6 Plasmid 
Lane 11: HindIII Ladder 
SuCoi! = Supercoiled 
Protected DNA 
SuCoil 163 ng (3.2%) 
Total 711 ng (14%) 
SuCoil 0 
Total 569 ng (28.4%) 
«10 ng 
396 ng (7.9%) 
A large band of supercoi!ed plasmid is seen in the protamine RSVE lane 
which may indicate some enhancement of encapsulation as the protamine 
appears to give little protection to supercoiled DNA. However, the 
protamine protects nicked circle and linear DNA from digestion, preventing 
any quantitative analysis of DNA encapsulation by this DNAase digestion 
method. 32p labeled DNA was again used in this experiment and showed 
association of 50%, 28% and 16% (Protamine, Lysozyme, Plain) of the DNA 




Figure S- Size Distribution of RSVE 
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Figure 6- Summary of some fluorescent fusion experiments 
Probe RSVE/Ghost (ug) t (sec) %Dequenching RSVE Contents· 
NBD/Rd 5/1.5x106t 2000 4 pDNA 
NBD/Rd 5/80 1000 4.8 pDNA 
NBD/Rd 5/80 1000 5.5 pDNA 
6% Rd 6/80 1000 2.6 
6% Rd 3/80 1000 4.0 
6% Rd 6/160 1000 3.8 
NBD/Rd 6/200 1000 2.7 pDNA 
NBD/Rd 3.6/200 1000 2.9 pDNA 
30,000 16.3 
NBD/Rd 6/50 25,000 8.6 pDNA 
NBD/Rd 7.2/40 3600 22.4 pDNA+protamine 
NBD/Rd 7.2/80 3600 16.3 pDNA+protamine 
• pDNA = plasmid DNA 
t CV-1 cells rather than ghosts 
Hemagglutination 
RSVE without DNA/Protamine >25,600 HAU/ml >172 HAU/ ~g protein 
RSVE with DNA/Protamine >25,600 HAU/ml >70 HAU/ ~g protein 
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Figure 7- Survival and Transfection Results 
(a) Experimen t 1-
Toxicity and Survival-
Identical loading and transfection experiments were conducted with two 
plasmids, one containing the luciferase gene under the Rous sarcoma virus 
(pRSVL) early promotor and the other with the gene under the SV40 early 
promotor (pSV2Iux) . 100 ~g of plasmid DNA was loaded into vesicles 
formed from 5 mg of starting Sendai virus protein with the reconstitution 
procedure described in methods. An approximate yield of 500 ~g protein 
RSVE was obtained for each reconstitution. 
A toxicity experiment was conducted where RSVE were mixed with HL60 
cells and counted after one day to determine cell survival. 
RSVE (~g) HL60 Cells Volume (m!) Survival (%) 
50 107 10 90 
5 106 1 82 
10 5x105 .5 47 
10 5x105 .1 21 
230 
Transfection-
Six different preparations of transfected cells were prepared, 
RSVE( !!g) Cells 
Ex.l- 100 2.0 x 107 HL60 cells "Low ratio" 
Ex. 2- 75 7.5 x 106 HL60 cells "High ratio" 
Ex. 3- 10 7.5 x 105 Cos cells "Low ratio" 
Ex. 4- 20 7.5 x 105 Cos cells "High ratio" 
Ex. 5- 40 7.5 x loS Cos cells "High ratio" 
Ex. 6- 25 1.3 x 106 Cos cells "Low ratio" 
The "Low ratio" Cos cells were combined together during the processing for 
the luciferase assay. Top values in the table below are "High ratio" 
expression and lower values are "Low ratio" values. 25 III out of 1 ml cell 
extracts were measured for luciferase activity: 
30 second integration Cos cells HL60 cells 
RSV Promotor 337 107 
664 114 
SV40 Promotor 1753 119 
1361 118 
A negative control gave a value of 63. 
A positive control with a small sample of Cos cells transfected by 
electroporation gave a value of 2126. 
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(b) Experiment 2- 10.4 ~g of pSV2Lux DNA were loaded into .5 mg of 
Sendai virus with the optional addition of 10 ~g polylysine or 1 mg 
protamine. 50 ~g of reconstituted protein was added to 107 HL60 cells and 
20 ~g RSVE was added to 2.6 xl06 Cos cells. 25 ~I out of 1 ml of the 
cytoplasm extract was measured for luciferase activity: 
30 second integration Cos Cells HL60 Cells 
Naked DNA 36527 54 
+ Polylysine 141 57 
+ Protamine 1037 53 
A negative control with untransfected Cos cells gave a reading of 53. 
A positive control on a small quantity of Cos cells transfected by 
electroporation gave a reading of 1186. 
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(c) Experiment 3-
Four experiments were prepared in which 10 ~g SV2Lux DNA was loaded 
into RSVE, 
Sendai (mg) Protamine ( 1 mg) 
ex 1. .35* ..J 
ex 2. 1 X 
ex 3. 1 ..J 
ex 4. 2 ..J 
* Sucrose purified 
Cos cells were transfected with these samples. After measuring the 
luciferase activity in the various samples the activities were normalized for 
the amount of protein in each sample (the average 25 ~l aliquot of cellular 
extract contained 4-6 ~g of protein). The measured activity for 30 ~g of 
protein for 30 seconds, 
Activity 
Negative control 85 
Electroporated cells 2.3 x 105 






30 ~g of SV2Lux plasmid was loaded into 3.6 mg of Sendai protein with or 
without 3 mg protamine. 50 ~g of the RSVE protein was added to 107 HL60 
cells or U937 cells. 20 ~g of RSVE protein was added to 7xl05 Cos cells. 25 ~ 
out of 1 ml cellular extract was measured for luciferase activity with a 10 
second integration of released photons . Each of the experiments was 
performed in duplicate with the following averages being found for 
expression, 
Cos cells HL60 cells U937 cells 
Naked DNA 200 14 18 
+ Protamine 1600 18 16 
A negative control of untransfected Cos cells gave a reading of 16. 
A positive control of a small sample of electroporation transfected Cos cells 
gave an average value of 23,000. 
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(e) Experiment 5-
Three different plasmids containing different promo tors were loaded into 
RSVE. 21 Ilg of a plasmid containing the CMV early promotor was loaded 
into 2.1 Ilg of Sendai with 200 Ilg protamine. The same conditions were 
used for a plasmid containing the Lux gene under the CDM promotor 
(another CMV promotor). 10 Ilg of a third plasmid containing the Lux gene 
under the SV40 early promotor was loaded into .7 mg of Sendai with 66 Ilg 
of protamine. 107 HL60 cells, 107 U937 cells and 6 x 105 Cos cells were 
transfected with these RSVE. In an additional experiment RNA transcripts 
coding for the Lux gene were transfected into the cells using Dotma 
(Jipofection) . After extracting the cytoplasm from the cells and measuring 
the amount of luciferase activity (30 sec. integration) in each sample, protein 
measurements of the samples were made and the samples were normalized 
for 30 Ilg of protein. The following values were determined, 
Cos Cells U937 cells HL60 cells 
Blank 0 
Electroporation 1 x 106 
CMV Pro. 80 0 0 
CDMPro. 11,500 0 0 
SV40 Pro. 2400 
RNA, Dotma 600 100 60 
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Chapter 7: Conclusions 
As separate conclusions were included with each chapter they will not all be 
repeated here. I will present some of the answers I found to the questions 
asked in the introduction. 
Chapter 2-
How reliable are the available assays for membrane fusion? How can we 
describe the kinetics of fusion between virus and target cells? 
None of the fluorescent assays for membrane fusion are optimal. The 
definition of membrane fusion determines in part whether the data given by 
the assays are relevant. Transfer of lipids between adjacent bilayers can occur 
with or without actual connectivity being established between the internal 
compartments of the bilayers. The same viral glycoproteins which destabilize 
a target bilayer allowing a virus to fuse with that bilayer should also catalyze 
the transfer of lipids between bilayers, due to the hydrophobic domains in 
these glycoproteins. The exchange of lipids between bilayers is most likely a 
preliminary step to complete membrane fusion. Therefore fluorescent 
membrane probe assays are likely to report dequenching (usually interpreted 
as fusion) even when only exchange is occuring. Contents mixing assays will 
report fusion long after the membrane continuity between compartments is 
complete (in addition these content assays are problematic in altering 
membrane behavior). 
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Of the two primary probe assays used in this thesis, the RIB fluorescent 
assay is susceptible to spontaneous transfer of the probe between proximal 
membranes, but is the only available probe for labeling intact membranes. 
The NBD/Rd membrane fusion assay system has the advantage of using 
double chained lipid membrane anchors which are less susceptible to transfer 
processes. This assay system was used to study fusion when allowed. 
Second order bireactant and mass action type kinetic models were both 
suitable for fitting the dequenching curves given by the interaction of virus 
with cells. The activity of the virus and the maximum number of sites of 
interaction of the virus with the cell surface were determined experimentally 
by studying high virus to cell ratios (to determine saturation of sites) and 
high cell to virus ratios (to determine viral activity). In general, the assay 
method used had some effect on the character of the dequenching curve as 
the curves given by the NBD/Rd assay were of a sigmoidal character and were 
fit better with the mass action model, while those obtained with the RIB assay 
were more exponential in character and were fit better with a second order 
bireactant model. The general rate of reaction for Sendai or mumps virus 
with a target fusion site was approximately 3 x 109 M-Isec l . 
Chapter 3-
What is the optimal detergent for reconstitution? Can one reconstitute 
functionally active mumps? What happens to reconstituted virus when it is 
introduced into animal systems? 
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The products given by octyl glucoside detergent dialysis reconstitution 
were undesirable as any behavior exhibited by the reconstitute may be 
attributed to any of the three different reconstituted products, including 
protein aggregates. Triton X-lOa and C12E8 reconstitution products were 
better defined in size and character and exhibited all the glycoprotein 
properties of the native mumps and Sendai virus. A maximum fusion 
activity of ~30% was found for the reconstituted mumps vesicles, similar to 
that of the whole mumps virus. 
Animal studies with reconstituted Sendai and mumps virus showed 
that these vesicles acted very similar to liposomes in circulation behavior. 
Uptake of the "virosomes" occurred primarily in the reticuloendothelial 
system, i.e., liver and spleen. The uptake of the mumps by the brain of the 
hamsters was near background blood levels and too near the "noise" level of 
the assay to draw any conclusive positive results. As an experimental system 
it was unclear whether the animal model for mumps (newborn Syrian 
hamsters) had a complete blood brain barrier. The reconstituted vesicles had 
reasonable stability in serum and good circulation time in the blood. 
Chapter 4-
What are the fusion activities and kinetics of the mumps virus? What do 
these activities tell us about the neurotropism of the virus? 
The mumps virus was able to fuse with both erythrocyte ghosts and 
CV-l cells, with a temperature optimum of 37° C. The binding site for the 
virus apparently was sialic acid residues on cellular gangliosides. Greater 
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than 80% of the virus were active in binding activity. A larger number of 
virus were able to bind to an erythrocyte than were able to fuse with it, giving 
some indication that an additional fusion site may be necessary for 
membrane fusion. As the cell surface became crowded with virus some 
inhibition of the fusion process occurred. Overall the activities of mumps 
were very similar to Sendai virus. The virus interacted with the cellular site 
with a rate constant of ~4 x 109 M-lsec- l . 
Neurotropic and nonneurotropic strains of mumps are both able to 
penetrate as far as the ependymal cells of the CNS by crossing into the 
cerebrospinal fluid at the choroid plexus. The common cellular receptor of 
mumps, and ability of the virus to fuse with most cells, likely allows the 
virus to cross into the CNS by infection of the choroid plexus and subsequent 
budding into the cerebral spinal fluid. Propagation of virus into the neurons 
by virus-cell fusion may be difficult due to restricted diffusion of the virus 
into the neuronal interstitial spaces, while cell-cell fusion would allow 
infection of nearest neighbors and continued penetration of the neuronal 
matter. This hypothesis would explain why strains of mumps that are non-
neurotropic lack syncytial capacity while neurotropic strains are highly 
syncytial. 
Chapter 5-
Can reconstituted Sendai virus be used as a delivery vehicle to H9 and PBL 
cells, model cell lines for HIV infection? 
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Reconstituted Sendai virus was able to fuse with both H9 and PBL 
cells. The process could be blocked by competing for the binding site sialic 
acids with fetuin or by preventing fusion by cleaving the F protein of the 
RSVE with trypsin. A large number of fusion events were observed with 
each cell, for PBL approximately 2 ~g of viral protein were observed to fuse 
with 1 xI06 cells, equal to about 7,800 reconstituted virus per cell. 
Reconstituted virus may provide a method for drug delivery to cells. 
The ability of the reconstituted virus to maintain contents is critical to 
delivery. Radiolabeled ribozyme was effectively loaded into these vesicles 
without any degradation. There are a number of research opportunities 
available in continuing this project. 
Chapter 6-
How can one optimize the loadinl; of nucleic acids into the reconstituted 
Sendai viral envelopes? 
HL60 and Cos cells? 
Can reconstituted Sendai virus be used to transfect 
Under normal Triton X-IOO reconstitution conditions the 
encapsulation of plasmid size DNA into RSVE was very low, <1%. 
Polylysine, lysozyme and protamine greatly increased the amount of 
encapsulated material in the RSVE to between 3 and 10 %. This amount of 
encapsulated material is approximately equivalent to the amount one would 
expect to find for the encapsulation of a small, neutral molecule. 
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Transfection was feasible using the reconstituted virus with luciferase 
protein being expressed in Cos cells. The efficiency of transfection was no 
better than already available techniques. No expression was observed in HL60 
celis, experimental evidence supporting a hypothesis that material can be 




Appendix 1: Computer program used to perform mass action kinetic fitting 
on fluorescent data 
This program was originally written in the C language by David Baselt 
to fit STM data curves and modified by David to allow fitting to my 
fl uorescence curves. 
The Simulation loop subroutine listed at the end of the program can be 
varied to describe any number of kinetic schemes or equations. 





#define XMIN 22 
#define XMAX 618 
#define YMIN 62 
#define YMAX 458 
#define MIN]OSITION 1 
#define MAX]OSITION 20 
#define V AR]OSITION 40 
#define PRERUN 0 




float take_number(int yposition, int xposition, char choice); 
void scale(int interval); 
void optimize(void); 
void skip_line (FILE 'fin); 
void smooth(void); 
float sim_data[1000J, exp_data[1000), 'data, mult=41.0f; 
extern float k1, k2, k3; 
long far colors[)=( _BLACK, _BLUE, _GREEN, _CYAN, _RED, _MAGENTA, 
_BROWN, _LIGHTMAGENTA, _GRAY, _LIGHTBLUE, _LIGHTGREEN, 
_LIGHTCYAN, _WHITE, 
LIGHTRED, LIGHTYELLOW, BRIGHTWHITE}; - - -
int current_color = 1, reps; 
int i, x, xmin, xmax, input = 0, something_changed, points=1000; 
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float ymin, ymax, yoffse t, yfactor, xoffset, xfactor, new_value; 







printf("Final values: \ n"); 
printf("kl = %f\ n", kl); 
printf("k2 = %f\ n", k2); 
printf("k3 = %f\ n", k3); 
printf("M = %f\ n ", mult); 
printf("VO = %f x e-12 \ n", VO'le12); 




float sim_ymin, sim_ymax, exp_ymin, exp_ymax; 
_setvideomodeC VRES16COLOR); 
if (!_remapallpalette(colors» printf("\a"); 
_settextcolor(7); 
_setcolor(11); 
_rectangleCGBORDER, XMIN-2, YMIN-2, XMAX+2, YMAX+2); 
_setcolor(9); 
_settextposition(1 , 0); printf("STEP RESPONSE SIMULATION"); 
_settextposition(2, MIN]OSITION); printf("XMIN: 0_"); 
_settextposition(2, MAX]OSITION); printf("XMAX: 1000"); 
_settextposition(2, VAR]OSITION); printf("l: %6.3f ", k1); 
_settextposition(3, VAR]OSITION); printf("2: %6.3f ", k2); 
_settextposition(2, VAR_POSITION+20); printfr'3: %6.3f ", k3); 
_settextposition(3, VAR_POSITION+20); printf("M: %6.3f ", mult'.01); 
xmin = 0; xmax = 999; 
something_changed = 1; 
for (i=O; i<lOOO; i++) exp_data[i] = 0; 
exp_data[999] = 100; 
while (1) { 
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if (something_changed) ( 
exp_ymin = exp_ymax = exp_data[xmin]; 
sim_yrnin = sim_ymax = sim_data[xmin]; 
for (i = xmin+l; i < xmax+l; i++) ( 
if (exp_data[i] < exp_ymin) exp_ymin = exp_data[i]; 
else if (exp_data[i] > exp_ymax) exp_ymax = exp_data[i]; 
if (sim_data[i] < sim_ymin) sim_ymin = sim_data[i]; 
else if (sim_data[i] > sim_ymax) sim_ymax = sim_data[i]; 
} 
if (sim_ymin < exp _ymin) ymin = sim_ymin; 
else ymin = exp _ymin; 
if (sim_ymax > exp _ymax) ymax = sim_ymax; 
else yrnax = exp_ymax; 
if (ymax == ymin) yfactor = 1; 
else yfactor = (f]oat)(YMAX-YMIN)j(ymax-ymin); 
yoffset = YMAX+ymin'yfactor; 
xfactor = (floa t)(XMAX -XMIN) j (floa t)(xmax-xmin); 
xoffset = -xmin'xfactor+XMIN; 
_settextposition(3, MIN]OSITION); printf("YMIN: %8.2f 
_settextposition(3, MAX]OSITION); printf("YMAX: %8.2£ 
_setcolor(O); /* clear old plot' j 
", ymin); 
", yrnax); 
_rectangleCGFILLINTERIOR, XMIN-l, YMIN-l, XMAX+l, YMAX+l); 
if (yrnax > 0) ( 
_setcolor(11); 
_moveto(XMIN-l, yoffset); _lineto(XMAX+l, yoffset); /* zero line 'j 
} 
if «xmax-xmin) < 51) scale(1); 
else if «xmax-xmin) < 501) scale(10); 
else scale(20); 
_setcolor(9) ; 
_moveto(XMIN, yoffset-exp _ da ta[xmin]'yfactor); 




_moveto(XMIN, yoffse t-sim_ da ta[xmin]'yfactor); 




if (ch != '0' I I (ch=='o' && kbhitO» ( 
ch = getchO; 
if (ch == 0) ch = getchO; 
reps = 0; 
} 
something_changed = 0; 
if (ch == Ox4b I I ch == Ox48) ( r left arrow' / 
if (input == 1 I I input == 0) ( 
input = 0; 
_settextposition(2, MIN]OSITION + 12); printf("_"); 
_settextposition(2, MAX]OSITION + 12); printf(" "); 
} 
else if (input == 2) ( 
input = 1; 
_settextposition(2, MAX]OSITION + 12); printf("_"); 
_settextposi tion(2, V AR]OSITION + 1 0); printf(" "); 
} 
else if (input == 3) ( 
input = 2; 
_settextposition(2, V AR]OSITION + 10); printf("_"); 
_settextposition(3, V AR_POSITION + 10); printf(" "); 
} 
else if (input == 4) ( 
input = 3; 
_settextposition(3, VAR]OSITION+10); printf("_"); 
_settextposition(2, VAR]OSITION+30); printf(" "); 
} 
else if (input == 5) ( 
input = 4; 
} 
_settextposition(2, V AR_POSITION +30); printf("_"); 
_settextposition(3, V AR_POSITION +30); printf(" "); 
} 
else if (ch == Ox4d I I ch == Ox50) ( r right arrow' / 
if (input == 0) ( 
input = 1; 
_settextposition(2, MIN]OSITION+ 12); printf(" "); 
_settextposition(2, MAX_POSITION + 12); printf("_"); 
} 
else if (input == 1) ( 
input = 2; 
_settextposition(2, MAX]OSITION+12); printf(" "); 
_settextposition(2, VAR]OSITION+ 10); printf("_"); 
} 
else if (input == 2) ( 
input = 3; 
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_settextposition(2, VAR]OSITION+I0); printf(" "); 
_settextposition(3, VAR_POSITION + 10); printf("_"); 
l 
else if (input == 3) ( 
input = 4; 
_settextposition(3, VAR_POSITION+lO); printf(" "); 
_settextposition(2, VAR]OSITION +30); printf("_"); 
) 
else if (input == 4 I I input == 5) ( 
input = 5; 
_settextposi tion(2, V AR]OSITION +30); printf(" "); 
_se ttextposition(3, VAR]OSITION+30); printf("_"); 
) 
else if (ch == '5') saveO; 
else if (ch == 'p') ( 
smoothO; something_changed = 1; 
_settextposition(2, MAX_POSmON); printf("XMAX: %4i", xmax); 
l 




something_changed = 1; 
else if (ch == 'q') break; 
else if (ch == Oxlb); 
else if (ch == '0') ( 
optimizeO; 
reps++; 
something_changed = 1; 
) 
else if (ch == 'e') ( 
_setcolor(O); r clear old plot" / 
_rectangleCGFILLINTERIOR, XMIN-l, YMIN-l, XMAX+l, YMAX+l); 
if (ymax > 0) ( 
_setcolor(11); 
) 
_moveto(XMIN-l, yoffset); _lineto(XMAX+l, yoffset); /" zero line"/ 
l 
if «xmax-xmin) < 51) scale(1); 
else if «xmax-xmin) < 501) scale(10); 
else scale(20); 
else if (ch == OxOd); 
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else if (input == 0) ( 
if «new_value=take_number(2, MIN_POSITION+7, ch)) != -1) 
xmin=new _ value; 
something_changed = 1; 
) 
else if (input == 1) ( 
if «new_value=take_number(2, MAX_POSITION+7, ch)) != -1) 
xmax=new _value; 
something_changed = 1; 
) 
else if (input == 2) ( 
if «new _ value=take_number(2, V AR_POSITION+5, ch)) >= 0) 
kl=new _ value*le+9; 
else if (new_value == -2) k1 "= 1.1; 
else if (new_value == -3) kl /= 1.1; 
) 
_settextposition(2, VAR]OSITION); printf("I: %6.3f", kl/le+9); 
somethin~changed = 1; 
simulateO; 
else if (input == 3) ( 
if «new_value=take_number(3, VAR]OSITION+5, ch)) >= 0) 
k2=new_ value/100; 
else if (new_value == -2) k2 "= 1.1; 
else if (new_value == -3) k2 /= 1.1; 
) 
_settextposition(3, V AR_POSITION); printf("2: %6.3f", k2"100); 
something_changed = 1; 
simulateO; 
else if (input == 4) ( 
if «new_value=take_number(2, VAR]OSITION+25, ch» >= 0) 
k3=new _val ue/1 00; 
else if (new_value == -2) k3 "= 1.1; 
else if (new_value == -3) k3 /= 1.1; 
) 
_settextposition(2, VAR]OSITION+20); printf("3: %7.3f", k3"100); 
something_changed = 1; 
simulateO; 
else if (input == 5) ( 
if «new_value=take_number(3, VAR_POSITION+25, ch» >= 0) 
mul t=new _ value"IOO; 
else if (new value == -2) mult "= 1.1; 
else if (new_value == -3) mult / = 1.1; 
_settextposition(3, VAR]OSITION+20); printf("M: %6.3f", mult".OI£); 













_settextposition(1, VAR_POSITION); printf("Filename: "); 
scanf("%s", filename); 
if (!strstr(filename, "."» strcat(filename, ".gra"); 
fout = fopen(filename, "w"); 
for (i = 0; i < points; i++) fprintf(fout, "%f\n", sim_data[i]); 




char filename[35L c_dummy[80]; 
int i=O, j; 
float Cdummy; 
FILE "fin; 
_settextposition(1, V AR]OSITION); 
printf(" "); 
_settextposition(1, VAR]OSITION); printf("Filename: "); 
scanf("%s", filename); 
if (!strstr(filename, "."» strcat(filename, ".awa"); 
if «fin = fopen(filename, "r"» == 0) ( 
_settextposition(1, V AR]OSITION); 
prin tf(" "); 
_settextposition(1, V AR_POSITION); 
printf("Cannot open: %s", filename); 
return; 
} 
for (i=O; i<3; i++) skip_line(fin); 
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for (j=0; j<PRERUN; j++) fscanf(fin, "%f", &Cdummy); 
for (i=O; i<1000; i++) ( 
if (fscanf(fin, "%s", c_dummy)==EOF) break; 
if (strncmp(c_dummy, "END", 3)==0) break; 
sscanf(c_dummy, "%f", exp_data+i}; 
) 
fclose(fin) ; 
points = i; 
xmax = i-I; 
xmin = 0; 
_settextposition(2, MIN_POSITION); printf("XMIN: 0"); 
_settextposition(2, MAX_POSITION); printf("XMAX: %4i", xmax); 
_settextposition(1 , VAR]OSITION); 
printf(" "); 
_settextposition(1 , VAR_POSITION); printf("VO x e-12: "); 
scanf("%f", &VO); VO '= le-12; 
_settextposition(1, VAR_POSITION); 
printf(" "); 
_settextposition(1, VAR]OSITION); printf("GO x e-12: "); 
scanf("%f", &GO); GO '= le-12; 
_settextposition(1 , V AR]OSITION); 
printf(" "); 
_settextposition(1 , VAR]OSITION); printf("Loaded file: %s", filename); 
) 
float take_number(int yposition, int xposition, char choice) 
( 
int i, j; 
char number[10]; 
floa t result; 
i = 0; 
while (choice!= OxOd && choice!= Oxlb && choice!= '.' && choice!= 'f') ( 
if (choice == Ox08) ( /. backspace • / 
i -= 1; 
if (i < 0) i = 0; 
_settextposi tion(yposi tion, xposi tion-2); printf(" "); 
_settextposition(yposition, xposition-i+5); 
for (j=O; j < i; j++) printf("%c", number[jl); 
) 
else if ( «choice>47) && (choice<58» I I choice=='.' I I choice=='-') ( 
number[i] = choice; 




for (j=O; j < i+l; j++) printf("%c", number[j»; 
i++; 
choice = getchO; 
} 
number[iJ = '\0'; 
if (choice == Oxlb) result = -1; r escape = cancel' / 
else if (choice == " ') result = -2; 
else if (choice == '/') result = -3; 
else if (!sscanf(number, "%f", &result» ( result = -1; printf("\a"); } 
return result; 
void scale(int interval) 
( 
in t posi tion; 
_setcolor(11); 
for (position = xmin; position < xmax+l; position+=interval) ( 
_moveto(position 'xfactor+xoffset, YMAX+ 1); 
_lineto(posi tion 'xfactor+xoffset, YMAX -4); 
if «intervakl0 && position%10==O) I I position%100==O) 
_lineto(position'xfactor+xoffset, YMAX-9); 
_moveto(position 'xfactor+xoffset, YMIN-l); 
_lineto(posi tion 'xfactor+xoffset, YMIN +4); 
if ((intervaklO && position%10==O) I I position%100==O) 
_lineto(posi tion 'xfactor+xoffset, YMIN +9); 
void optimize( void) 
( 
float offspring3rray[ 4], best_array[4], original_array[4], mutation_value; 
float avg, std_dev, best_std_dev, sd_dif, 'data, rand_max, r; 
int i, j, x, dummy_direction, dummy _data_type, dummy_mode; 
original_array[OJ = offsprin~array[OJ = kl; 
original3rray[IJ = offsprin~array[lJ = k2; 
original3rray[2J = offspring_array[2J = k3; 
original3rray[3J = offspring_array[3J = mult; 
for (i=0; kl0; i++) ( 
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if (i>0) ( 
for (j=0; j<4; j++) r generate mutations * / 
offspring_array[jl = «(float)randO / rand_max)*0.191f + 
0.909f)*originai_array[j]; 
kl = offspring_array[O]; 
} 
k2 = offspring3rray[l]; if (k2 > 1.0f) k2 = 1.0f; 
k3 = offspring_array[2]; if (k3 > 1.0f) k3 = 1.0f; 
/* muit = offspring_array[3]; * / 
} 
simuiateO; 
data = sim_data; 
std_dev = O.Of; 
for (x=xmin; x<xmax; x++) ( 
sd_dif = sim_data[x]- exp_data[x]; 
if (sd_dif < 0) sd_dif *= -1; 
. std_dev += sd_dif; 
} 
if (std_dev<best_std_dev I I i==O) ( /* see if it's the best so far * / 
best_std_dev = std_dev; 
} 
for (j=O; j<4; j++) best_array[j] = offspring_array[jl; 
} 
kl = best_array[O]; 
k2 = best_array[I]; if (k2 > 1.0f) k2 = 1.0f; 
k3 = best_array[2]; if (k3 > 1.0f) k3 = 1.0f; 
/* mult = best_array[3]; * / 
_settextposition(2, VAR]OSmON); printf("I: %6.3f ", kl/le+9); 
_settextposition(3, V AR]OSITION); printf("2: %6.3f ", k2*100.0f); 
_settextposition(2, V AR]OSITION+20); printf("3: %7.3f ", k3*100.0f); 
_settextposition(3, VAR_POSmON +20); printf("M: %6.3f ", muit*.010f); 
_settextposition(I, V AR]OSITION); 
printf("Pass: %3i Std dey: %6.3f ", reps, best_std_dev /(xmax-xmin»; 
void skip_line (FILE *fin) 
( 
int ch; 




int i, j; 
for (j=O; j<2; j++) { 
for (i=0; i<points; i++) 
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exp_data[ij = (exp_data[ij + 2*exp_data[i+lj + exp_data(i+2])*0.25; 
points--; xmax--; 
I 
/* SIMULA nON PROGRAM * / 
extern float sim_data[lOOOl, VO, GO, mult; 
extern in t poin ts; 





float vg=O, f=O, dvg, df, v, g; 
for (i=0; i<1000; i++) sim data[ij = 0; 
v = VO; g = GO; 
for (i=O; i<points; i++) ( 
dvg = kl *v*g - k2*vg - k3*vg; 
df = k3*vg; 
vg += dvg; 
f += df; 
v = VO - vg - f; 
g = GO - vg - f; 
sim_data[ij = mult*f/VO; 
I 
